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ABSTRACT 
The gene for yeast tRN A ligase has been sequenced and its transcription start sites 
have been mapped. Three other open reading frames in the vicinity of the tRNA ligase 
gene were characterized. One open reading frame, ORF4, is the yeast ARG3 gene. ORFl 
is probably not transcribed or translated in yeast. ORF2 is an unidentified but essential 
gene in yeast. 
A deletion of the central 200 amino acids has been engineered in the ligase protein. 
This deletion protein, designated DAC, was characterized in the in vitro tRNA splicing 
reaction with regard to the structure of the joined tRNA product. Cofactor requirements for 
tRNA joining activity and polynucleotide kinase activity were also determined. DAC 
possesses a GTP-dependent joining activity that is not manifested by wild-type ligase. In 
addition, both the wild-type and DAC proteins exhibit polynucleotide kinase activities that 
are more efficient with GTP than with ATP. Joining reactions with wild-type ligase 
indicate that joining of tRNA halves is more efficient in the presence of both GTP and ATP 
than with either cofactor alone. Wild-type tRNA ligase can incorporate they-phosphate of 
GTP into the splice junction of joined tRNA, but only when A TP is also provided. The 
ligase protein contains two distinct nucleotide triphosphate binding sites- one specific for 
GTP and one specific for ATP. A revised mechanism for tRNA splicing in yeast is 
presented. 
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INTRODUCTION 
Transfer RNAs, or tRNAs, have long been studied as a means of understanding the basic 
translation mechanism for cellular proteins, as they are responsible for interacting with the 
ribosome and the messenger RNA to attach amino acids to the growing polypeptide chain. 
Goodman et al. (l) and Valenzuela et al. (2) independently discovered that genes coding for 
functional yeast tyrosine and phenylalanine tRNAs, respectively, contained a sequence 
within the DNA called an intron which was not present in the mature functional tRNA 
transcript. These introns would have to be removed from the precursor tRNA (pre-tRNA) 
in order to form the functional product; a process termed tRNA splicing (for a review, see 
3). Many other steps are involved in the maturation of pre-tRNAs, including removal of 
the 5' leader and 3' trailing sequences (for a review, see 4), tRNA base modifications (5), 
and, in eukaryotes, addition of the CCA amino acid acceptor sequence to the 3' end of the 
tRNA (4). The subject of this discussion will be based primarily on tRNA splicing in yeast 
- the enzymes involved in removing the introns to form the mature tRNA, interactions 
between these enzymes and their tRNA substrates and cofactors, yeast mutants which have 
proven to have a direct effect on the splicing enzymes in vivo, and comparisons to tRNA 
splicing systems from other organisms. 
It is estimated that there are approximately 360 tRNA genes in yeast (6) . Of the 
predicted 46 different tRNA species, ten isoacceptors are now known to contain introns. 
These isoacceptors are represented by a documented minimum of 45 gene copies. If there 
is an average of eight gene copies per tRNA species (6), then approximately 80 tRNA 
genes, or about one-fifth of the genes in yeast, contain introns. 
3 
History of tRNA Splicing 
A temperature sensitive mutant in Saccharomyces cerevisiae, rna], accumulates precursor 
tRNAs as well as other RNA intermediates when shifted to the nonpermissive temperature · 
(7). This mutation was instrumental in paving the way for future research in tRNA 
splicing. Knapp et al. (8) isolated intron-containing pre-tRNAPhe and pre-tRNATyr from 
rna] cells and used them to screen wild-type yeast extracts for an activity involved in tRNA 
splicing. The ribosomal wash fraction of cell-free yeast extracts, as well as yeast nuclear 
extracts, were found to contain activities which excised the intron and joined the two tRNA 
halves to form the mature tRNA (8, 9). The splicing reaction was shown to occur in two 
major stages, separable by the absence or presence of ATP in the in vitro splicing assay 
( 10) . Pre-tRNA treated with soluble yeast extract in the absence of added ATP 
accumulated as tRNA half-molecules and excised intron. The tRNA halves were purified 
and could subsequently be joined to form mature-length tRNA upon the addition of ATP. 
This result indicated that the joining step was not necessarily coupled to the cleavage step in 
vitro (10). Analysis of the structure of the splicing intermediates revealed the 5' half tRNA 
to be phosphorylated at its 3' end (11), and this structure was shown to be a 2' ,3' -cyclic 
phosphate (12) . The presence of this phosphate moiety was required for ligating the two 
tRNA halves (11). The 3' half tRNA possessed a 5' -hydroxyl. The excised intron proved 
to be linear rather than circular, with a phosphate at its 3 '-end and a hydroxyl at its 5' -end, 
identical to the cleavage termini of the tRNA halves (11). The structure of these 
intermediates added further support for a splicing pathway which proceeds by two 
separable enzymatic steps - cleavage of the precursor at the boundaries of the mature 
sequence to release the intron, followed by joining of the two tRNA halves (10). 
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Enzymes of Yeast tRNA Splicing 
Yeast tRNA Splicing Endonuclease 
The two steps of tRNA splicing could now be examined independently in yeast extracts in 
order to further purify the components for cleavage and joining. The endonuclease activity 
was separated from the ligase activity by nonionic detergent extraction of yeast membrane 
preparations, a method which indicated that the endonuclease behaves as an integral 
membrane protein during purification (12). This partially purified endonuclease fraction 
did not demonstrate any appreciable ligase activity, although a 2 ' ,3' -cyclic 
phosphodiesterase activity was detected (12). Though the endonuclease has previously 
proven refractory to purification, it has now been purified to homogeneity (13) and creates 
the same termini at the cleavage sites as described above. It does not possess any 
appreciable phosphodiesterase activity. The enzyme consists of three polypeptide subunits, 
a, ~. andy, of 31, 42, and 51 kDa, respectively. Glycerol gradient sedimentation and gel 
filtration analysis show the .endonuclease exists as a heterotrimer of these three subunits. 
The powerful methods of yeast genetics have been used to identify mutants 
defective in pre-tRNA cleavage. Two unlinked recessive mutations, senl-1 and sen2-l , 
were identified from a collection of temperature sensitive mutants (14) by testing yeast 
nuclear mini-extracts of strains grown at the permissive temperature for temperature 
· sensitive in vitro pre-tRNA cleavage (15). The senl-1 mutation is temperature sensitive for 
growth, and exhibits defective endonuclease activity in vitro and accumulates uncleaved 
pre-tRNAs in vivo at both the permissive and nonpermissive temperatures. The SEN I 
gene has been isolated and shown to complement the senl-1 defect in vivo (16). SEN I is 
essential for growth in yeast and the sequence codes for a 239 kDa protein of the same size 
·as the SENl protein detected by Western blot. The amino-terminal region of the SENI 
gene corresponding to approximately 100 kDa of the protein can be deleted and is not 
essential in yeast. The sen I-1 lesion has also been isolated and sequenced and the mutation 
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is a single nucleotide change resulting in substitution of an aspartic acid for a glycine 
residue. This lesion is located in the carboxy-terminal essential region of SEN 1 and 
changes a glycine residue which is conserved in a region of two other proteins with 
sequence similarity to SENJ, mouse Mov-10 protein and yeast UPF 1 protein (16). The 
functions of these two proteins are unknown, however upfl cells are involved in the 
messenger RNA degradation pathway in yeast ( 17). 
The sen2-1 mutation exhibits defective endonuclease activity in vitro at the 
nonpermissive temperature, however, it is not temperature sensitive for growth and does 
not accumulate pre-tRNAs at either the permissive or nonpermissive temperatures (15). 
Yeast extracts from a senl-11 sen2 -1 heterozygous diploid show wild-type endonuclease 
activity in the in vitro assay at all temperatures tested, as would be expected for the 
complementation of two unlinked mutations. However, mixing of separate extracts from 
senl-1 and sen2-1 strains grown at the permissive temperature do not complement the 
sen2-1 thermosensitive in vitro phenotype. The defects in tRNA endonuclease activity of 
both senJ-1 and sen2-1 extracts cofractionate with endonuclease during partial purification, 
suggesting a direct enzymatic role in endonucleolytic cleavage of pre-tRNA for these two 
gene products. 
A different collection of temperature sensitive yeast mutants (18) was screened for 
defective tRNA splicing by hybridizing RNA prepared from the strains grown at the 
nonpermissive temperature to an intron-specific probe (19). This assay revealed a strain, 
tsa373, which accumulates a splicing intermediate consisting of the 5' -half tRNA still 
joined to the intron, termed a pre-tRNA splicing "2/3" intermediate. The tRNA 
endonuclease defect of tsa373 is recessive and does not cosegregate with the original 
temperature sensitive phenotype. However, the growth rate of tsa373 is reduced at low 
temperatures (15 °C) compared to wild-type, and this pseudo-cold sensitive phenotype is 
linked to the in vivo accumulation of "2/3" molecules. 
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A tsa373/sen2-l heterozygous diploid displays the in vivo accumulation of the 
"2/3" molecule as well as the in vitro thermosensitive splicing defect of the sen2-l allele. 
This result suggests that the two genes are closely linked and both mutations are presumed 
to be allelic. Thus tsa373 has been designated sen2-3 as the third identified allele of SEN2. 
The sen2-3 strain contains a substantial amount of spliced tRNATyr as well as the "2/3" 
intermediate. It was concluded that the lesion probably does not completely block 
endonucleolytic cleavage at the 5' -splice site, and allows enough complete splicing activity 
to permit growth at normal temperatures (19). 
Yeast tRNA splicing endonuclease was purified from the sen2-3 strain and shown 
to have identical chromatographic properties as the wild-type enzyme (19). The SEN2 
gene has been isolated and complements the sen2-3 defect in vivo, and immunological 
studies have indicated that the SEN2 gene codes for the 42 kDa ~-subunit of tRNA splicing 
endonuclease (unpublished results, cited in 13). 
Since antibodies to the SEN1 protein do not crossreact with purified endonuclease, 
it is unlikely that SEN I codes for either the a- or y-subunits of endonuclease. Current 
experiments are addressing the issue of whether the SEN1 protein interacts directly with the 
endonuclease in a splicing complex, or is a positive effector of other cellular processes 
affecting endonuclease production or localization (16). 
Yeast tRNA Ligase 
The separation and partial purification of the tRNA ligase responsible for the second step of 
tRNA splicing was accomplished by a high salt extraction of a soluble fraction of yeast 
extract followed by several chromatographic ~teps (20). A polynucleotide kinase activity, a 
cyclic phosphodiesterase activity, and the ligase activity all copurified with a protein which 
could be adenylylated with [a-32P]ATP. Adenylylated protein releases its AMP under 
conditions where splicing is allowed to proceed (i.e., adding pre-tRNA half substrates). 
The ligation product contains·a 2' -phosphomonoester, 3' ,5' -phosphodiester linkage at the 
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splice junction. The externally-derived y-phosphate of ATP was incorporated at the 3 '-5' 
phosphodiester bond of this splice junction (20). 
A model was proposed for tRNA splicing which addresses the above enzyme 
activities, and considers the observed structure of the termini of the two tRNA halves 
created by endonuclease cleavage (20). The 2' ,3' -cyclic phosphate of the 5' -half tRNA is 
opened to a 2' -phosphate by the 2' ,3' -cyclic phosphodiesterase activity; the 5' -hydroxyl of 
the 3 '-half tRNA is phosphorylated by the polynucleotide kinase activity; the protein is 
adenylylated and transfers its AMP residue to the 5'-phosphate of the 3' -half tRNA; and 
ligase joins the two tRNA halves with the concomitant release of AMP. Final tRNA 
products still retain a 2' -phosphate at the splice junction. 
Yeast tRNA ligase was further purified to homogeneity using tRNA affinity elution 
from heparin-agarose, and antibody was prepared against the protein (21). The protein is a 
single polypeptide of approximately 90 kDa and exhibits all the activities proposed for 
ligase in the splicing model. An intermediate of the splicing reaction containing an AMP 
residue covalently linked to the 5' -phosphate of the 3' -half tRNA was also detected during 
assays for these activities. This was expected from the predicted splicing mechanism. 
The amino-terlninal sequence of the purified protein was obtained and the gene was 
isolated by screening a yeast DNA library for this sequence (21) . The gene was placed 
under control of the GALl 0 promoter region of yeast, and a yeast strain harboring this 
plasmid overproduces tRNA ligase activity 25-fold over wild-type when grown on 
galactose. In addition, tRNA ligase can be overproduced in E. coli when expressed from a 
vector with an E. coli promoter. The gene for yeast tRNA ligase (RLGJ) was sequenced 
and the in vivo transcription start sites were mapped (22). The gene is uninterrupted by 
intervening sequences and codes for an 827 amino acid basic protein of approximately 95 
kDa. 
Protease resistant fragments of the tRNA ligase polypeptide were detected during 
purification from E. coli (23). Three of these fragments were shown to contain only some 
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of the activities of intact tRNA ligase (24). These fragments, of 65, 40, and 25 kDa, were 
further purified and amino-terminal protein sequence data were obtained. Both the 65 kDa 
and 40 kDa fragments are from the amino-terminus of ligase, and the 25 kDa fragment is 
C-terminal. Only the 25 kDa fragment still retains 2' ,3 '-cyclic phosphodiesterase activity. 
Both the 40 kDa and 65 kDa fragments can be adenylylated. Protease digestion of an 
adenylylated intact ligase polypeptide followed by fractionation of the peptides and mass 
spectrometry identified lysine-114 as the site of adenylylation (24). The region 
surrounding this lysine-114 is similar in sequence to the region surrounding the lysine-99 
of T4 RNA ligase implicated in the phage T4ligase adenylylation reaction (24-26). 
These results suggest that the tRNA ligase protein consists of distinct enzymatic 
domains, each responsible for a specific activity involved in the joining step of tRNA 
splicing. A structural and functional analysis of tRNA ligase was undertaken to attempt to 
define these domains and the activities they exhibit. A set of ligase gene deletions was 
fused to E. coli dihydrofolate reductase to facilitate protein purification from E. coli (25). 
Detailed enzymatic analyses of these purified deletion polypeptides confirmed some 
previous results as well as revealing new information. 1) An approximately 43 kDa 
amino-terminal fragment of ligase is sufficient for adenylylation of the protein. 2) An 
approximately 28 kDa C-terminal fragment is sufficient for cyclic phosphodiesterase 
activity. 3) Pre-tRNA substrate binding could not be directly correlated with a single 
domain, but rather appeared to be associated with any two of the domains, implying that 
the substrate binding site might consist of more than one component along the linear 
peptide sequence. 4) Polynucleotide kinase activity could only be demonstrated for a large 
fragment containing the C-terminal431 amino acids of ligase. 5) Surprisingly, a deletion 
construct missing the center 200 amino acids of ligase (designated "DAC") was able to join 
tRNA halves efficiently in vitro to form mature tRNA of the correct structure (25). This 
centrally-deleted ligase construct demonstrated the ability to join tRNA halves in the 
presence of GTP alone, a novel activity not found in wild-type ligase (S. K. Westaway, 
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H. G. Belford, B. Apostol, J. Abelson, and C. Greer, Journal of Biological Chemistry, in 
press). This result led to the discovery that both DAC and the full-length wild-type ligase 
fusion possessed a GTP-dependent polynucleotide kinase activity . Further experimentation 
demonstrated that the full-length DHFR/tRNA ligase protein incorporated radiolabel from 
[y-32P]GTP into the 3' ,5' -phosphodiester bond at the splice junction of tRNA only when 
incubated with ATP. A modified mechanism for tRNA splicing was proposed in which 
wild-type tRNA ligase would preferentially use GTP for the polynucleotide kinase step and 
reserve ATP for the subsequent adenylylation and ligation steps. This mechanism is 
supported by earlier results that the tRNAjoining activity required two molar equivalents of 
ATP (Greer et al., 1983), and by the results of nucleotide binding and competition assays. 
The competition assays demonstrated the presence of two distinct NTP binding sites in the 
ligase protein - one specific for GTP and one specific for ATP (H. G. Belford, S. K. 
Westaway, J. Abelson, and C. L. Greer, Journal of Biological Chemistry, in press). 
The deletion construct described above (DAC) is capable of joining tRNA halves in 
vitro, but has not been shown to complement a ligase-deficient yeast strain in vivo (Mark 
Berlin, personal communication). This result is supported by previous results that either a 
large insertion (27) or a large deletion (28) in the ligase gene is lethal to the cell. Yeast 
tRNA ligase is a single copy gene and is essential in yeast, as would be expected for an 
enzyme directly involved in the splicing of essential tRNAs. 
New genetic studies have uncovered two temperature sensitive yeast mutants in the 
tRNA ligase gene, designated rlg 1-4 and rlg 1-10 (28). Both mutant genes have been 
isolated and sequenced and code for a single amino acid substitution within the amino-
terminal region of ligase. These lesions probably confer the temperature sensitive 
phenotype. As expected, neither of these temperature sensitive mutations are at the lysine-
114 adenylylation site. Any amino acid substituted at lysine-114 (other than perhaps 
arginine) should result in a protein incapable of adenylylation and therefore unable to 
complete the tRNA joining process at any temperature. Phizicky et al. (28) discovered that 
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tRNA half molecules and introns accumulate not only in rlg 1-4 and rlg 1-10 when shifted to 
the nonpermissive temperature, but also in a strain conditionally expressing tRNA ligase 
when grown under nonexpressing conditions. This is expected for a mutation in tRNA 
ligase, as tRNA splicing endonuclease should still be fully functional in cleaving pre-
tRNAs, and uncut pre-tRNAs should not accumulate. 
The versatility of mutagenesis in the genes for tRNA ligase (RLG1) and the~­
subunit of endonuclease (SEN2) encourages further examination of potential mutant 
proteins and their structural and enzymatic properties in vitro. Possession of both tRNA 
splicing endonuclease and tRNA ligase point mutants also permits a search for extragenic in 
vivo suppressors of these mutations, leading perhaps to the elucidation of other elements 
involved in the organization of nuclear tRNA splicing in yeast. 
NAD-Dependent 2' -Phosphotransferase 
As previously described, ligation of the two tRNA halves by purified yeast tRNA ligase 
results in a 2' -phosphomonoester, 3' ,5' -phosphodiester bond at the splice junction of 
joined tRNA. Removal of this 2' -phosphate must occur subsequent to tRNA joining, as 
mature yeast tRNAs do not contain a 2' -phosphate at the splice junction. An activity which 
specifically removes this internal 2' -phosphate was partially purified from yeast extracts by 
chromatography followed by reconstitution of specific flowthrough fractions with eluted 
fractions (29). This result indicated that the 2' -phosphatase activity was composed of two 
separate components of yeast extracts. 
The 2' -phosphatase activity prefers ~n authentic tRNA substrate over an eight-
nucleotide oligomer with an internal. 2' -phosphate, and has no phosphatase activity on 3'-
or 5' -phosphates (29). This result is opposite to that obtained with a nonspecific 
phosphatase. Experiments imply that the 2' -phosphatase, like the tRNA ligase and 
endonuclease, is specific for a subset of tRNAs, in this case those containing an internal 2'-
phosphate. Further purification of component I and II of this phosphatase activity has 
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revealed that component I is most likely NAD+ (30). Component I is highly heat stable 
and resistant to micrococcal nuclease, inferring that it is neither protein nor RNA. Gel 
filtration indicates that component I is a small molecule close in size to ATP, and 
experiments with the phosphatase reaction show it is not a divalent cation. Only NAD+ can 
substitute effectively for component I in the 2 ' -phosphatase assay, and component I 
cochromatographs with NAD+ on a C 18 column. 
Interestingly, the 2' -phosphate from the splice junction is not released as free 
phosphate, as might be predicted for a solitary protein carrying out a phosphate hydrolysis 
reaction . Instead, the 2' -phosphate is transferred to an acceptor molecule, whose 
chromatographic properties differ from NADP+, a product which would be expected from 
a phosphotransfer reaction involving NAD+. It has also been shown that the partially 
purified phosphatase activity does not have the properties of NAD+ kinase. McCraith and 
Phizicky (30) speculate that the acceptor molecule may be NAD+ with the phosphate 
transferred to a position other than the 2' -hydroxyl of NAD+. Recently, a similar NAD+-
dependent 2' -phosphotransferase activity has been discovered in extracts from both HeLa 
cells and Xenopus oocytes (31, 32). 
Removal of the 2' -phosphate from the ligated tRNA is the last step specific to the 
tRNA splicing pathway of intron-containing pre-tRNAs. Since the splice junction of 
mature tRNA is located only one base 3' to the anticodon in mature tRNA, the presence of 
a 2' -phosphate in an incompletely processed tRNA might sterically interfere with mature 
tRNA function in vivo. This interference might involve preventing essential post-splicing 
modifications of nucleotides in or near the tRNA anticodon, or inhibiting the association of 
the tRNA with either the cognate aminoacyl tRNA synthetase or the ribosomal translation 
machinery. For this reason, it is conceivable that genetic analysis of yeast mutants might 
reveal a mutation in component II of the 2' -phosphotransferase activity which would 
accumulate spliced tRNA still retaining the 2' -phosphate at the splice junction. It will be 
interesting to follow future discoveries of the identities of the phosphate-acceptor molecule 
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and of component II, and how these factors interact with the rest of the cellular splicing 
machinery. 
Protein-Protein Interactions Among tRNA Splicing Enzymes 
During the original assay for splicing activities, other important features of precursor tRNA 
processing began to emerge. Knapp et al. (8) showed that intron-containing pre-tRNAs 
which accumulated in the rna] strain at the nonperrnissive temperature possessed some 
modified nucleosides, while other base modifications were absent. In addition, none of the 
pre-tRNAs still retained 5' leader sequences, and all had 3'-end CCA termini. Apparently, 
5' and 3' end processing had already occurred as well as post-transcriptional addition of the 
uncoded CCA acceptor. This result suggested that there was a temporal order for 
processing of pre-tRNAs, and that splicing was a late step in the processing pathway. 
Difficulty in fractionating nuclei from cytoplasm in the yeast system has 
complicated the unequivocal assignment of a cellular location for the three enzymes 
involved in tRNA splicing. However, early in vivo studies in Xenopus oocytes provided 
compelling evidence that the splicing machinery was located in the frog nucleus. By 
injecting yeast tDNA Tyr into both nuclear and cytoplasmic compartments of Xenopus 
oocytes, a generic order was defined for the steps in tRNA processing, and it was 
demonstrated that removal of introns occurs in the nucleus, at least in Xenopus (33). The 
consecutive order for processing nuclear tRNA transcripts in Xenopus appears to be: 1) 5' 
leader trimming accompanied by some base modifications; 2) removal of the 5' leader, the 
3' trailer, and addition of the CCA terminus, accompanied by further base modifications; 
3) removal of the intron and splicing of the two tRNA halves; and 4) transport of the 
mature tRNATyr from the nucleus to the cytoplasm, accompanied by final base 
modifications (33). Though the splicing step occurs late in the maturation pathway, these 
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results suggest it is still completed in the nucleus prior to transport of the tRNA to the 
cytoplasm. 
The nuclei in Xenopus oocytes have been fractionated into nuclear envelope and 
nucleoplasm, and the Xenopus endonuclease activity is associated only with the soluble 
fraction (34). This nuclear fractionation has not been accomplished in yeast. However, in 
contrast to Xenopus fractions, yeast tRNA splicing endonuclease behaves as an integral 
membrane protein during purification (12). 
The ability to separate the enzymatic steps of tRNA splicing in vitro and the 
observation that pre-tRNA splicing intermediates can be detected in normal yeast cells (35) 
might lead to the assumption that the splicing enzymes act independently in vivo. Evidence 
to the contrary emerged from in vitro competition assays with yeast tRNA splicing 
endonuclease, yeast tRNA ligase, T4 RNA ligase, and T4 polynucleotide kinase (36). The 
T4 enzymes are able to ligate tRNA halves produced by yeast tRNA splicing endonuclease, 
but the product tRNA has a different structure from that of the yeast ligase reaction (37). 
Analysis of product ratios in competition assays revealed that yeast ligase has preferential 
access to the products of endonuclease cleavage (36). This preference is evidence for the 
assembly of a splicing complex of ligase and endonuclease and/or pre-tRNA in vitro. This 
result is curious in that it suggests that other proteins may not be necessary in vivo for the 
assembly of a concerted splicing apparatus. 
The purification of tRNA ligase and preparation of anti-tRNA ligase antibody have 
enabled cytological studies to determine the cellular location of tRNA ligase. Immune 
fluorescence and immune electron microscopy have localized tRNA ligase to the inner 
membrane of the nuclear envelope, possibly associated with nuclear pores (38). The ligase 
protein also appears to be positioned at a second location, 100-200 nm into the 
nucleoplasm. It has also been shown that tRNA ligase binds precursor tRNA in vitro (39). 
Yeast ligase can be crosslinked to pre-tRNA (40). The sites of one minor and two major 
crosslinks occur in the intron of the pre-tRNA, either near the anticodon-intron stem or 
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surrounding the single-stranded region of the 3 '-splice site. Based on these results, a 
spatial model for splicing complex formation in vivo was proposed (38, 40; Chris Greer, 
personal communication). The tRNA ligase at its intranucleoplasmic location might bind 
5'- and 3' -processed intron-containing pre-tRNA, move to the nuclear envelope acting as a 
substrate "shuttle," form a complex with the pre-tRNA, endonuclease, and other splicing 
machinery, and allow splicing to proceed. Upon completion of the ligation reaction, tRNA 
product would be released, presumably to be transported to the cytoplasm through the 
nuclear pore. Ligase would also be released from the complex to return to its intranuclear 
depot. This model should involve some sort of conformational transition in either tRNA 
ligase polypeptide or in the endonuclease subunit which may interact with ligase, in order 
to dissociate upon completion of the splicing reaction. 
A yeast strain containing a large deletion (457 amino acids) of the tRNA ligase gene 
accumulates tRNA halves when production of the wild-type plasmid copy of ligase is 
conditionally repressed (28). If tRNA ligase were the only mechanism by which pre-
tRNAs could be transported to the splicing apparatus at the nuclear envelope, then one 
might at first expect that such a large deletion in the protein would render the enzyme 
incapable of its proposed pre-tRNA shuttling function, as well as its ligase function. This 
should result in the accumulation of precursor tRNAs, and not tRNA halves. However, 
several different large deletions of the tRNA ligase protein are still competent at pre-tRNA 
binding in vitro (25). Therefore, even a large deletion of tRNA ligase may still be capable 
of functions other than the final ligation step in vivo. 
A physical association between tRNA ligase and endonuclease has not yet been 
emphatically demonstrated. However, ATP-independent in vitro stimulation of 
endonuclease activity by the presence of tRNA ligase and preferential access of ligase over 
T4 enzymes to tRNA halves are good evidence for a complex of the enzymes in vivo. In 
this respect, it will be interesting to discover which of the three endonuclease subunits and 
what region of tRNA ligase may be involved in endonuclease-ligase interaction. The yeast 
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NAD+ -dependent 2' -phosphotransferase activity has been shown to be specific for internal 
2' -phosphates, and would not be expected to act on the phosphate termini of unligated 
tRNA halves. This activity would interfere with the splicing reaction. Therefore it is 
conceivable that the dephosphorylating enzyme also resides near the nuclear membrane or 
nuclear pore in a complex with endonuclease or ligase, awaiting its final role in the tRNA 
splicing pathway (32). 
tRNA Splicing Substrates and Interactions with the Splicing Enzymes 
Ten isoacceptor species of pre-tRNA in yeast contain introns, comprising 45-80 gene 
copies. These tRNAs are listed in Table 1 (data compiled from 6, 41-43). 
Table I List of Yeast tRNA Precursors Containin~ Introns . 
tRNAa Intron (nt} # Genes 
tRNASerGCU 19 3 
tRNATyr 14 8 
tRNAPhe 18, 19 10 
tRNALysUUU 23 N.D.b 
tRNAProUGG 28,31 5 
tRNATrp 34 ~4 
tRNASerCGA 19 1 
tRNALeuUAG 19 N.D.b 
tRNALeuCAA 32, 33 ~10 
tRNAIIeUAU 60 2 
atRNAs are identified by the unmodified sequence of their anticodons. 
bN.D., not determined. 
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It is evident that since many species of yeast precursor tRNAs do not contain 
introns, the presence of an intron cannot be required for other tRNA processing steps. 
However, the observation that yeast tRNA ligase is an essential gene in yeast is supported 
by the fact that there has been only one isoaccepting species found for each of tRNAPhe, 
tRN A Trp, and tRNATYr, and all genes for these tRNAs contain introns . In addition, a 
minor but nonetheless unique species of serine-accepting tRNA (tRNASercaA) is single 
copy in yeast and contains an intron. 
It is clear from Table I that pre-tRNA introns differ in size, however, lengths and 
nucleotide sequences are very similar among tRNAs within a single family. The sequences 
of introns show no similarity between families, but it is important to note that they are all 
positioned alike within the precursor (i.e., one base downstream of the anticodon (41)). 
The next logical step was to examine how a subset of precursor tRNAs with introns 
might interact with splicing enzymes. These enzymes should normally be outside the 
pathway of pre-tRNA processing for intronless tRNAs. Experiments addressing this issue 
have largely centered on testing the fidelity of splicing using altered tRNA substrates. It is 
beyond the scope of this discussion to detail all the substrates which have been tested (for a 
more comprehensive review, see 44). However, general points can be made to present an 
emerging picture of the recognition signals required by the substrate for accurate splicing. 
Introns in pre-tRNAs are not conserved between families, and only a limited set of 
base positions in the mature domain of tRNAs are conserved among the different 
isoacceptors (45) . This is in contrast to the consensus sequences found in messenger RNA 
introns, which are necessary for recognition by the mRNA splicing machinery (for a 
review, see 3). Previous evidence has suggested that the intron plays little or no part, 
beyond its mere presence, in the recognition by the splicing enzymes (46). An 
unstructured poly(U) intron variant of pre-tRNAPhe is accurately spliced in vitro (47). The · 
common theme from pre-tRNA splicing studies is that the secondary and tertiary structure 
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of the mature domain of the precursor tRNA is recognized by the splicing enzymes. Some 
evidence supporting this model and some exceptions to the rule are noted below. 
Cleavage by endonuclease at the 5' -splice site of the intron has been shown to be 
dependent upon the presence of a purine residue 5' to the cle~vage site (47) . Cleavage by 
endonuclease at the 3' -splice site may be more dependent on structure than absolute 
sequence. A cut at this site requires the region to be in a single-stranded accessible 
conformation, and not base paired in a helix (48, 49) . This result is supported by the 
conservation of this single-stranded structure in the predicted secondary conformations of 
all intron-containing pre-tRNAs (41, 43). 
A single base change at an important site in the mature domain of precursor tRNA 
can block splicing completely (see below). Until recently, such small changes in the intron 
have had little effect, though there are some exceptions (49). New experiments suggest 
that most normal intron-containing pre-tRNAs possess a tertiary base pair interaction 
between a pyrimidine in the anticodon loop and a purine in the intron (50). This tertiary 
interaction is required for accurate cleavage by the Xenopus splicing endonuclease. 
One might expect that pre-tRNAs altered in their introns would only affect 
endonuclease cleavage, as the resulting tRNA halves should be normal ligase and 2'-
phosphotransferase substrates. This assumption may be premature if the ligase plays a role 
in recognition and delivery of uncut pre-tRNAs to the endonuclease. As with the rnal 
phenotype in vivo, there are several yeast mutants which accumulate all or a subset of 
intron-containing precursor tRNAs under nonpermissive conditions, and these mutants are 
not all direct protein catalysts of the splicing steps (for a review, see 44). 
Certain alterations in the mature domain of tRNA have deleterious effects on 
endonucleolytic cleavage or ligation. Disruption of predicted tertiary interactions (51), 
single nucleotide changes in primary sequence (47, 52), lack of a proper D-stem (53, 54), 
disruption of the anticodon-intron helix (55-57), or even improper conformation of a 
precursor (58) have all been shown to affect splicing. Mutations in the mature domain 
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which lengthen the anticodon stem are inaccurately spliced (47, 59). This result coupled 
with the invariant location of the intron in all pre-tRNAs led to the proposal of a model 
where the endonuclease chooses its splice sites by a "ruler" mechanism, binding the 
precursor tRNA and measuring a specified distance to where the cuts should be made (47, 
52) . 
Structure of the mature domain of pre-tRNAs containing introns is similar to mature 
tRNA structure (42, 60). The secondary and tertiary structure surrounding the splice sites 
and the presence of an anticodon-intron helix presents a means for the splicing enzymes to . 
distinguish between intron-containing pre-tRNA substrates, mature spliced counterparts, 
and intronless pre-tRNAs, while still retaining the ability to recognize a tRNA structure 
common to all ten intron-containing tRNA species. 
tRNA Splicing in Related Systems 
Precursor tRNA splicing has been studied in a variety of organisms besides yeast. The 
best characterized systems are wheat, Xenopus, HeLa cells, and phage T4. The 
mechanism of nuclear tRNA splicing differs radically from other known classes of RNA 
splicing. Recent reviews discuss tRNA splicing among different organisms and 
implications on the evolutionary origin of this unique reaction (44, E. M. Phizicky and C. 
L. Greer, Trends in Biochemical Sciences, in press). One could almost wish for the 
complication of a system in which mitochondrial tRNAs might contain introns in need of a 
splicing apparatus. Such a system might have provided other clues to the evolutionary . 
origin of tRNA splicing in diverse systems. As yet, no intron-containing mitochondrial 
tRNAs have been found. However, there are two enzymes in phage T4 capable of tRNA 
splicing, though its bacterial host does not have tRNA genes containing introns. 
The ligation of yeast tRNA half molecules in vitro requires both T4 polynucleotide 
kinase and T4 RNA ligase to substitute for the single yeast ligase protein. The mechanism 
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of joining by the T4 enzymes is slightly different. The phosphatase activity of T4 
polynucleotide kinase removes the phosphate of the 5' -half tRNA prior to ligation, 
resulting in a spliced tRNA lacking the 2' -phosphate at the splice junction (37). Otherwise, 
the mechanisms of the two ligases are remarkably similar. Both require adenylylation of 
the protein at a lysine residue and transfer of the AMP to the 3 '-half tRNA. Both the T4 
polynucleotide kinase and T4 RNA ligase genes have limited sequence similarities to yeast 
tRNA ligase (24, 25). It is not clear what functions the T4 enzymes have in vivo, or what 
evolutionary relationship, if any, they have with the yeast tRNA ligase splicing mechanism. 
Both wheat germ extracts (61, 62) and Chlamydomonas extracts (63) also contain 
tRNA splicing activities, and the mechanisms are the same used by the yeast system. 
Wheat germ RNA ligase has a much broader substrate range than yeast ligase, which 
prefers cognate tRNA halves in the in vitro splicing assay (21). 
In higher eukaryotes a different tRNA splicing mechanism was initially discovered. 
Both Xenopus laevis and HeLa cell extracts possess tRNA splicing activity with yeast pre-
tRNA substrates. However, the major tRNA product of these reactions did not contain a 
2' -phosphate at the splice junction. Moreover, the phosphate moiety of the 5' -half tRNA 
was retained as the 3' ,5' -splice junction phosphate in tRNA product (64-66) . This is in 
contrast to the yeast ligase which incorporates the y-phosphate of ATP at the splice 
· junction. Filipowicz and Vicente (67) have characterized a 3' -phosphate cyclase from 
HeLa cells but its in vivo function is still unknown. 
The differences in ligation mechanisms between the yeast/wheat germ and 
Xenopuslhuman systems leads one to speculate that the mechanism of tRNA splicing is not 
conserved among lower and higher eukaryotes. More recent evidence indicates that the 
mechanism common to yeast and wheat germ exists in human cells as well. Zillmann et al. 
(31) have discovered a ligase activity in HeLa cell extracts that can incorporate the"(-
phosphate of ATP into the 3' ,5 '-splice junction of yeast tRNAPhe. The splice junction is 
RN ase T !-resistant due to the presence of a 2' -phosphate. This product is more than 
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reminiscent of the yeast ligase mechanism, though it has previously gone undetected in 
similar experiments. Furthermore, a yeast-like NAD+ -dependent 2' -phosphotransferase 
has been discovered in both HeLa cells and Xenopus oocytes. This activity carries out 
removal of the internal 2' -phosphate at the junction of spliced tRNA the same as the yeast 
activity (32) . Admittedly, only a minority of tRNA spliced in the HeLa cell extracts ends 
up as the yeast-like product. However, it is suggested that the conservation of the yeast-
like ligation pathway in higher eukaryotes implies an essential function in at least some part 
of pre-tRNA splicing (32). Two different pathways capable of in vitro tRNA splicing with 
heterologous tRNA substrates awaits further clarification regarding their true functions in 
vivo. 
An important lesson can be learned from the past 15 years of research in tRNA 
splicing. Purification of the splicing enzymes and in vitro biochemical characterization led 
to elucidation of the two-stage pathway of cleavage followed by ligation. However, results 
of in vitro assays with artificial substrates can be misleading and should be interpreted with 
care. The advantages of yeast genetics cannot be ignored. In turn, analysis of genetic 
results in yeast can be quite complicated compared to simpler bacterial systems. An 
unexpected genetic result in yeast, however, can often illuminate a new process or 
condition that is associated in vivo with the problem under study. The yeast system is 
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ABSTRACT 
We report here the DNA sequence of the entire coding region of the Saccharomyces 
cerevisiae tRNA ligase gene. tRNA ligase is one of two enzymes required for tRNA 
splicing in yeast, and the enzyme is likely a single polypeptide with multiple activities. We 
find that tRNA ligase is a basic protein of 827 amino acids corresponding to a molecular 
weight of approximately 95,400. The inferred amino acid sequence for tRNA ligase is not 
significantly homologous to that of other known proteins of similar activity. In addition to 
the tRNA ligase reading frame and several other unidentified open reading frames, we have 
found two open reading frames, ORFI and ORF2, near the 5' -end of the ligase structural 
gene. One of these, ORF2, produces a divergent transcript which initiates only 125 
nucleotides upstream of the tRNA ligase transcript, and is present in approximately the 
same relative abundance as the transcript for tRNA ligase. 
INTRODUCTION 
tRNA processing in the yeast, Saccharomyces cerevisiae, as well as in other eukaryotes, 
often involves a splicing step. The substrates for tRNA splicing are a subset of tRNA 
precursors which contain introns ((1, 2) see Ref. 3). Unlike the case of introns in mRNA 
precursors, the introns in precursor tRNAs do not have obvious conserved sequences at 
their splice junctions or within the intron; the major common feature these introns share is 
their location, which is one base removed from the 3' -end of the anticodon (4) . In contrast 
to the splicing of mRNA precursors, which involves several different ribonucleoproteins in 
complexes (for a review, see Ref. 5), the removal of introns from yeast tRNA precursors 
has been shown to be a relatively simple process involving two enzymes (6) (Fig. 1). 
After an endonuclease excises the intron to leave 5' -hydroxyl and 2' ,3' -cyclic 
phosphodiester ends, tRNA ligase joins the cognate 5' and 3' tRNA half-molecules (7, 8). 
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tRNA ligase protein is a single 90-kDa polypeptide which is likely to contain three 
activities required for the tRNA splicing reaction (9). tRNA ligase phosphorylates the 5' 
terminus of the 3' half-tRNA in the presence of ATP; opens the 2' ,3' -cyclic phosphodiester 
bond of the 5' half-tRNA, leaving a 2' -phosphomonoester; and, in a second ATP-
dependent reaction, ligates the two tRNA halves (7) (see Fig. 1 ). Ligation occurs through 
an adenylylated enzyme intermediate, presumably at a lysine residue as it is in T4 RNA 
ligase (7, 10). The AMP moiety of this intermediate is transferred to the 5' -phosphate of . 
the 3' half-tRNA to form a 5' ,5' -phosphoanhydride bond and is then released upon ligation 
of the two tRNA halves (9). tRNA ligase has been purified to near homogeneity, and the 
three activities described above cosediment with this protein in the final glycerol gradient 
step (9). (Another enzyme presumably removes the 2' -phosphate which remains at the 
splice junction after the action of tRNA ligase.) 
In order to study the functional domains of the tRNA ligase protein, we have cloned 
the gene from S. cerevisiae (9). We present here its DNA sequence, which encodes a 
. protein of 827 amino acids (95.4 kDa). The ligase amino acid sequence does not resemble 
that of other proteins with similar activities. 
The transcript for tRNA ligase starts at two major sites, 104 and 125 nucleotides 
upstream from the initiation codon. Near the 5' -end of tRNA ligase, there are two other 
open reading frames, ORF1 1 and ORF2. ORF1 begins upstream from tRNA ligase and 
overlaps the beginning of the ligase gene. We discuss experiments suggesting that its 
translation is not essential. The ORF2 reading frame begins 342 nucleotides upstream from 
the ligase initiation codon and proceeds in the opposite direction. This gene is transcribed 




Strains and Plasmids. Escherichia coli JMlOl (11) was used for preparing M13 
phage for sequencing and restriction analysis. Yeast strain TSY6-11 Ba (MAT a prcl -6.2 
pep4-3 ura3 -52 leu2-3, 112 his4) was used as the host for analysis of transcription products 
and transcript mapping and was obtained from Dr. S. Emr (California Institute of 
Technology) . Yeast strain SWY497 (our nomenclature) has an ochre mutation within 
ORFl constructed by site-directed oligonucleotide mutagenesis of single-stranded Ml3 
phage (12, 13) followed by standard yeast gene replacements methods (14, 15) using yiPS 
(15) as the integrating vector. EMPY20 is the parent yeast diploid for SWY497 and was 
constructed by mating SS328 (MATa his36.200 lys2-801a ade2-101" uraJ-52 GAL suc2) 
to SS330 (MATa his36.200 tyr1 ade2-JOJ" uraJ-52 GAL suc2). SS328 and SS330 were 
obtained from Dr. S. Scherer (University of Minnesota): Construction of plasmid pUC12-
RLG was described previously (9). Plasmid pEP99 (our nomenclature) is a derivative of 
yEP24 which contains the entire tRNA ligase gene as well as 5 kilobases of upstream 
DNA. This plasmid was obtained by screening an E. coli library of yeast genomic DNA 
(16) for inserts that hybridize to the ligase DNA (the library was provided by Dr. J. 
Campbell). Screening was performed as described by Maniatis et al. (17) . Transformation 
of this plasmid and its parent, yEP24 (18), into strain TSY6-11Ba was done as described 
byitoetal. (19). 
M13 Template Construction and Sequencing. Four unique restriction sites were 
used to subclone the 4-kilobase EcoRI insert of plasmid pUC12-RLG into phage M13 for 
sequencing (see Table I). Phage were purified by CsCl density gradient centrifugation 
prior to sequencing (20). These templates were sequenced by the Sanger dideoxy 
sequencing method (21) by first using the Ml3 sequencing primer and then by priming 
with synthetic oligonucleotides as needed (22, 23). These oligonucleotide primers were 
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synthesized on an Applied Biosystems 380A DNA synthesizer (deoxyoligonucleotides 
were provided by Dr. S. H. Horvath, California Institute of Technology). 
Preparation of RNA. Yeast cells were grown in SM minimal minus uracil media (24) 
to 2 X 107 cells/mi. After harvest, RNA was extracted by disruption of the cells with glass 
beads in the presence of cold phenol (25). The polyadenylated RNA was separated from 
total RNA on oligo(dT)-cellulose (17). 
RNA Analysis. 3 f.lg of polyadenylated RNA was resolved on a 1.5% formaldehyde-
agarose gel and transferred to nitrocellulose (17). Single-stranded DNA probes used in the 
Northern blot were made by primer extension with [a-32P]dCTP across the ligase insert of 
the Ml3 template followed by restriction cutting, denaturation of the duplex DNA, and 
isolation of the labeled single-stranded DNA. The primers and templates were selected 
from those listed in Table I and Fig. 2. Prehybridization, hybridization, and washing of 
the Northern blot were carried out according to Thomas (26). 
Transcript mapping by primer extension using 20-40 units of reverse transcriptase 
was carried out as described previously (27) with 3 f.lg of polyadenylated RNA. S 1 
nuclease analysis was performed as described (28, 29) with 3 f.lg of polyadenylated RNA 
and the appropriate kinased and primer-extended oligonucleotides. The oligonucleotide 
used as a primer for detecting the tRNA ligase transcript is complementary to the first 30 
nucleotides of the tRNA ligase coding region. 
Sequence Analysis. Sequence data was assembled, translated, and analyzed using 
Versions 4.2 and 4.5 of the Intelligenetics GENED, GEL, SEQ, and PEP programs of the 
BIONET™ National Computer Resource for Molecular Biology. All protein sequences 
used in homology searches were obtained using the Intelligenetics QUEST, !FIND, and 
XFASTP programs with the National Institutes of Health sequence and National 
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Biomedical Research Foundation protein data bases in BIONET™, unless otherwise 
referenced. 
Materials. M13 sequence primer was from New England Biolabs. [a-32P]dNTPs were 
purchased from Amersham Corp. dNTPs, dideoxy-NTPs, and S I nuclease were from 
Pharmacia LKB Biotechnology Inc. Klenow fragment of DNA polymerase was purchased 
from Bethesda Research Laboratories. Reverse transcriptase was from Boehringer 
Mannheim. 
RESULTS 
tRNA Ligase Sequence. The 4-kilobase EcoRI fragment containing the yeast tRNA 
ligase gene was sequenced according to the strategy outlined in Fig. 2 and described under 
"Experimental Procedures." Five unique restriction fragments were cloned in both 
orientations into phage M13 (Table I). M13 sequencing primer was used to obtain initial 
sequence information. Oligonucleotides corresponding to unique regions of nucleotide 
sequence were then used as primers in directing continued synthesis along the same strand 
of each clone (22, 23). In this way, we obtained the sequence of both strands of each 
restriction fragment. To confirm the sequence at the restriction site junctions, separate 
clones were sequenced which span the junctions .(Table I) . The entire sequence is shown 
in Fig. 3. 
The ligase reading frame begins at nucleotide 551 and extends to nucleotide 3031. 
This sequence encodes a protein of 827 amino acids, with a molecular mass of 95.4 kDa, 
comparable to that estimated (90 kDa) from the migration of purified tRNA ligase on 
sodium dodecyl sulfate-polyacrylamide gels (9). We have shown previously that the 
amino-terminal sequence of purified tRNA ligase begins at the amino acid residue 
immediately following the methionine codon at nucleotide 551, and we presumed that this 
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codon was the initiation codon (9). This AUG is indeed the initiation codon. It is the first 
AUG in the open reading frame corresponding to ligase, and, as we show below, it is the 
first AUG in any reading frame following the ligase transcription initiation site. 
Other Open Reading Frames. There are two other open reading frames, ORFl and 
ORF2, near the 5' -end of the ligase structural gene. These are diagrammed in Fig. 4 
together with all open reading frames that contain a start codon and are greater than 150 
amino acids in length. ORFl precedes the ligase reading frame and overlaps the beginning 
of the ligase protein-coding region by eight nucleotides. We have sequenced this region of 
overlap in both directions from each of two independent ligase clones isolated from 
different yeast libraries (pUC12-RLG and pEP99) and have obtained identical nucleotide 
sequences. We are thus confident that ligase and ORF1 are out-of-frame with respect to 
one another and that ligase is translated beginning at nucleotide 551 of this sequence (see 
also below). 
If ORF1 is translated in yeast, its translation product is not essential for cell 
viability. By standard methods (see "Experimental Procedures"), we have constructed a 
diploid strain (SWY497) in which ORF1 is interrupted by an ochre mutation before the 
region of overlap with the ligase gene. This diploid sporulated to yield four healthy viable 
spores in 18 of 20 tetrads dissected, comparable to the frequency of four-spore tetrads in 
the parent strain. Southern hybridization of genomic DNA from three of these tetrads 
confirms that in each case two of the four spores contained the ochre mutation. In addition, 
the homozygous diploid sporulates normally (data not shown). These results demonstrate 
that ORF1 is not translated to yield an essential gene product, either independently or as a 
frameshift fusion protein, as has been seen for the Ty elements in yeast (30, 31). We 
cannot detect an ORFl transcript or a transcript fusing ORF1 to the full-length tRNA ligase 
gene (see below). In addition, we detect no polypeptide using immune precipitation or 
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immune blot analysis with antibodies raised to a synthetic oligopeptide corresponding to the 
amino-terminal sequence of ORF1.2 
The second open reading frame, ORF2, begins 342 nucleotides upstream from the 
tRNA ligase coding region and proceeds in the opposite direction. We have obtained 
evidence, which will be described elsewhere, that ORF2 encodes an essential gene 
product.3 The other two open reading frames depicted in Fig. 3, ORF3 and ORF4, are as 
yet uncharacterized. 
Transcript Analysis. Because of the proximity of ORFl and ORF2 to tRNA ligase, 
we have fully analyzed the transcripts upstream of and within the coding region of tRNA 
ligase. We isolated polyadenylated RNA from two yeast strains. One strain carried the 
yeast plasmid yEP24 and the other strain carried a derivative of yEP24 (pEP99) containing 
all of the tRNA ligase gene, as well as all of the ORFl and ORF2 DNA sequences. The 
polyadenylated RNA from these two strains was resolved on gels, transferred to 
nitrocellulose, and analyzed by hybridization to various probes. One such example is 
shown in Fig. 5. 
A ligase-specific probe hybridizes to a major 2.8-kilobase transcript (Fig. 5A), 
which is of sufficient size to accommodate the entire tRNA ligase coding region. This 
transcript is detected with each of the probes we used (EcoRI to Hpal, Hpal to Bglll, Bglll 
to Hindlll, and Hindlll to Xbal, see Fig. 5C). In addition, there is a minor transcript of 
2.2 kilobases which is about 50-fold less abundant than the major ligase transcript. This 
minor transcript is only faintly detected with a probe to the 3' -end of the ligase gene 
(Hindlll to Xbal, data not shown). We did not detect small transcripts which could 
correspond to the ORFl-polyadenylated RNA nor a larger 3 .1-kilobase transcript which 
could correspond to a transcript of ORFl fused to tRNA ligase. 
The ORF2-specific probe hybridizes to a 2.1-kilobase transcript (Fig. 5B), of 
comparable abundance to the major tRNA ligase transcript. This ORF2 transcript is not 
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detected using probes within the tRNA ligase gene. As expected, after longer exposure of 
the autoradiogram, all of the transcripts described above are detected in polyadenylated 
RNA isolated from the wild-type strain. Fig. 5C summarizes the transcripts, their 
direction, and their relative abundance for this region. 
We have mapped the 5'-ends of the ligase and ORF2 transcripts more thoroughly, 
using both S 1 nuclease and reverse transcriptase. The results are shown in Fig. 6. As is 
the case for some other yeast mRNA transcripts (32-37), the ligase transcript has multiple 
transcription initiation sites (Fig. 6A). In each of two independent experiments, two major 
transcription initiation sites were detected for the tRNA ligase transcript with both reverse 
transcriptase and S 1 nuclease, together with several minor transcription initiation sites. 
(Some of these minor sites are seen preferentially with one or the other method.) The two 
major transcription initiation sites for tRNA ligase are diagrammed in Fig. 6C, relative to 
the coding region of ligase. Both of these sites, as well as all of the minor initiation sites, 
begin upstream of the initiation codon at nucleotide 551, and this AUG is the first in any 
reading frame following any of the transcription initiation sites. This AUG, therefore, 
represents the initiation codon for tRNA ligase. 
The ORF2 transcript begins at about seven different positions (Fig. 6B) within the 
40-base pair region from nucleotides 263 to 303 (numbers refer to the sequence shown in 
Fig. 3). The four most intense initiation signals are depicted in Fig. 6C. Two of these start 
sites are followed immediately by an AUG codon at nucleotides 291-289, which has an in-
frame stop codon two amino acids downstream. The next AUG occurs at nucleotide 209 
and represents the beginning of the ORF2 open reading frame. We do not know how 
ORF2 translation is affected. Either ORF2 is only translated from the two shorter 
transcripts, or the false AUG at nucleotide 291 plays some role in the regulation of ORF2 
expression. Such a regulatory role has been ascribed to the multiple AUG codons at the 5'-
end of the GCN4 gene in yeast (38). 
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DISCUSSION 
tRNA Ligase Sequence Analysis. We have sequenced the yeast tRNA ligase gene 
and mapped the 5' -end of its transcript. Purified ligase protein begins at the amino acid 
residue following the methionine codon at nucleotide 551 (9). The data presented here 
provide further evidence that this methionine residue is the correct amino terminus of the 
tRNA ligase gene. (The methionine residue itself is presumably removed after translation.) 
tRNA ligase is 827 amino acids long and has a molecular mass of 95.4 kDa. As 
might be expected for a protein involved in tRNA metabolism, tRNA ligase is a basic 
protein. Greater than 10% of all the amino acid residues are lysine, and the net charge of 
the protein is calculated to be + 12.5 if histidine is counted as +0.5. 
We have previously reported that yeast tRNA ligase is a relatively rare protein 
present in approximately 400 copies/yeast cell (9). A comparison of the codon usage of 
tRNA ligase to other yeast proteins (32, 39-42) indicates that tRNA ligase uses a large 
percentage of rarely used codons (data not shown). These observations fit well with the 
hypothesis proposed by Bennetzen and Hall (39) that less abundant proteins do not require 
the extreme codon bias toward "preferred codons" as is seen for highly abundant proteins. 
Since yeast tRNA ligase is directly involved in the processing of intron-containing tRNAs, 
its expression might be controlled by the levels of that subset of tRNAs. We, therefore, 
examined the codon usage of tRNA ligase relative to the codons in yeast which are 
specifically translated by tRNAs whose precursors contain introns (see Ref. 3). We were 
unable to detect any such correlation. There is no codon bias either for or against the use of 
spliced tRNAs to translate tRNA ligase. 
The mechanism by which yeast tRNA ligase ligates RNA is very similar to that 
used by T4 RNA ligase and T4 DNA ligase. All three enzymes proceed through an 
adenylylated enzyme intermediate whose adenyl moiety is used to activate their substrates 
(for reviews, see Refs. 43 and 44) . Available evidence indicates that both yeast tRNA 
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ligase and T4 RNA ligase are adenylylated at a lysine residue (7, 10). Given these 
similarities in mechanism, it was of obvious interest to compare the sequence of tRNA 
ligase with that of other ligases . We were unable to detect any obvious sequence 
homologies between yeast tRNA ligase and either of the T4 ligases. Another T4 enzyme, 
polynucleotide kinase, phosphorylates 5' -hydroxy termini of RNA molecules and 
possesses a 3'-phosphatase activity (45, 46) resembling the kinase and 2',3'-cyclic 
phosphodiesterase activities catalyzed by the tRNA ligase protein (47) . There is, however, 
no obvious sequence homology between tRNA ligase and T4 polynucleotide kinase. In 
fact, a screen of the entire protein data base (SNBRF, BIONET) for homologies also 
proved negative. 
Studies in progress indicate that tRNA ligase does have separable domains 
responsible for some of the different activities observed during tRNA splicing.4 Results 
from this type of analysis should pinpoint the location of these domains within the tRNA 
ligase protein. This, in turn, will allow us to search for more subtle similarities between 
tRNA ligase and other proteins of similar function. 
Transcription Analysis. Upstream of ligase there are two other open reading frames, 
ORF1 and ORF2. As described above, the evidence indicates that ORF1 does not encode 
an essential protein. By contrast, ORF2 is transcribed, and our preliminary results indicate 
that it is essential. The divergent ORF2 and tRNA ligase transcripts do not overlap, but 
they are separated by only 125 nucleotides at their closest points. Although closely situated 
divergent transcripts are relatively common in yeast (48-50), to our knowledge, tRNA 
ligase and ORF2 are closer than most transcripts. Though we have no evidence that bears 
directly on this, it is possible that tRNA ligase and ORF2 share regulatory elements. In this 
connection, the region between the tRNA ligase and ORF2 transcript initiation sites 
contains a 17-base pair GC-rich region (nucleotides 349-365, see Fig. 3), bounded on the 
ORF2 side by two possible "TATA"-Iike sequences (nucleotides 338-334 and 310-306), 
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and on the ligase side by a "TATA"-like sequence (nucleotides 413-416), 11 nucleotides 
upstream from the first major transcription initiation site. The significance of these 
sequences is unknown. 
The 3 '-end of the tRNA ligase transcript has not been mapped; however, both 
tRNA ligase and ORF2 mRNAs are clearly polyadenylated (see Fig. 5). tRNA ligase 
contains the sequence "AAUAA" 111 nucleotides downstream of the termination codon 
(see Fig. 3), which is a close match to the polyadenylation signal consensus of AAUAAA, 
proposed to be important in polyadenylation of messenger RNA in other eukaryotic genes 
(51). Several other yeast genes including enolase gene 8, enolase gene 46, and 
glyceraldehyde-3-phosphate dehydrogenase gene 63 (52, 53) also contain this "AAUAA" 
sequence in their 3 '-nontranslated regions. 
Yeast tRNA ligase protein possesses several different properties which make it 
unique. tRNA ligase catalyzes three separate enzymatic activities responsible for the 
splicing of precursor tRNAs; there is evidence indicating that tRNA ligase forms a tRNA 
splicing complex in vitro in the presence of endonuclease and tRNA precursors (54); tRNA 
ligase has been localized to a specific site at or near the inner nuclear membrane (55), so 
therefore it ought to contain a nuclear localization signal of some sort and/or a site which 
recognizes the nuclear component to which it binds; finally, tRNA ligase must be able to 
recognize all of the different pre-tRNA substrates for splicing. Studies in this laboratory 
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FIGURE LEGENDS 
Figure 1. The mechanism of tRNA splicing in yeast, as originally described 
by Greer et al. (7). An endonuclease from yeast is responsible for the first step, 
cleaving the precursor tRNA into two tRNA half-molecules. Yeast tRNA ligase likely 
carries out the remaining steps of the process, leaving a tRNA with a 2' -phosphate at the 
splice junction. See text for details. IVS, intervening sequence. 
Figure 2. Restriction map of the 4.2-kilobase insert in pUC12-RLG. 
Sequencing directions and distances are shown above and below the restriction map. Open 
boxes indicate positions of primed synthesis using M13 sequence primer. Closed boxes 
indicate positions of synthetic oligonucleotide primers. R(A), EcoRI (site A); Hp, Hpal; 
Sc, Seal; Bg, Bglll; Hd, Hindlll; K, Kpnl; RV, EcoRV; X, Xbal; R(B), EcoRI (site B). 
nt, nucleotide. 
Figure 3. Sequence of the 4168-nucleotide EcoRI fragment of pUC12-RLG. 
The tRNA ligase coding region is shown translated. A putative initiation codon and the 
direction of transcription are shown for ORF2. The start and stop positions for ORFl are 
also indicated. 
Figure 4. Diagram showing open reading frames (containing an AUG codon) 
found within the sequence of the EcoRI fragment of pUC12-RLG. The two 
ORFs downstream of tRNA ligase, ORF3 and ORF4, are uncharacterized. Other possible 
open reading frames of less than 150 amino acids have been omitted for clarity. aa, amino 
acids; other abbreviations are same as defined in the legend to Fig. 2. 
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Figure 5. Transcripts of tRNA ligase and ORF2. Polyadenylated RNA from a 
wild-type strain (WT) and a strain carrying an overproducer of tRNA ligase and ORF2 
(OP) was resolved on gels, transferred to nitrocellulose, and hybridized to various probes 
as described under "Experimental Procedures." MW, molecular weight markers of single-
stranded DNA. A, RNA was hybridized with a single-stranded DNA probe 
complementary to tRNA ligase and spanning the region between Hpal and Bglll (see C). 
B, RNA was hybridized with a single-stranded DNA probe complementary to ORF2 and 
spanning the region between EcoRI (site A) and Hpal (see C). C, diagrammatic 
representation of the positions and relative abundance of the major transcripts for ORF2 
and tRNA ligase. R, EcoRI; H, Hpal; B, Bglll; Hd, Hindlll; X, Xbal. Numbers 
correspond to the transcripts shown in A and B. 
Figure 6. Transcription initiation sites for tRNA ligase and ORF2. WT, 
analysis of a wild-type strain; OP, analysis of a strain overproducing tRNA ligase and 
ORF2. (Transcripts are detected from wild-type cells upon overexposure of the 
autoradiograms.) A, S 1 nuclease and reverse transcriptase primer extension analysis for 
tRNA ligase. S 1 nuclease lanes (Sl) are on the left, reverse transcriptase lanes (RT) are in 
the middle, and Sanger dideoxy sequencing ladders are on the right. The arrows indicate 
positions of major transcription initiation sites as diagrammed in C. B, analysis of the 
ORF2 transcription initiation sites; symbols are the same as in A. C, diagram of the EcoRI 
to Hpal region depicting the major transcription initiation sites for both tRNA ligase and 
ORF2. Numbers correspond to those used in Fig. 3. The translation start sites (ATG) are 
shown for each gene. 
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TABLE! 
Cloning strategy for sequencing the yeast tRNA ligase gene 
Restriction Fragmenta M13 vector Vector sites 
EcoRI(A) - Hpal mplO and mpll EcoRl- Smal 
Hpal- Bglll mplO and mp11 Smal- BamHl 
Bglll - Hindlll mp10 and mpll BamHl - Hindlll 
H indlll - Xbal mplO and mp11 Hindlll- Xbal 
Xbal- EcoRI(B) mplO and mp11 Xbal- EcoRl 
EcoRI(A) - Seal mpll EcoRI- Smal 
Seal- Kpnl mp18 Smal- Kpnl 
EcoRV - EcoRI(B) mpll Smal- EcoRl 
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t:co RJ IAI 
1 GAATTCAATC To\CTT'TCAAT ATTTCTTTCT A.A.TCTGGTTA A.A.ACATTATT 1'CTAGCMGA ATACGACTCA ACACTTCACT CGATTGATTC CATCTAGC'TC ... 
1e1 CA.A~~O~~CATTTA TTCA1"TT'CGA A.ACTCACTTT ACTTCTCTTT TCTAACTCCT C'f'CAT~C TAATACCTCA ~:r~'I'T'!'C , .. 
2e1 ~ TCTo\TAMTC CTTTTGATAT TATAAAACCA CAACACTTTA ATGCACC'f'TT GCTATTCACT GCCACCACTT TAAGGCTACA 'I'TCACC'T'I'GC , .. , .. 
TTTTCM.ATA CCTTTA.AGCA CACTCTTTCA CTAAATTATC TTTA.TCTTCC ACCGGGCCGG CCGCCT.\CTT 1"TCC.ATT'GAT AAAA'I'TTCAC TATCACTTTA 
TCCCAAACAA ACTATACAGA AGAGCATCTA ATTC.ATTCCA. TTCTCTTCAC A.ATTGCTTCC AGCA.AA'I'TTT ACCCAT'f'TGC ATACTCTTTC TTTCT'T1'CAA 
A.ATCTACACT TTC..\C'M'TILC TCATCATA.AA ILCTATTCATA cc!:~~-~-~ CCA TAT CAC CGT AM ACA ACA CTA ACT CAC CTT 





tUA Ligaae-----> Met P£o Sel' Pro Ty1: A.ap Cly Lya Arg Tbr Val Tbl' Cln Leu 
~~~~~~~~-~-~~=~=~~~~~~~~-~~ 
Val Aan Clu Leu Clu Lya Ala Clu Lp Leu s.e,. Cly Al'CJ Cly &1:9 Ala Ty1: Arg Arg Val Cya Aap Leu 5el' Hia 5er Aan 
~--~~=-~~~=~~=--~~~~=~-=~=~ 
Lya Lya Val lle Se£ Ta::p Lya Pbe Aan Clu T1:p Aap Tyr Cly Lya Aan Thl: lle Tb£ Leu Pro Cya Aan Ala ArC) Cly Leu 
~~~~~~~-=~~~=~~~~~~=--=~~~~ 
Pbe lle Ser Aap Aap Tbr Tbr Aao Pro Val lle Val Ala A.t:CJ C1y Tyc Aap Lya Pbe Pbe Aan Val Cly Clu Val Aan Pbe 
~~=~-~~~~~~~~~~~~~~~-~~~~~~ 
Tbc Lya Tcp Aao Tcp lle Clu Clu Aan Cya Tbc Cly Pco Tyc Aap Val 'l'bc lle Lya Ala A.ao Cly Cya lle lle Pbe lle 
~~~~~~~~-=~~~~=~~~~~~-~~~~= 







Clu Ale Cly Glu Lye Glo Leu Leu A1'9 Cln Leu Ala Ale "•t Aan Jle Aao ACCJ ler Aap Pbe Ala Ac9 "et Leu Tyc Tbl' 
1•7t CAT AAT CTC ACC GCT C'I'C CCA. C..U TAT 1'CC CAT CAT TCA 'I'T'I' C..U CA..o\ CAC A1"C 1'TA GAG TAT CCC CT'1' CA..o\ A..\A GCT GGC 1159 
Hia Aan Vel Tbc Ala Vel Ale Glu Tyc Cya Aap o\ap Sec Pbe Glu Clu Hia lle Leu Glu 1'yr Pco Leu Glu Ly• Ala Gly 
116a CTA TAC 1'To\ CAT GCT CTA AAT CTT A.AT AAA CCC C..U TTT CA...\ ACT TGC CAT A'I'C AAA CAT GTT 'TCC CA.\ A!'C CCC ACT AAA 114. 
Leu Tyc Leu Hia Gly Vel Aan Val Aan Lya Ala Clu Pbe Glu Tbc Tcp o\ap Met Lya Aap Val 5ec Cln "•t Ala 5ec Lya 
1241 TAC GCA TrC AGC 'T'GC G1"C CAA TGC ATT AC.A 'TCC A.AC ACC T'I'C GAG CAT T'I'C AAA A.AC TTC CYA CAT AAC TGC TCT GCA ACC 1111 
Tyc Gly Pbe Acg Cya Val G1n Cya I le 1'bl' Sec Aan Tbc Leu Glu Aap Leu Lya Lya Pbe Leu Aap Aao Cya 5ec Ala 1'bc 
ll2l GC.\ TCT TTT GAA GCC CA.\ CAC A.TT CA.A OCT TTT G1'T ATC AGC TGC CAC T'I'C o\.AC ACT ACT G.\A AAG CCA TTT TTT TTC AAC 1Ul 
Gly Sec Pbe Glu Gly Gln Clu lle Glu Gly Pbe Val lle Acg Cya Hia Leu Lya S:er The Glu Lya Pco Phe Pbe Phe Ly" 
14.1 TAT AAA TTT GAA GAA CCC TAT T'I'C ATC TAC CGT CAG T'GC ACA GAlt CTT ACT AAA CAC TA'I' ATT 1"CC MC AAC TCA AC.A. CTC Ull 
Tyr Lya Pbe Glu Glu Pco Tyc Leu "et Tyc ACCJ Gln Tcp Ac9 Glu Val Tbc Lya Aap Tyc lle Sec Aan Lya Sec Ac9 Val 
1414 TTT AAA 'I'TT AGA AA.C CAT AAA TTT A'I'A ACe AAC o\AG TAT CTT CAT TTC CCA. o\1"C CCA ATA TTC CAC 'I'CA TCA. CCC AAC o\TC U64 
Phe Lya Phe Acq Lya Hie Lya P~ lie The Aan Lya Tyr Leu Aap Phe Ala lle Pco lle l..eu Clu Sec Sec Pro Lya Jle 
lS6S 'rC't CAC o\AT TA.C TTC AAA CCT TTT GCT CTC ATT GM 'I'TC A.GA A.A'I' A.AC TTT CTA CAA TCA TAT GGC ATC ACT CGC CTC CM 164 S 
Cya Glu Aan Tyc Leu Lya Cly Phe Cly Val lle Clu Leu Ar9 o\an Lya Phe Leu Cln Ser Tyc Cly Ket Sec Cly Leu Clu 
1646 A.TC TTA AAC CAC CAA. AAA CTC Gee CA.C TTC CAA TTA AAA A.JtC Gee A1'T CAT TA'I' CAT AAA CTA CAC GAA CGC ACT MA TTT 1726 
lle Leu Aan Hia Clu Lya Val Ala Glu Leu Clu Leu Lya Aan Ala lle Aap Tyc Aap Lya Val Aap Clu Ar9 The Lya Phe 
1121 TTA A1"C TTT CCA ATA !CA. CTT ATT GCA TCT CGC A.AA ACA ACA ACT TCC CA.C ACA TTA GTC AA'I' TTC T'TC CCT CAC t.GC TGC llll 
Leu lle Phe P1:o lle Ser Val lle Cly Cya Cly Lya The The Tbr Sec Cln The Leu Val Aan ' Leu Phe Pro Aap Sec Tcp 
1111 GCT CAT ATT CAA. A.AT CAT CAT ATT ACA CCT lu\A CAT AAA TCT CA.A TTA A'I'C A.U. A..\A 1'CA. TT'C CAA CTA TTA TCC lu\A lu\A 11111 
Cly Hia lle Gln Aan Aap Aap lle Thr Cly Lya Aap Lya Sec Cln Leu "et Lya Lya Sec Leu Glu Leu Leu Ser Lya Lya 
lilt GAo\ AT'C lu\A TCT CTC ATA CTT CAC o\CA. MC o\AT CAC CAA TTC CCC CAA. o\CA. ~ CA.A TTA TTT CU TGG T'I'C A.AT CAA CTA 196t 
Clu lle Lya Cya Val lle Val Aap ACCJ Aan Aan Hia Cln Phe Al"CJ Clu Ar9 Lya Gln Leu Phe C1u Trp Leu Aan Clu Leu 
lt7• a.AA. GAlt CAT TAT TTC GTC TAT CAT ACC o\AC AT'C MG CTA AT'C GGC GTC TCA T'TC CCC CCA. TAT CA.C A.AA CYA TCC GAA ATA liSI 
Lya Glu Aap Tyc Leu Val Tyr Aap The Aan lle Lya Val lle Cly Val Ser Phe Ala Pco Ty1: Aap Lya Leu Sec Clu I le 
liS1 ACA CA.C ATA ACA CTC CA.A ACA CTA AT'C AM ACA CCT AAC MT CAC CAA ACT ATT AM TGC CAC GA.A TTA GGA CA.C AAG AM 21]1 
Ar9 Aap lle Thr Leu Gln Acg Val lle Lya Ar9 Gly Aan Aan Hia Gln Sec lle Lya t'cp Aap Clu Leu Gly Glu Lya Lya 
21]2 GTC CTA GGC ATC ATC A.AT GQC TTT T'TC AM A.CA TAT CAA CCT CTT AAT TTA GA.C AAA 'rCA CCA CAT A.AT o\TC TTT CAT TTA 2212 
Val Val Gly lle "et Aan Cly Phe Leu Lya Acg Tyc Cln Pro Val Aan Leu Aap Lya Ser Pco Aap Aan Ptet Pbe Aap Leu 
2213 ATG ATA CA.G TTA CAT ftT GCA. CAA CCA. CAC TCT 'rCA TTA ACe MT CCC AAA CAA A1"C CTC A.AT C.o\A AT'T CA'I' A.AA GCT TAT 2191 
"et lle Glu Leu Aap Phe Gly Gln Ale o\ap Ser Ser Leu Thr Aan Ala Lya Gln Jle Leu Aan Clu lle Hia Lya Ala Tyr 
22t4 CCA ATT TT'C GTA CCA GAG ATC CCG AM GAT CAT GM ATT CAC ACA CCC TTC ACA A.GC A.CC 1'TA CAt' 1'AC A.AA CCT ACT GTC 2ll4 
Pro lle Leu Val P1:o Glu lle Pco Lya Aap Aap Clu Jle Clu The Ala Phe AI:CJ ACCJ lee Loeu Aap Tyr Lya Pco Th1: Val 
lll5 A.CA A.A..\. ATA CTT GCT AAA CGC AAC MT AAT CAA CM MA ACC CCT o\AC TTA ATT AAA CCT ACA TAT ATC TCA GCT MA ATA 24SS 
Arg Lys lle Val Gly Lya Gly Aan Aan Aan Gln Gln Lya Thr Pro Lya Leu lle Lya Pro Th1: Ty1: lle Se1: Ala Lya lle 
24~ CAA AAC TAC GAT GAA ATT ATT G.\A. TTG GTC o\AG ACC TGT A1'T GCT ACC CAT GCA GAG CTC ACY G.\C AAA TT'C AA.C CAT TTA 2Sl6 
Clu Aan Tyr Aap Clu lle lle Clu Leu Val Lya A1:9 Cya lle Ala Sec Aap Ala Clu Leu Th1: Glu Lya P~ Lya Hia Leu 
lSJl CTA GCT ACT GCA AAA CTT CAC A.AC CAA CTT CAT ATA ACA TTA CCT CAT CT'C ATC 'TCC TCC CGT GA.A AAA GAG GCA AAA MC 2617 
Leu Ala Sec Cly Lya Val Cln Lya Glu Leu HJ& lle Thr Leu Gly Hia Val "et Ser Ser Al"CJ Glu Lya Glu Ala Lya Lya 
l6U TTC TGC AM TCA TAT TCT AAC ACA TAC ACT Co\C CAC ATA ACG GAG TAC AAT AAC o\AC CCC ATA CAA MT CCA CM CGC TCT 1691 
Loeu Tcp Lya Sec Tyc Cya Aan A1:9 Tyr Thr Aap Cln Jle The Glu Tyc Aan Aan Aan Acg Jle Glu Aan Ala Gln Gly Sec 
l6t9 CGT MT MC CM MT ACG CAG CTA M.A. ACG A.CC CA.C A.AA CTC AAT TTT ACC CTC CA.A A.AA CTA !'CT 1'GG CAT GAA AM ATC 2ll9 
Cly Aan Aan Gln Aan Th1: Gln Val Ly• The The Aap Lya Leu Aan Phe Ar9 Leu G1u Lya Leu Cya T1:p Aap Glu Lya Jle 
1781 ATT GeT ATT CTA GTG CAA CTC TCT A.AA CAT A.AA CAT GGA TGC ATA ATT CAT GAA o\AC o\.AT GAG A.AA ATT AAA GGG T'I'C TCT 2161 
lle Ala lle Val Val Clu Leu Sec Lya Aap Lya A•p Cly Cya lle lle Aap Glu Aan Aan Glu Lya lle Ly~~o Gly Leu Cya 
2861 TCT CA.A. o\ltl; AAA ATT CCT CAT ATT A.CC CTC 'T'GC A.AA CTT C.o\.A ACT GCT GTT MG GCT CTT TAT TCC A.AT GTT CTo\ TG1' CAC 2941 
Cya Cln Aan Lya lle Pco Hia lle The Leu Cya Lya Leu Clu Ser Cly V•l Lya Ala V•l Tyr lee A.an Val Leu Cya Glu 
2942 A.AC GTT CA.A TCT GCT C4A. GTT CAT C.o\.A A.AT ATA AAA CTC GTC A.AA TTG CAC AAC 1'CG A.AC GAA T1'T CTT GGC AGT CTA TAT ]Ill 
Lya Val Clu Ser Ala Glu Vel Aap Glu Aan lle Lya Val Val Lya Leu Aap Aan Ser Lya Clu Phe Vel Gly Ser: Val Ty1: 
>02 
Jill TTA AAT TT1' f!!g A.CCGCC GT'CTCGCTCT CTTAAAA.o\CG TTMT'n'CCT T'TAACCA.ACT GCTTTATTTG CT'I"GGAATCT AACATACTTT TACTA.ACATT ll:le 
Leu Aan Phe /// 
1121 TTTTTTTTTT MTTGACATT GCA..A.A.ATA.AT CA.ATGTATAT CATTATTCAT CCATCTATAT CTCTATTTAT A'I'ATTACTTA TTA.AGAACAC CA.AACAAGCA ll11 
1121 TTATTT'CAAG TCCTTCAA.AT TACCTTTATT ATT~ ATATC4AT'GC CA.CACATA.GC TGCATATA.AT CTCTTTTCTG CTTCT'f'CAAA CACTAT'CGA.A lll• 
llll TCCTCTCCA.T A.AA.\G.ACATC ATCAC'To\.ACT TCT"TCTTC.AT CTCTTGGCAC ACAATGCA.TA MTTTCTACT TTGCATCAGC CACA.CACAC.\ o\CTTC'TTG.\T 1421 
l4l1 TCATTTGAAA ACCT'T'TCA.AT TCTTTC.A.CCT TGGCCTCT'TT CCCAAATTCT TCA.CCCATGG AAAC'GAAACT AT'CGGTTACT A.ATATATT'CG CATTCC'I'GCA JS21 
3S21 GGCC'TTTAAA CAC'TCCTGTC TTAATTCAAA TCTCCCACCG TTTC'TCTC.AG CAACTTTCTT TGCTTCATCC ACAATATCGC AATCCATTTC MTA..CC'GICGC 1621 
Jill GC.A.C'TGCA.AA TAC'TCACACT TATACC'GAAT TTCACACATC CGATGCACAT ATCATTTATG ACATTATTGC CA'TCACCAAT CCATCCCA.TC T'TCAAT'TTTC llll 
]711 o\.ATTCATTCC CTTATTTACT TCATCTACAC ATATATT'CA.A. CTTTTCCATT AT'I'CTTA.AAA GATCAC.A.A.AT TGCTTCCAAA GGCTGGAATT TCTCACATAG ]Ill• 
1121 ACA.GT'TCATC ATCGCTACAC AGCAATCCTT CCAA.AA.AGCA ACTATCTCTT CA!'CTTTCTT CACACGGGCA o\.AAATACATC AAACCATACA TC.ATACAACC JtU 
ltll TTGCT'GCTAT CGTAAAATCA TTCATTCACA CCAAGCTCAA TATCCTCTTT o\CCTA.AAA.A.C ATCGCTTGGC CACCAAACA.A GCTGGCTGCA. CCTTCGCTCC Ull 
tell MATTCTCCT TCTAGT'TCAT CTTTTACTM ATATTAAGCC TATAGTTCTA CCCMTACTT TCAC.A.TGGTT GCATT'GGA.AA TC.o\T'TCCT'TT TAT'TTGCTTT 4121 
4111 #oi.AAACATTC TTCA.MTCTT CAGCTCTTTC TACTAACATT CTCAATTC 4168 
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Open Reading Frames Near the tRNA Ligase Gene 
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RATIONALE 
As previously reported, there are four open reading frames (ORFl, ORF2, ORF3, and 
ORF4) in proximity to the yeast tRNA ligase open reading frame (Westaway et al., 1988). 
Detailed studies of the characteristics of these open reading frames were undertaken to 
further elucidate the requirements for tRNA ligase activity. Figure 1 is a diagram depicting 
their locations with respect to the tRNA ligase coding region, as well as their directions and 
predicted length in amino acids. 
Comparison of the amino acid sequence deduced from ORF4 with that of the yeast 
ARG3 gene (Huygen et al., 1987) revealed that these genes are identical. The termination 
codons for tRNA ligase and ORF4 (ARG3) are separated by 186 nucleotides (Huygen et 
al., 1987; Westaway et al., 1988) and the genes do not overlap. This 186 nucleotide 
region at the 3' -ends of both genes is A:T rich. The previous determination that the gene 
for ARG3 was localized to yeast chromosome X (Hilger et al., 1982) and its close 
association with tRNA ligase now permit the latter gene to be assigned a chromosomal 
location. 
ORF3 has not as yet been characterized, however, it is unlikely to be transcribed or 
translated in yeast. This open reading frame is on the opposite strand from ORF4 (ARG3). 
Two complementary strands of DNA do not often code for two divergent genes in yeast, as 
they do in E. coli. Therefore ORF3 was not characterized further. Instead, we have 
concentrated our efforts on investigating the two open reading frames 5' to the ligase gene, 
ORF1 and ORF2. 
ORFl. ORF1 was of interest due to its proximity to the 5' -end of the tRNA ligase coding 
region. This ORF is 122 amino acids in length (see Figure 1), and its start codon is on the 
same strand approximately 360 nucleotides upstream from the start codon of tRNA ligase. 
Its termination codon lies 8 nucleotides downstream of the ligase start codon. Although the 
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two open reading frames overlap, ORFl is out-of-frame with respect to the tRNA ligase 
reading frame. An expanded diagram of these two overlapping reading frames is shown in 
Figure 2. This overlap between the two open reading frames suggested that their activities 
might be related. 
At approximately the same time as ORF1 was discovered, Clark and Abelson 
(1987) showed that the tRNA ligase protein is localized to the yeast cell nucleus. Potential 
nuclear localization signals were not found within the amino acid sequence of the tRNA 
ligase gene itself. It was initially thought that ORF1 might provide this signal. (However, 
more recent sequence comparisons suggest there may be two different potential nuclear 
localization signals in tRNA ligase, one very near the beginning of the coding region but 
not within ORF1, and these are currently under investigation (Mark Berlin, personal 
communication).) 
Another possibility was that ORF1 was translated as a frameshift fusion protein to 
tRNA ligase. Frameshift translations are not unknown in yeast, as was demonstrated for 
the Ty elements in yeast (Clare and Farabaugh, 1985; Mellor et al., 1985). As a frameshift 
fusion, ORFl could be part of a signal to localize tRNA ligase to the yeast cell nucleus. At 
that time, these signals inCluded short sequences within the SV 40 large T antigen (Kalderon 
et al., 1984), the yeast alpha-2 protein (Hall et al., 1984), and the yeast histone H2B 
(Moreland et al., 1987). Therefore the predicted amino acid sequence of ORFl was 
searched for similarities to these nuclear localization signals. However, no similarities with 
these sequences were discovered in ORFl. 
Yeast tRNA ligase protein behaves during purification from yeast cells as a soluble 
or peripheral membrane protein (Peebles et al., 1983; Greer et al., 1983). Therefore, there 
was also the possibility that ORF1 , translated as a frameshift fusion to tRNA ligase, was 
acting as a membrane transfer signal which could be cleaved post-translationally after 
delivery of ligase to the nucleus, much like the signal leader sequences delivering newly 
translated polypeptides to the endoplasmic reticulum. Alternatively, ORF1 could be a 
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transmembrane domain fused to ligase to anchor it near the nuclear membrane, possibly 
being lost in the purification procedure of ligase from yeast cells. Two transplantation 
antigens of the murine major histocompatibility complex, mouse H-2Ld (Goodenow et al., 
1982; Moore et al., 1982) and mouse H-2Kb (Uehara et at., 1980a; Uehara et al., 1980b) 
of the mouse histocompatibility complex, contain transmembrane domains. Therefore, the 
predicted ORFl amino acid sequence was analyzed for its hydrophobicity (using Versions 
4.2 and 4.5 of the Intelligenetics PEP Hydropathicity programs of the BIONETfM National 
Computer Resource for Molecular Biology), and the profile was compared to that generated 
for the transmembrane domains of the mouse proteins. The plots of the mouse antigens 
were very similar to the hydrophobicity profile of the carboxyl-terminus of ORFI, which is 
near the overlap of the tRNA ligase gene. A comparison of these hydrophobicity profiles is 
shown in Figure 3. Because of these intriguing characteristics of the predicted ORFl 
sequence, experiments were conducted to determine if ORFl coded for RNA or protein in 
vivo (see Results, ORF 1). 
ORF2. ORF2 begins 342 nucleotides upstream from the beginning of the tRNA ligase 
coding region and proceeds in the opposite direction (Westaway et al., 1988; see Figure 1). 
This ORF produces a polyadenylated RNA transcript of approximately 2.1 kilobases that 
begins only 125 nucleotides away from the tRNA ligase transcription initiation site 
(Westaway et al., 1988). This proximity of the two transcription initiation sites suggested 
that tRNA ligase and ORF2 might share transcriptional regulatory signals. Very few other 
divergently transcribed genes in yeast are as closely situated with respect to their 
transcription initiation sites as are ORF2 and tRNA ligase. The possibility that ligase and 
ORF2 shared regulatory signals Jed to the speculation that the cellular function of ORF2 
might somehow be related to tRNA ligase, i.e., ORF2 might have some function in tRNA 
metabolism. 
The proximity of ORF2 to tRNA ligase and the possibility that they shared 
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regulatory signals or functions in the cell led to experiments which would determine: I) Is 
ORF2 an essential yeast gene?; 2) What are the in vivo genetic complementation 
characteristics of ORF2 and tRNA ligase?; 3) Does ORF2 perform a function in the yeast 
cell related to tRNA processing?; and 4) What is the nucleotide sequence and predicted 
amino acid sequence of ORF2 and does it possess similarity to any other genes? These 
questions are addressed in Results, ORF2. 
EXPERIMENTAL PROCEDURES 
Plasmids. Plasmid pYSW11, containing the E. coli beta-galactosidase gene fused to the 
first fifteen amino acids of yeast tRNA ligase was constructed as follows. Plasmid pSEY8 
was constructed by Scott Emr and is a derivative of yiP5 (Struhl et al., 1979) containing 
the yeast 2 micron fragment and the polylinker from pUC8 (Vieira and Messing, 1982). 
Plasmid pEP9B was constructed by Eric Phizicky and contains the 4.2 kilobase EcoRI 
fragment of pUC-RLG (Phizicky et al., 1986) inserted in the EcoRI site of pSEY8. The 
vector portion of pEP9B digested with BamHI and Nhel was ligated to the BamHI-Nhel 
gene fragment containing the tRNA ligase and ORF2 genes from pEP108 to create 
pYSW9. Plasmid pEP108 was constructed by Eric Phizicky and is an approximately 
7-kilobase Xbai-Xbal fragment of pEP99 (described in Westaway et al., 1988) inserted 
into the Xbal site of pUC12 (Vieira and Messing, 1982). Plasmid pSEYlOl, provided by 
Scott Emr, has a 1015-arnino acid fragment of E. coli beta-galactosidase (missing the first 9 
amino acids, including the initiation codon, replaced with an EcoRI-Smai-BamHI 
polylinker (Casadaban et al., 1980) inserted in pSEY8. The blunt Smal- Nrul fragment of 
beta-galactosidase from pSEY101 was inserted into pYSW9 in frame at a unique Hpal site 
fifteen amino acids downstream of the start codon of tRNA ligase to create p YSW11 . 
Figure 4 presents a schematic of the cloning procedure to create the ochre mutation 
in the predicted open reading frame of ORFl. Plasmid pSW30d was constructed by 
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cleaving pUC12-RLG (Phizicky et al., 1986) with Xbal and religating to remove the 
multiple cloning site downstream of tRNA ligase. M13 phage mpSW162 contains the 
ochre mutation at amino acid 76 of the ORF1 sequence, and is derived from site-directed 
oligonucleotide mutagenesis of M13 mpSW116, and M13mp11 derivative (Messing, 1983) 
containing the 595 base pair EcoRI(A) - Hpal fragment of the 4.2 kilobase EcoRI fragment 
containing ORF1 and the tRNA ligase gene (described in Westaway et al., 1988). Plasmid 
pEP108 is described above. 
Plasmid p YSW 18 was created by inserting the Xbal fragment of pEP99 (W estaway 
et al., 1988) into the Nhel site of yiPS (Struhl et al., 1979). Plasmid pYSW20 is the 
plasmid containing the ORF2/Xhol disruption and was created by cleaving pYSW18 at a 
unique Xhol site within ORF2, filling in the restriction site overhang, ligating, and 
transforming to E. coli JM101 (Messing, 1979). 
Plasmids created by Nuclease BAL31 digestion, diagrammed in the middle portion 
of Figure 10, were created by cleaving pEP108 (described above) at a unique Sal! site 
downstream of the ORF2 gene, treating with Nuclease BAL31 for various times, cleaving 
at the unique Xbal site downstream of the tRNA ligase gene, and inserting the resulting 
different-sized fragments into the Xbal and blunt Smal sites of pSEYC58. Plasmid 
pSEYC58 was constructed by Scott Emr and is a derivative of yCP50 (Johnston and 
Davis, 1984) containing the pUC8 polylinker, CENIV, ARS1, and URA3 yeast genes. 
Plasrnids created by Nuclease BAL31 digestion, diagra1Tl1Tled in the bottom portion 
of Figure 10, were first prepared by cleaving pEP108 (described above) at a unique Smal 
site downstream of the tRNA ligase gene, treating with Nuclease BAL31 for various times, 
cleaving at the Sal! site downstream of ORF2, and inserting the resulting different-sized 
fragments into the vector pSEY8. Plasmid pSEY8 was first prepared to accept the blunt-
ended Nuclease BAL31 ends by cutting with BamHI, filling in the restriction site 
overhang, and cleaving with Sal!. The resulting set of plasmids (pYSW21-24) were 
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digested with Smal and BamHI and the different fragments were inserted into the Smal and 
BamHI sites of pSEYC58. 
Plasmid pYSW93, which contains the intact ORF2 gene and the tRNA ligase gene 
missing the Kpnl fragment, was constructed by inserting the BamHI - Xbal fragment of 
p298-1 (Phizkky et al., 1992) in the identical sites of pSEYC58. 
Plasmid pYSW101A was constructed as follows. pYSW22 is one of the Nuclease 
BAL31-generated plasmids described above which contains approximately 680 base pairs 
of DNA upstream of the first EcoRI site in ORF2 (see Figure 10). The Smal - BamHI 
fragment of pYSW22 was inserted in the identical sites of pUC18 (Yanisch-Perron et al., 
1985) to create pSW82. A Hindlll- Sall fragment from pBM150 (Johnston and Davis, 
1984) containing the yeast GALlO promoter was filled in and inserted at a unique Nael site 
of pSW82 to create pSW86. The Sacl - BamHI fragment of pSW86 containing the GALl 0 
promoter fused 58 nucleotides upstream of the first ORF2 transcription start site, along 
with the entire ORF2 gene, was inserted at the Sacl and BamHI sites of pSEYC68 to create 
pYSWlOlA. Plasmid pSEYC68 is a derivative of pSEYC58 containing the pUC18 
poly linker, and was provided by Scott Ernr. 
Strains. EMPY20 (his3-!1200 ade2-101 o ura3-52 GAL+ suc2) is the diploid yeast strain 
constructed by Eric Phizicky by mating SS328 (MATa his3-!1200 lys2-80Ja ade2-101 o 
ura3-52 GAL+ suc2) to SS330 (MATa his3-!1200 tyrl ade2-101 o ura3-52 GAL+ suc2) 
(Westaway et al., 1988). Strains SS328 and SS330 were obtained from S. Scherer. 
SWY484A is EMPY20 with plasmid pYSWlOO integrated at the ORFllocus (see Figure 
6). SWY497 has been described previously (Westaway et al., 1988). SWY506A-D, 
507 A-D, and 508A-D are the haploid yeast strains resulting from sporulation of SWY 497. 
SWY333 is EMPY20 ORF2+forf2--VXhol and is represented as "3B8" in Figure 8. 
SWY515 (MAT a his3-!1200 lys2-80Ja ade2-JOr ura3-52 GAL+ suc2 orf2--VXhol 
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(pYSWJOJA)) is a haploid yeast strain resulting from the sporulation of SWY333 
transformed with pYSWIOIA. 
Bacterial strain E. coli JM 101 (Messing, 1979) was used for all recombinant 
plasmid and M13 phage manipulations. 
Bacterial and DNA Manipulations. Restriction enzyme digests were performed 
according to the manufacturer's instructions. Nuclease BAL31 digestions, bacterial 
transformations, plasmid ligations, filling in of restriction site overhangs, and plasmid 
preparations from bacterial cells were performed according to Maniatis et al. (1982). DNA 
sequencing was by the method of Sanger et al. (1977). 
Mutagenic oligonucleotides were provided by S. Horvath (California Institute of 
Technology), and were synthesized on an Applied Biosystems 380A DNA Synthesizer. 
Oligonucleotides were purified on 20% polyacrylamide 7 M urea gels, eluted in 1% phenol 
at 3TC, and ethanol precipitated. Mutagenesis, detection of mutant plaques, and isolation 
of double-stranded and single-stranded M13 phage were performed essentially as described 
by Maniatis et al. (1982). Briefly, the mutagenic oligonucleotide primer was 
phosphorylated with T4 polynucleotide kinase and hybridized to mpSW116. Klenow 
DNA polymerase and deoxyribonucleotides were used to synthesize the complement 
strand, and T4 DNA ligase and ATP for ligation. Tris-acetate agarose gels were performed 
to test the conversion of single-stranded M13 phage to the double-stranded species. Plaque 
lifts were performed on E. coli JM101 cells transformed with this construct. The viral 
DNA was denatured, neutralized, and bound to the filter by baking. The filters were 
probed with the oligonucleotide containing the mutation at increasing temperatures to 
iden6fy the positive plaques containing the ochre mutation. Probe was prepared by 
phosphorylation with T4 polynucleotide kinase and [y-32P]ATP, followed by separation of 
the 32P-labeled oligonucleotide from unincorporated label on a DE52 column. Positive 
plaques were plaque purified and retested as above, and double-stranded and single-
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stranded phage were prepared. Restriction site analysis of the double-stranded DNA and 
sequencing of single-stranded DNA confirmed the presence of the mutation. 
Yeast Methods. Transformations of competent yeast cells were essentially by the 
method of Ito et al. (1983). In vivo gene replacement by transformation and treatment with 
5-fluoroorotic acid was by the method of Boeke et al. (1984). Yeast cell growth and 
sporulation media were as described in Sherman et al. (1982). When yeast strains were 
grown in 2% galactose, 2% glycerol and 2% ethanol were added to supplement the carbon 
source, and glucose-free galactose was used (Phizicky et al., 1992). 
Small scale yeast extracts were prepared according to. Phizicky et al. (1992) and 
used to test splicing activity of yeast tRNA ligase. Splicing assays were performed 
according to Greer et al. (1983). The preparation of rabbit anti-tRNA ligase antibody has 
been described previously (Phizicky et al., 1986). Antibody against ORF1 was prepared 
from a New Zealand White rabbit after injection of a synthetic peptide corresponding to the 
first fifteen amino acids of the predicted ORF1 sequence (Phizicky et al., 1986). 
Spheroplasts were prepared by resuspending yeast cell pellets in 0.1 M phosphate citrate 
buffer (pH 5.8), 1.2 M Sorbitol, and 1 mg/ml Zymolyase. Spheroplasts were stored at 
-7o·c. SDS-polyacrylamide gels were performed according to Laemmli (1970). Proteins 
were visualized by silver-staining (Wray et al., 1981) or were transferred to nitrocellulose 
and probed with rabbit anti-ORF1 or rabbit anti-ligase antibody, or anti-beta-galactosidase 
antibody, conjugated to horseradish peroxidase, using BioRad Laboratories antibody 
staining kits. 
Genomic yeast DNA was prepared from yeast spheroplasts by the method of Davis 
et al. (1980). Southerns were performed according to Maniatis et al. (1982) using 
GeneScreen™ Hybridization Transfer Membranes (NEN Research Products, Boston, 
Mass.) according to the manufacturer's directions. Southern probes were prepared from 
double-stranded DNA fragments eluted from low melting point agarose Tris-acetate gels 
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after treatment of the appropriate plasmid with restriction enzymes. Probes were labeled by 
the method of Feinberg and Vogelstein (1984) using mixed sequence hexadeoxynucleotides 
pd(N)6 (Pharmacia), deoxyribonucleotides, [a-32P]dCTP, and Klenow DNA polymerase. 
Tetrad dissections were performed using a 1:30 dilution of Glusulase (NEN). 
32P-Orthophosphate Labeling of Yeast Cells and RNA Extraction. S WY 515 
and rna] cells were labeled with -orthophosphate essentially as described by Ogden et al. 
(1979) . Briefly, SWY515 cells were grown in galactose-glycerol-ethanol, harvested. 
washed, and diluted into low phosphate media containing glucose or galactose, and 
allowed to multiply for one generation (-2.5 hours) before labeling with 4 mCi 32Pi. Yeast 
strain rna] cells were grown at 23·c in glucose, harvested, washed, resuspended in low 
phosphate media containing glucose and allowed to grow for one generation ( -3 hours). 
Half of the rna] cells were equilibrated to 3TC (nonpermissive temperature) and then both 
the 23 ·c and 3TC cultures were labeled with 32Pi. Labeled RNAs were extracted from 
cells using the hot phenol method, separated on 10% polyacrylamide 4 M urea gels, and 
autoradiographed (Knapp et al., 1978). The small RNA region of this first dimension gel 
corresponding approximately to 4-5.8S RNA was cut out and reseparated in the second 
dimension on 20% polyacrylamide 7 M urea gels and autoradiographed (Knapp et al., 
1978). 
Materials. [a-32P]dNTPs and [y-32P]ATP were from Amersham Corp. 
Deoxyribonucleotides and mixed sequence hexadeoxynucleotides pd(N)6 were from 
Pharmacia LKB Biotechnology, Inc. Klenow fragment of DNA Polymerase I and T4 
polynucleotide kinase were from Bethesda Research Laboratories. Antibody staining kits 
were from BioRad Laboratories. Restriction enzymes were from New England Biolabs or 
Boehringer Mannheim. 32P-orthophosphate was from New England Nuclear. T4 DNA 
ligase was from Boehringer Mannheim. 
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RESULTS AND DISCUSSION 
ORFl. As previously reported (Westaway et al., 1988), Northern hybridization did not 
detect any polyadenylated RNA from yeast which could correspond to ORFl, either alone 
or as a fusion to the yeast tRNA ligase transcript. This did not rule out the possibility that 
ORF1 was transcribed alone and was not polyadenylated. In addition, no polypeptide of 
the correct size representing a translational frameshift fusion of ORFl to the yeast tRNA 
ligase protein was detected using anti-tRNA ligase antibodies to protein purified from yeast 
(Phizicky et al., 1986). This also did not rule out the possibility that ORFl was translated 
from a nonpolyadenylated RNA to produce a protein which contained only the ORF1 122 
amino acids. 
In collaboration with Michael Clark, a synthetic polypeptide corresponding to 
amino-terminus of ORFl was synthesized and used to generate polyclonal antibodies in 
rabbits. Spheroplasts were prepared from SS328 yeast cells harboring pEP99, a 2 micron 
plasmid overproducing the tRNA ligase gene (Westaway et al., 1988) and loaded on SDS-
polyacrylamide gels. Proteins were transferred to nitrocellulose and probed with the anti-
ORFl antibody. No ORFl protein was detected using this procedure (data not shown). 
This negative result could have been due to a very low and undetectable level of ORFl 
protein in vivo, or the amino acids of ORFl which would be recognized by the antibody 
may have been hidden in the predicted intact protein. Therefore we fused ORFl upstream 
of the E. coli beta-galactosidase gene to enable the use of a more effective antibody. 
Plasmid p YSWll was constructed containing all of the upstream ORF2 gene, all of ORFl, 
and the first fifteen amino acids of tRN A ligase fused to beta-galactosidase. Yeast strain 
SS328 was transformed with this plasmid, spheroplasts were prepared and proteins were 
separated on SDS-polyacrylamide gels. Proteins were transferred to nitrocellulose and 
probed with anti-beta-galactosidase antibody . Only two bands were detected, one 
corresponding to the size of beta-galactosidase alone, and one corresponding to the size of 
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beta-galactosidase with an additional 15 amino acids from tRNA ligase (data not shown). 
No protein was detected in the size range of beta-galactosidase plus the 122 amino acids of 
ORFl. However, these results did not preclude the possibility that very small amounts of 
ORFl were translated alone in vivo and were perhaps responsible for some other required 
function unrelated to tRNA ligase. 
To determine if translation of ORFl was essential in yeast, a nonsense mutation 
was constructed in ORFl by site-directed oligonucleotide mutagenesis in M13, using a 
synthetic oligonucleotide of the sequence: 5 '-AAGT ATAAAGAAGAGCA-3'. This 
mutation changes a tyrosine (TAC) residue at amino acid 76 of the ORF1 open reading 
frame to an ochre stop codon (T AA) and also deletes an Accl restriction enzyme cleavage 
site. It was necessary to make a relatively small disruption in this region, in this case only 
a one nucleotide change, in order to avoid disturbing either the ORF2 or tRNA ligase 
potential transcription signals. This mutated oligonucleotide was annealed, extended, 
ligated, and transformed to E. coli strain JM101 competent cells. Double-stranded M13 
was rescued which contained the mutation as detected by Accl restriction site analysis (data 
not shown). Single stranded M13 was also isolated and sequenced to insure the presence 
of the mutation (data not shown). An EcoRI to Bell DNA fragment containing the mutation 
was then substituted into a plasmid containing the entire tRNA ligase gene as well as all 
upstream DNA containing the ORF2 gene, and transferred to a yiP5 vector (Struhl et al., 
1979). Figure 4 is a diagram of the cloning procedure. The final vector, p YSWlOO, was 
cleaved once within the ORF2 gene at a unique Xhol restriction site, and used to transform 
competent EMPY20 yeast cells (Phizicky et al., 1992). 
Transformants were selected on media minus uracil and genomic DNA was 
prepared. DNA was digested with Accl, separated on a 1% TBE agarose gel, transferred 
to GeneScreen™ and probed with a fragment corresponding to the EcoRI to Hpal region 
encompassing the ORF1 gene. Figure 5, panel A is an autoradiograph of a representative 
yeast clone containing the mutation integrated in the chromosome at the ORFl locus. 
62 
The strain containing the mutation (SWY 484A) was then grown on 5-fluoroorotic 
acid to force loss by recombination of the URAJ+ gene, accompanying yiPS DNA, and the 
extra copy of the ORF2-0RF1-Iigase DNA sequence (Boeke et al., 1984). Genomic DNA 
was prepared from diploids which were now ura- and reanalyzed for the presence of the 
lesion. Figure 5, panel B is an autoradiograph of a representative yeast clone (SWY 497) 
containing one wild type and one mutated chromosome. This diploid was sporulated and 
tetrads were dissected. Figure 6 is a photograph of a dissection plate and indicates that 10 
of 10 tetrads dissected from SWY497 segregated 41ive and none dead. These haploids all 
demonstrated the correct segregation of markers (data not shown) and genomic DNA was 
prepared from each set. Figure 7 is an autoradiograph of a Southern blot with 
representative tetrad sets (SWY506A-D, 507 A-D, and 508A-D), indicating that in each 
tetrad, two of the four live spores still retained the mutation. The results of the ochre 
mutation indicate that ORFl is not an essential protein in yeast. Taken together with the 
lack of polyadenylated RNA detected for ORFl (Westaway et al., 1988), these results 
suggest that ORFl is probably not produced in yeast, either as an RNA or a protein, or if it 
is, it is not an essential gene. 
ORF2. The initial analysis of ORF2 function was undertaken in collaboration with Eric 
Phizicky. These studies were propelled by an early result of unusual genetic 
complementation with a chromosomal interruption in the yeast tRNA ligase gene. These 
results at first indicated that portions of the ligase coding region might be necessary for the 
production of ORF2, and are described below. 
As previously reported (Abelson et al., 1986), a disruption of the yeast tRNA ligase 
gene was made by cloning the HISJ+ gene into a unique Bglii site in the middle of the 
ligase gene. This disrupted gene was transformed into a his- diploid, integrated into the 
chromosomal tRNA ligase locus, and sporulated. Dissection of the resulting tetrads 
yielded two live and two dead spores, with the live spores all his-. This indicated that such 
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a disruption of the only chromosomal copy of tRNA ligase in a haploid yeast cell was lethal 
to the cell (Abelson et al., 1986). The RLG+frlg::HISJ+ diploid was then transformed 
with the 4.2 kilobase EcoRI fragment containing the entire yeast tRNA ligase gene (see 
Figure 1), either on a single copy URAJ+ plasmid (CEN) or a multicopy URAJ+ plasmid 
(2 micron). The transformants were selected on media lacking uracil and sporulated. The 
intact tRNA ligase gene on either plasmid failed to complement the disruption of the 
chromosomal copy of ligase (data not shown), even when the tRNA ligase gene was placed 
under the control of the GALlO promoter in order to induce overproduction of the protein 
(see below). However, assays for ligase activity in vitro using yeast extracts from the 
parental transformed diploids indicated that ligase activity was elevated 5-25 times over 
wild type activity, and protein gels hybridized to anti-tRNA ligase antibody demonstrated 
the presence of a correct size tRNA ligase polypeptide. Only when at least 2.3 kilobases of 
DNA upstream from the tRNA ligase gene was included on the plasmid was 
complementation obtained. Figure 8 is a schematic of these complementation results (Eric 
Phizicky, unpublished data). The 2.3 kilobases of DNA upstream from tRNA ligase 
necessary to complement the ligase disruption was approximately the same size as the 2.1 
kb transcript of ORF2. This result led us to believe that tRNA ligase was indeed being 
produced from the smaller plasrnids, but that the HISJ+ disruption at the chromosomal 
locus of tRNA ligase was deleterious to the upstream gene, ORF2. 
A different disruption of the yeast tRNA ligase gene was constructed using two 
unique Kpn! sites, deleting 1371 nucleotides (or 457 amino acids) from the center of the 
ligase coding region (Phizicky et al., 1992). A yeast diploid with this disruption in one 
chromosomal homologue was transformed with a plasmid containing the ligase gene under 
the control of the GALl 0 promoter, in which the GALl 0 promoter is fused near the 
beginning of the tRNA ligase coding region, omitting DNA upstream of the ligase gene 
(Phizicky et al., 1986). When this strain was sporulated, complementation by this plasmid 
was obtained (Phizicky et al., 1992), leading to the hypothesis that the original HISJ+ . 
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disruption was moving some region of the ligase gene too far downstream, possibly 
interfering with the transcription of ORF2. Alternatively, the Kpnl deletion disruption was 
moving this essential region closer, and therefore not interfering in the production of 
ORF2. 
Due to these unusual complementation results, it was necessary to determine if 
ORF2 was an essential gene in yeast. To accomplish this, a small disruption in the ORF2 
coding region was constructed by cleaving at a unique Xhol site mapped within the length 
of the ORF2 RNA transcript, filling in the restriction site overhang, and religating. Again, 
this type of small disruption was preferred, as a larger change may have affected the 
upstream tRNA ligase gene. This disruption added an additional four nucleotides within 
the putative ORF2 coding region, presumably throwing the coding region out of frame by 
one nucleotide, as well as destroying the unique Xhol site. Although the sequence of 
ORF2 was not known when this mutation was made, it was anticipated that it should have 
created a new stop codon downstream or created an altered amino acid sequence which 
presumably would no longer be capable of carrying out the ORF2 cellular function. This 
alteration is now known to have created a stop codon 8 amino acids downstream of the 
Xhol site, thus shortening the length of the ORF2 polypeptide from 623 amino acids to 297 
(Komatsoulis et al., 1987). 
The mutant ORF2 sequence was cloned into the yiP5 vector (Struhl et al., 1979), 
and the resulting plasmid (p YSW20) was linearized at a unique Nhel site located within the 
tRNA ligase gene and transformed into EMPY20 diploid yeast cells. Transformants were 
selected on media minus uracil, and genomic DNA was prepared. DNA from eight 
transformants was digested with EcoRV and Xhol and Southern analysis was performed to 
verify integration at the ORF2 locus (lanes 1-8, Figure 9). These diploids were subjected 
to 5-fluoroorotic acid treatment, and genomic DNA was prepared from the resulting ura-
diploids and redigested with EcoRV and Xhol. Southern analysis was performed to 
determine which diploids retained the Xhol mutation. Figure 9 is an autoradiograph of the 
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DNA from diploids before and after 5-fluoroorotic acid treatment. These diploid yeast 
were sporulated, and those retaining the mutation segregated 2 live:2 dead (data not 
shown). These tetrad sets correspond to the parent diploids from the lanes labeled I E5, 
3B8 (SWY333, see below), 4E2, and 6B9 in Figure 9. Those tetrad sets not retaining the 
mutation segregated 4 live:O dead (data not shown), and these tetrads correspond to the 
parent diploids from the lanes labeled 2CJ, 5D4, 7C6, and 8B3 in Figure 9. These results 
confirm that ORF2 is an essential gene in yeast. 
A yeast strain defective in ORF2 could now be tested in vivo using plasmid 
complementation to determine how much ORF2 and tRNA ligase sequence is necessary to 
restore life. In collaboration with Eric Phizicky, a set of plasmids was constructed and 
transformed to a yeast diploid with the ORF2 mutation in one chromosomal homologue 
(SWY333). These plasmids were created by exonuclease BAL31 treatment of an 
approximately 7-kilobase Xbal DNA fragment containing both the tRNA ligase and ORF2 
genes. Yeast diploids harboring the chromosomal ORF2 mutation and deletions of ORF2 
and/or ligase sequence on single copy URAJ+ centromere plasmids were sporulated, and 
live spores were analyzed for the correct segregation of markers in the strain itself, or on a 
plasmid, if present (data not shown). Strains lacking sufficient plasmid sequences to 
complement the ORF2 chromosomal lesion segregated 2 live:2 dead, while those with an 
activity complementing the ORF2 mutation segregated 4 live:O dead, 3 live: 1 dead, or 2 
live:2 dead, depending on the segregation of the plasmid's URAJ+ marker. These results 
are diagrammed in Figure 10. 
Nucleotide numbering in Figure 10 corresponds to the distance upstream or 
downstream of the first EcoRI site in ORF2. The first set of complementation results 
indicate that at least 1700 base pairs downstream from the EcoRI site in ORF2 are 
necessary to complement the ORF2 disruption. The beginning of ORF2 is 204 nucleotides 
upstream of the EcoRI site (Komatsoulis et al., 1987). Therefore approximately 1900 
nucleotides of ORF2 are necessary to complement the chromosomal disruption. This 
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represents all of the ORF2 open reading frame as well as approximately 40 nucleotides of 
downstream 3'-untranslated DNA (Komatsoulis et al., 1987). A plasmid with only 1560 
nucleotides downstream of the EcoRI site, or approximately 1700 nucleotides of ORF2, is 
insufficient to complement the ORF2 disruption. This plasmid is missing about 150 
nucleotides, or 50 amino acids, of the carboxy-terminus of the coding region of ORF2. 
The second set of complementation results are depicted at the bottom of Figure 10. 
These results indicate that 680 nucleotides upstream of the EcoRI site, or approximately 
4 70 nucleotides upstream of the ORF2 start codon, are not sufficient to rescue the ORF2 
disruption phenotype. It should be noted that this noncomplementing region contains all 
four of the transcription start sites mapped for ORF2 (Westaway et al., 1988). Some part 
or all of the stretch of DNA between 680 and 1680 nucleotides upstream of the EcoRI site 
is necessary in "cis" on the plasmid to restore life, and this region is contained entirely 
within the coding region of tRNA ligase. To narrow down the required nucleotides, 
plasmid pYSW93 containing all of ORF2 and tRNA ligase but missing the center Kpnl 
fragment containing 457 amino acids of tRNA ligase was used to test complementation of 
the ORF2 disruption. This plasmid contains up to 937 nucleotides upstream of the EcoRI 
site (same numbering as in Figure 10), and does restore life (data not shown). This result 
indicated that a region between nucleotides 680 and 937, or what corresponds to amino 
acids 44 through 130 of the tRNA ligase coding region, is sufficient to restore 
complementation of the ORF2 disruption. At this time, it is unknown what, if any, 
transcriptional regulatory signals might be contained within this region necessary for ORF2 
production. Additional evidence has shown that a plasmid construct containing the ORF2 
coding region fused to the GALlO promoter 58 nucleotides upstream of the first ORF2 
transcription start site (see below) is also sufficient to complement the ORF2 chromosomal 
disruption when grown on galactose media, but not on glucose (data not shown). It is 
assumed that this construct is overproducing the ORF2 transcript when grown on 
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galactose, and the GALlO promoter may be taking the place of a possible transcription 
regulatory signal in the 680-937 nucleotide region of tRNA ligase. 
Because of the close proximity of the transcriptional start sites of ORF2 and tRNA 
ligase and the unusual genetic complementation results described above, it was of interest 
to determine if the cellular function of ORF2 was related in any way to tRNA processing. 
A haploid yeast strain containing the chromosomal ORF2 disruption and harboring a 
suppressible copy of the wild-type ORF2 gene was needed. This strain would be used to 
detect defective tRNAs made in vivo after suppression of transcription of the plasmid-borne 
gene. Strain SWY515 contains a single copy centromere plasmid with the wild-type ORF2 
sequence under control of the GALl 0 promoter (p YSW 101 A). Growth curves on glucose 
or galactose media were first performed for SWY515, in comparison with EMPY439, a 
similar strain containing a chromosomal tRNA ligase disruption harboring the wild-type 
tRNA ligase gene under control of the GALlO promoter (Phizicky et al., 1992). This 
growth curve is shown in Figure 11 and indicates that cells deficient in ORF2 production 
cease multiplying on glucose in fewer generations than the 6-8 generations needed for 
tRNA ligase deficient cells (Phizicky et al., 1992). 
To ascertain whether a subset of incompletely processed tRNAs (i.e., precursor 
tRNAs or tRNA half molecules) accumulated in an ORF2-deficient strain, SWY515 was 
grown in galactose, shifted to either galactose or glucose media, and labeled with [32P]-
orthophosphate. RNA was extracted and separated by two-dimensional gel electrophoresis 
and the resulting autoradiographs were compared to those resulting from the treatment of 
temperature sensitive rna] cells at the nonpermissive temperature, which accumulate 
precursor tRNAs containing introns when incubated at the nonpermissive temperature 
(Hopper et al., 1978; Knapp et al., 1978). 
Figure 12, panels a and b, are autoradiographs of rnal cells at the permissive and 
nonpermissive temperatures. Several spots are seen to accumulate in the upper portion of 
the autoradiograph (see arrow) in the RNA extracted from cells treated at 3TC (b), but not 
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from cells grown at 23°C (a). These spots have been previously identified as precursor 
tRNAs containing introns (Knapp et al., 1978). However, no such accumulation is seen 
for SWY515 cells on either galactose or glucose (Figure 12, panels c and d), indicating that 
ORF2 is probably not a component of the yeast tRNA endonuclease and may not play any 
role in tRNA processing. 
The function of ORF2 in vzvo is still unknown, however, ORF2 has been 
completely sequenced and contains an open reading frame 1869 nucleotides long, coding 
for a putative protein of 623 amino acids, or 71.3 kDa (Komatsoulis et al., 1987). ORF2 
probably does not contain an intron, as the sequence does not contain the canonical 
"T ACTAAC" box presumed necessary for mRNA splicing in yeast (Komatsoulis et al., 
1987). The ORF2 amino acid sequence was not found to be significantly homologous to 
any protein in the NBRF database (National Biomedical Research Foundation protein 
database of the BIONET™ National Computer Resource for Molecular Biology) 
(Komatsoulis et al., 1987). Sequences yet to be reported for essential yeast genes, or 
future sequences of proteins from yeast or other organisms could reveal a potential function 
for the essential ORF2. 
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FIGURE LEGENDS 
FIG. 1. Open Reading Frames Near the tRNA Ligase Gene. Open reading 
frames coding for potential proteins of greater than 150 amino acids are shown as linear 
arrows (not to scale) above and below the linear representation of the yeast genomic 4.2-
kilobase EcoRI fragment containing the tRNA ligase gene (from Westaway et al., 1988). 
The designations (ORFJ, ORF2, ORF3, and ORF4(ARG3)) are shown above each arrow 
(0RF4 is the yeast ARG3 gene, see Rationale) and their potential length in amino acids 
(aa's) is shown below. Relevant restriction enzyme recognition sites are depicted to 
provide points of reference. 
FIG. 2. Enlargement of the Overlap Between the Predicted ORFl Sequence 
and the tRNA Ligase Gene. The nucleotide sequence of the region of overlap 
between ORFl and tRNA ligase is depicted with small brackets above and below indicating 
the codons and their corresponding amino acids for both open reading frames. OPEN 
READING FRAME indicates ORF1; tRNA LIGASE indicates the tRNA ligase open 
reading frame. The large black arrow indicates the initiation codon for tRNA ligase. 
FIG. 3. Hydrophobicity Profiles of ORFl vs . Murine Transplantation 
Antigens. A hydrophobicity profile (see text) is shown for the predicted ORFl amino 
acid sequence compared to two transplantation antigens of the mouse histocompatibility 
complex, mouse H-2Ld (Goodenow et al., 1982; Moore et al., 1982) and mouse H-2Kb 
(Uehara et al., 1980a and 1980b). Only the profile of the transmembrane domains of the 
mouse antigens are shown, and are raised two units above the origin line for clarity. 
Hydrophobic regions are plotted above the axis and hydrophilic regions below the axis. 
5'-0PEN READING FRAME designates the profile for ORFl; symbols are as follows: 
(• ), ORF1; (o), mouse H-2Kb; (x), mouse H-2Ld. 
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FIG. 4. Diagram of the Cloning Procedure for the ORFl Ochre Mutation. A 
diagram of the cloning procedure for pYSWlOO is presented. Arcs filled in black 
correspond to fragments of or an intact tRNA ligase ge.ne. Arcs with cross hatching 
indicate an intact ORF2 gene. Arcs with light stippling correspond to the putative ORFl 
reading frame, and the "X'' within this arc represents the ochre mutation described in the 
text. Pertinent genes in the yiPS and pYSWlOO vectors are indicated as follows: AMP, 
ampicillin resistance gene of E. coli (beta-lactamase); TET, tetracycline resistance gene; 
URA3, yeast URA3+ marker; and T, the disrupted TET gene in pYSWlOO conferring 
tetracycline sensitivity for selection of the insert in E. coli. Pertinent restriction sites in the 
plasmids are indicated by the following abbreviations: E, EcoRI; Ace/, Accl; Be, Bell; Xb, 
Xbal; Hp/Hc, the Hpal!Hincll junction of M13 phage mpSW116 (see Experimental 
Procedures); Na, Nael; Nh, Nhel; B, BamHI; and Xh, Xhol. Restriction digests are 
indicated by the letters inside the bridges between the arrows in the flowchart. The 
construction of plasmid pSW30d and M13 phage mpSW162 is described in Experimental 
Procedures. Double-stranded mpSW162 and pSW30d were digested as indicated and the 
EcoRl- Bell fragment of mpSW162 containing the ochre mutation ("X'') and deleting the 
Accl site was inserted in the vector portion of pSW30d to create pSWS4. The construction 
of pEP108 is described in Experimental Procedures. Plasmids pSWS4 and pEP108 were 
digested as indicated and the Nael - Nhel fragment of pSWS4 was inserted in the vector 
portion of pEP108 to create pSW99. Plasmids pSW99 and yiPS were digested with 
BamHI and the fragment of pSW99 containing the ochre mutation was inserted in the 
tetracycline resistance gene of yIPS to create p YSW 100. 
FIG. S. Southern Hybridization of Genemic DNA From Strains with an 
Ochre Mutation in ORFl. Panel A shows genomic DNA isolated from a strain 
(SWY484A) transformed with an integrating plasmid containing the ochre mutation before 
treatment with S-fluoroorotic acid. The DNA was digested with Accl, separated on an 
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agarose gel, and hybridized to a probe spanning the region of the ochre mutation (see 
Experimental Procedures). Panel B shows genomic DNA from SWY 484A after treatment 
with 5-fluoroorotic acid (SWY497). Approximate lengths of Accl-digested DNA 
fragments are shown at left. Controls in both panels are as follows: pEP 108 (lane 1, 
panels A and B), plasmid DNA containing the wild type sequence indicates the migration of 
two expected Acci fragments; pYSWJOO (lanes 2 and 3, panels A and B), plasmid DNA 
containing the ochre mutation indicates migration of an Acci fragment which is the sum of 
the two fragments in lane 1, and indicates the deletion of the Acci site at the ochre mutation; 
EMPY20 (lane 4, panels A and B), genomic DNA from the parent strain without the ORFl 
mutation; SWY484A (lane 5, panel A), genomic DNA containing the wild type ORFl 
sequence on both chromosomal homologues as well as the extra copy of the ORFl locus 
containing the ochre mutation; SWY497 (lane 5, panel B), genomic DNA containing the 
wild type ORFl sequence on one chromosomal homologue and retaining the ORFl ochre 
mutation with the Accl site deleted on the other homologue after treatment with 5-
fluoroorotic acid. 
FIG. 6. Segregation of Spores From SWY497 Tetrads. A photograph of a 
representative tetrad dissection plate is shown for diploid strain SWY 497 containing one 
wild type and one mutated ORFl chromosomal locus. The patch at the top is SWY497 
taken from a sporulation plate and treated with glusulase to dissolve the encapsidated 
tetrads. Ten tetrads were dissected top to bottom and indicate a segregation for the 
mutation of four live spores. 
FIG. 7. Southern Hybridization of Haploid Strains From the Sporulation of 
SWY 497. Three representative tetrad sets from the plate in Figure 6 were analyzed for 
the presence of the ORFl mutation (SWY506A-D, SWY507A-D, and SWY508A-D). 
Genomic DNA was isolated, digested with Acci, separated on an agarose gel, and probed 
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with the appropriate DNA fragment (see Experimental Procedures). Approximate sizes of 
Accl DNA fragments are shown to the right. Controls (EMPY20 and pYSWJOO) are the 
same as for Figure 5. For each tetrad set, two haploids still retain the ochre mutation in 
ORFl. 
FIG. 8. Plasmid Complementation of a HIS3 Chromosomal Disruption of 
Yeast tRNA Ligase. A diagram of the genetic complementation results of a 
RLG+Irtg::H/SJ+ chromosomally disrupted strain is shown (Abelson et al., 1986). The 
HIS3 gene insert at the Bglii site of the yeast tRNA ligase chromosomal locus is shown at 
the top. The 4.2 kilobase EcoRI fragment is the line with hash marks at each end and the 
tRNA ligase open reading frame is indicated below with a solid black circle indicating the 
ligase start codon, followed by an arrow for the length of the polypeptide. Vectors are 
described as either yeast single copy plasmids (CEN), yeast multicopy plasmids (2J.1), or a 
single copy plasmid with the tRNA ligase open reading frame fused to the yeast GALl 0 
upstream activation sequence (CEN + GAL UAS). Splicing activity of diploids with the 
HIS3 disruption containing either the 4.2 kilobase EcoRI fragment on a 2).1 plasmid or a 
CEN plasmid with ligase fused to the GAL UAS is indicated as 5-fold (5X) or 25-fold 
(25X) over wild type ligase activity . For these two strains, the presence of the correct size 
ligase polypeptide is indicated, as measured by Western blot. Hash marks on lines in the 
lower section of the figure indicate the presence or absence of additional genomic DNA 
upstream of the yeast tRNA ligase gene, including all or part of the ORF2 open reading 
frame. Complementation by each plasmid as determined by sporulation of the respective 
diploid strain is indicated in the far right column. POOR(GALACTOSE) indicates that 
growth on galactose of spores from the tetrad is much slower than wild type (data not 
shown). When the strain is sporulated on glucose (NO(GLUCOSE)), which represses the 
GAL-controlled plasmid copy of tRNA ligase, the CEN + GAL UAS plasmid does not 
rescue the chromosomal disruption. 
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FIG. 9. Southern Hybridization of Diploid Strains Containing a Disruption 
in ORF2. Genomic DNA was isolated from EMPY20 transformed with an integrating 
plasmid containing a 4 base pair insertion at the Xhoi site in ORF2 (see Experimental 
Procedures). DNA was digested with Xhoi and EcoRV, separated on an agarose gel, and 
probed with the appropriate DNA fragment (see Experimental Procedures). Approximate 
sizes of hybridizing fragments are shown at the right. The -2680 nucleotide band 
corresponds to an EcoRV - Xhoi fragment of ORF2; the -4080 nucleotide band 
corresponds to a larger EcoRV- EcoRV fragment of ORF2 resulting from the elimination 
of the Xhoi recognition site. Controls (pYSWJOO andpYSW18) are plasmid DNA 
digested with EcoRV and Xhoi. pYSW18 is a plasmid containing the wild type ORF2 
sequence and p YSW20 is p YSW18 with the X hoi site in ORF2 cleaved, filled in, and 
religated, destroying the Xhoi site (see Experimental Procedures). Lanes labeled 1-8 are 
DNA from eight isolates of EMPY20 transformed with the integrating plasmid containing 
the ORF2 disruption, before treatment with 5-fluoroorotic acid. Lanes labeled 2CJ, 5D4, 
7C6, and 8B3 are DNA from four ura- isolates of the above strain after treatment with 5-
fluoroorotic acid, and indicate that the ORF2 mutation has been "popped out," leaving 
behind a wild type ORF2 sequence on each chromosome. Lanes labeled JE5, 3B8, 4E2, 
and 6B9 are DNA from four ura- isolates of the above strain after treatment with 5-
fluoroorotic acid and show that one chromosomal homologue still retains the ORF2 
mutation. 
FIG . 10. Plasmid Complementation of the Xhoi Disruption of ORF2. A 
diagram of the genetic complementation results of an ORF2+!orf2--VXhol strain 
(SWY333, see text and Experimental Procedures) is shown. The four base pair insert at 
the X hoi site of the ORF2 chromosomal locus is shown at the top. The -7 -kilo base 
genomic DNA fragment containing the ORF2 and tRNA ligase (RLG) genes is shown 
below the arrows indicating the reading frames for each gene, with relevant restriction 
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sites. All plasmids used for the complementation studies were single copy yeast vectors 
(CEN). Complementation by each plasmid as determined by sporulation of the respective 
transformed diploid strain is indicated in the column labeled COMPLEMENTATION?. 
BAL31 brackets indicate in which orientation the exonuclease reaction was allowed to 
proceed. Numbers above each linear plasmid represent the approximate length in 
nucleotides left or right from the most 5' EcoRI recognition site (with respect to the 
direction of the gene) in ORF2. 
FIG. 11. Growth Curves for Galactose or Glucose Incubation of SWY515 
and EMPY 439. Haploid strains containing chromosomal disruptions of either the ORF2 
gene (SWY515) or the tRNA ligase gene (EMPY439) but harboring plasmids with their 
corresponding genes under the control of the GALlO promoter (see text and Experimental 
Procedures) were grown in galactose or glucose and A6oo was monitored. Strains were 
diluted into fresh media in order to maintain log phase growth. Symbols for each plot are 
identified in the legend at the right of the graph. Legend designations are as follows: 
GAL, growth in galactose; GLUC, growth in glucose; Diln, first dilution in galactose for 
both strains; Diln# 1, first dilution in glucose for both strains; Diln#2, second dilution in 
glucose for EMPY 439 only (SWY515 ceased vegetative growth). 
FIG. 12. Two-Dimensional Gels of RNA Extracted From rnal and SWY515 
Cells. Autoradiographs of two-dimensional 4-5.8S small RNAs extracted from mal cells 
grown at the permissive (23 °C, panel a) or nonperrnissive temperatures (JrC, panel b), or 
SWY515 cells grown in galactose (GAL, panel c) or glucose (GLUC, panel d) are shown 
(see Experimental Procedures). Brackets indicate migration of pre-tRNAs or mature 
tRNAs as identified by Knapp et al. (1978). 
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INTRODUCTION TO CHAPTERS III & IV 
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In the following research, attention has been focused specifically on the structure and 
function of tRNA ligase from Saccharomyces cerevisiae. Yeast tRNA ligase is responsible 
for the second step in tRNA splicing: ligation of the two tRNA halves resulting from 
endonucleolytic cleavage of those precursor tRNAs containing an intron (Peebles et al. , 
1979; Greer et al., 1983; Peebles et al., 1983). In the first step of tRNA splicing, yeast 
endonuclease removes the intron in an ATP-independent reaction by cleaving at the 5' and 
3' splice sites, leaving a 2',3'-cyclic phosphate at the 3' end of the 5' halftRNA and a 5'-
hydroxyl on the 3' half tRNA (Knapp et al., 1979; Peebles et al., 1983). Yeast tRNA 
ligase possesses multiple activities which are necessary to correctly splice the two termini, 
resulting in a mature tRNA. An ATP-independent cyclic phosphodiesterase activity opens 
the 2' ,3' -cyclic phosphate of the 5' half tRNA to a 2' -phosphate. An ATP-dependent 
kinase activity phosphorylates the 5' -hydroxyl of the 3' half tRNA. An ATP-dependent 
adenylylate synthetase activity adenylylates the newly created 5'-phosphate of the 3' half 
tRNA through an adenylylated enzyme intermediate. Finally, a ligase activity joins the two 
activated tRNA halves, resulting in a 2' -phosphomonoester, 3' ,5' -phosphodiester bond at 
the splice junction. 
Yeast tRNA ligase has been cloned and overexpressed in E. coli (Phizicky et al., 
1986), and the gene has been sequenced (Westaway et al., 1988). Protease resistant 
fragments of tRNA ligase purified from E. coli still retain a subset of the multiple activities 
listed above (Xu et al., 1990). In order to futher delineate the domains of ligase 
responsible for each of these activities, a gene deletion analysis was performed in 
collaboration with Barbara Apostol, Heather Belford, and Chris Greer of the University of 
California, Irvine. The results of this deletion study are summarized below and are 
presented in Apostol et al. (1991). 
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Since some of the deletions might result in completely inactive protein, to facilitate 
protein purification, these deletion mutations were joined at the amino-terminus to E. coli 
DHFR (dihydrofolate reductase). The plasmid used to construct all the deletions has an 
inducible bacterial promoter (ptac), fused to DHFR, then fused in frame to full-length yeast 
tRNA ligase using a linker which was designed to contain a Factor Xa cleavage site. This 
site allowed removal of the DHFR portion of the protein after purification, in case DHFR 
was shown to interfere with any of the ligase activities. The yeast ligase sequence is 
followed by translation termination codons in all three reading frames, and the rrnB 
bacterial transcription terminator. After transformation into E. coli, the fusion proteins 
were purified using an affinity column containing methotrexate, which is an analog of 
DHFR's natural substrate. The DHFR portion binds the column and the fusion protein can 
then be washed and eluted with folate. 
Figure 1 is a schematic of the deletion mutants constructed (after Apostol et al., 
1991). D stands for E. coli dihydrofolate reductase, designated by the single black line. 
The light stippled section is the A region and contains the site of adenylylation. K stands 
for the proposed kinase region, in white, assigned on the basis of sequence similarities and 
enzymatic assays of protein fragments. C, the dark stippled section, stands for the cyclic 
phosphodiesterase region. Each possible combination of domains was constructed, i.e., 
full-length fusion protein DAKC, containing all three domains; single domain constructs, 
DA, DK, and DC; double domain constructs DAK, DKC, and DAC; and two other 
deletions made using available restriction sites within the ligase gene, DRD.Ndel and 
DMXmni. The amino acids of yeast tRNA ligase that are included in each deletion 
construct are shown in Figure 1. The construction of these deletions is described in detail 
in Apostol et al. (1991). Important points to note are that a new Hpal site has been created 
at amino acid 396 of the tRNA ligase coding region using oligonucleotide mutagenesis. 
This mutation changes amino acid #397 from an aspartate to a serine, and amino acid #401 
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from a lysine to a serine. These amino acid substitutions had no effect on the joining 
activity of the full-length fusion protein, DAKC. 
These deletion constructs were purified and tested for all of the separate activities of 
tRNA ligase. For complete splicing activity, each fusion protein was tested for joining of 
radiolabeled tRNA3LeusUP53 halves in the presence of ATP, and separated on denaturing 
polyacrylamide gels. For kinase activity, the ability of the fusion protein to radiolabel a 
cold oligonucleotide using [y-32P]ATP was tested, and the products were separated on 
denaturing polyacrylamide gels. For cyclic phosphodiesterase activity, a radiolabeled RNA 
of repeating 6-mers was transcribed in vitro and cleaved by Nuclease N1 to yield 
radiolabeled 2' ,3' -cyclic phosphate ends. These oligomers were used to test the ability of 
the fusion protein to open a 2' ,3' -cyclic phosphate to a 2' -phosphate, and the products 
were digested with RNase A, separated by thin layer chromatography, and 
autoradiographed. The assay for protein-AMP adduct formation, or adenylylate 
synthetase, was autoradiography of the fusion protein on SDS-polyacrylamide gels after 
incubation with [a-32P]ATP. Finally, substrate binding was measured by incubation of 
the fusion protein with radiolabeled pre-tRNA3Leu followed by gel shift in non-denaturing 
protein-RNA gels. Table 1 depicts the results of these activity assays for each of the fusion 
proteins. 
Several interesting results emerge from the activity assays catalogued in Table 1. 
The cyclic phosphodiesterase assays indicate that only those deletion constructs containing 
the carboxyl terminus, or C region, of ligase contain cyclic phosphodiesterase activity. 
This confirms the result of Xu and coworkers that a C-terminal fragment of intact tRNA 
ligase still retains the cyclic phosphodiesterase activity (Xu et al., 1990). 
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1T bl a e 1. Activities o fDHFR/L" tgase Dl. C e etwn onstructs. 
Name of Phospho- Adenylylate tRNA 
Deletion Lig_ation Kinase diesterase Synthetase Binding 
DAKC YES YES YES YES YES 
DA POOR2 NO NO YES3 NO 
DK NO NO NO NO NO 
DC NO NO YES NO NO 
DAK POOR2 NO NO YES YES 
DKC NO YES YES NO YES 
DAC YES NO YES YES3 YES 
DMNdei NO NO YES POOR NO 
DMXmnl NO NO YES NO NO 
I Results are from Apostol et al. (1991). 
2Fusion proteins DA and DAK ligated tRNA halves only poorly, requiring a 100-1000 fold 
excess of protein to detect spliced product. 
3Fusion proteins DA and DAC were adenylylated approximately twice as efficiently as 
DAKC. 
The adenylylate synthetase activity is also as expected. Only those deletion 
constructs containing an approximately 40 kilodalton amino-terminal fragment of tRNA 
ligase, or the A region, can be adenylylated with ATP. DA and DAC adenylylate more 
efficiently perhaps because they are more stable than wild-type; or perhaps the K domain 
has an inhibitory effect on adenylylation. The deletion construct DR~Ndel adenylylates 
only poorly, and DMXmni does not have any adenylylate synthetase activity, indicating 
that almost all of the amino-terminal 396 amino acids are required for this activity. 
Pre-tRNA binding is negative for the single domain constructs, but positive for any 
of the two domain constructs, and therefore requires any two of the three domains, 
indicating that the single pre-tRNA binding site of ligase (Apostol and Greer, 1991) may be 
composed of more than one element within the linear ligase sequence. Neither the Ndel or 
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Xmnl deletion constructs were capable of pre-tRNA binding, and this could reflect a 
general instability of these proteins. 
A surprising result was that kinase activity was seen only for DKC, and not for OK 
or DAK, which also contain the proposed kinase domain. Perhaps the kinase domain 
extends beyond the boundary at amino acid #595, and into the C domain, as neither DK 
nor OAK contain any C-terrninal region. 
The most surprising result obtained is that joining activity is seen for DAC, which 
does not contain the proposed kinase domain. The kinase assay at this time indicated that 
DAC did not possess a kinase activity. However, the mechanism of joining tRNA halves 
for the wild-type yeast enzyme requires the phosphorylation of the 3' half tRNA (Greer et 
al., 1983). The joining mechanism of DAC might be different than that of tRNA ligase, or 
the structure of the final product may not be authentic mature tRNA. 
For this reason, we undertook a detailed analysis of the DAC joining reaction to 
determine the exact structure of the spliced product, as well as any other characteristics of 
the splicing reaction which might differ from the full-length DHFR/ligase fusion protein, 
DAKC. These results are covered in Chapter 3, and Chapter 4 presents experiments which 
deal with the extrapolation of the results with the DAC mutant protein to the full-length 
OAK C. 
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FIGURE LEGEND 
FIG. 1. DHFR/Ligase Deletion Constructs. A schematic is shown (as presented in 
Apostol et al. , 1991) depicting the DHFR fusion to a set of deletion constructs of the yeast 
tRNA ligase gene. D stands for the amino-terminal dihydrofolate reductase gene from E. 
coli, indicated by the single black line. A stands for the adenylylate synthetase region, 
indicated by the light stippled box. K stands for the proposed kinase domain, indicated by 
the white box. C stands for the cyclic phosphodiesterase domain, indicated by the dark 
stippled box. Amino Acids of RNA ligase which each deletion construct still retains are 
indicated. Numbering above the top line indicates the amino acid number at each junction. 
Letters corresponding to hash marks below the top line indicate relevant restriction enzyme 
sites used in the constructions. Abbreviations are as follows: H, Hpal; X, Xbal; N, Ndel ; 
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SUMMARY 
Yeast tRNA ligase possesses multiple activities which are required for the joining of tRNA 
halves during the tRNA splicing process: cyclic phosphodiesterase, kinase, adenylylate 
synthetase, and ligase. A deletion polypeptide of a DHFR-ligase fusion protein, designated 
DAC, was previously shown to join tRNA halves although A TP-dependent kinase activity 
was not measurable in the assay used. We describe here a characterization of the 
mechanism of joining used by DAC and the structure of the tRNA product. DAC produces 
a joined tRNA and a splice junction with a structure identical to that produced by DAKC, 
the full-length DHFR-ligase fusion . Furthermore, DAC can use GTP as the sole cofactor 
in the joining reaction, in contrast to DAKC, which can only complete splicing in the 
presence of ATP. Both enzymes exhibit GTP-dependent kinase activity at 100-fold greater 
efficiency than with ATP. These results suggest that a potential function for the center 
domain of tRNA ligase (missing in DAC) is to provide structural integrity and aid in 
substrate interactions and specificity. They also support the hypothesis that ligase may 
prefer to use two different cofactors during tRNA splicing. 
INTRODUCTION 
In the yeast, Saccharomyces cerevisiae, there are about 400 tRNA genes, of which 
approximately 20% contain an intron which interrupts the functional portion of the tRNA 
(Ogden et al., 1984, reviewed in Abelson, 1991). These introns are small (13-60 bases), 
and are all located at the same position in each gene, one base downstream from the 
anticodon. For those precursor tRNAs (pre-tRNAsl) containing an intron, processing of 
transcripts includes a three-step reaction called tRNA splicing. The tRNA splicing pathway 
in yeast has been extensively characterized (Peebles et al., 1979; Peebles et al., 1983; Greer 
et al., 1983). The first step requires tRNA endonuclease, which removes the intron in an 
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A TP-independent reaction by cleaving at the 5' and 3' splice sites of the intron, resulting in 
a 2',3'-cyclic phosphate at the 3'-end of the 5'-halftRNA, and a 5'-hydroxyl on the 3'-half 
tRNA. The second step requires tRNA ligase, which joins the two halves to form a tRNA 
with a 2'-phosphate and a 3'-5' phosphodiester bond at the splice junction. The final step 
of splicing is the removal of the 2' -phosphate by a novel NAD-dependent 2'-
phosphotransferase (McCraith and Phizicky, 1991). 
In this research, we have focused specifically on the second enzyme in the splicing 
pathway, the tRNA ligase. The gene encoding tRNA ligase is essential in yeast (Abelson et 
al., 1986). It has been cloned (Phizicky et al., 1986) and sequenced (Westaway et al., 
1988), and encodes an 827 amino acid basic protein of molecular mass 95 kDa. The 
protein can be overexpressed and purified from E. coli . The ability to obtain large 
quantities of purified protein which is fully active in splicing provides a unique opportunity 
to study structure/function relationships in this complex enzyme. 
Yeast tRNA ligase possesses multiple enzymatic activities which accomplish the 
joining step of splicing: 1) cyclic phosphodiesterase activity to open the 2' ,3' -cyclic 
phosphate of the 5' -half tRNA to a 2' -phosphate; 2) kinase activity to phosphorylate the 5'-
hydroxyl of the 3'-half; 3) adenylylate synthetase activity to activate the 3'-half by 
transferring an AMP residue to the 5' -phosphate through an adenylylated enzyme 
intermediate; and 4) ligase activity to join the activated tRNA halves. 
Evidence is compelling that the several activities of tRNA ligase are organized into 
distinct enzymatic domains. Partial proteolysis of the intact polypeptide and assay of the 
fragments for ligase-associated activities has confirmed that the region responsible for 
cyclic phosphodiesterase activity resides in the carboxy-terminus of the polypeptide, while 
the site of adenylylation lies in the amino-terminal half, specifically, at amino acid residue 
lysine-114 (Xu et al., 1990). It is appropriate to note that bacteriophage T4 RNA ligase 
and T4 polynucleotide kinase together can substitute for yeast tRNA ligase in in vitro 
splicing reactions (Greer et al., 1983), because T4 RNA ligase also adenylylates the 5'-
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phosphate of its RNA substrate through an adenylylated enzyme intermediate (reviewed in 
Uhlenbeck and Gumport, 1982). There are distinct regions of limited sequence similarity 
between yeast tRNA ligase and both of the T4 enzymes, including the sites of adenylylation 
of the yeast and T4 ligases (Xu et al., 1990; Apostol et al., 1991), adding further 
corroboration for a domain-like organization of tRNA ligase. 
Previous work has focused on the delineation and characterization of the domains 
of tRNA ligase (Apostol et al., 1991 ). We reported the fusion of the tRNA ligase gene to 
the E. coli dihydrofolate reductase gene (DHFR I) to facilitate purification of the protein. 
The full-length DHFR-ligase fusion and large deletions of that fusion were characterized 
with respect to cyclic phosphodiesterase, kinase, adenylylate synthetase, and ligase 
activities, and binding of pre-tRNA substrate. The nomenclature of these fusion proteins 
reflects the domains and proposed activities which are still present in each deletion. Thus, 
the full-length DAKC fusion includes the DHFR domain "D" (present in all deletions and 
the full-length fusion), the "A" domain (adenylylate synthetase), the "K" domain (for 
proposed kinase), and the "C" domain (cyclic phosphodiesterase). Using these deletions, 
we showed that any two domains of tRNA ligase (i.e., A+ K, K + C, or A+ C) were 
sufficient to bind pre-tRNA. We have shown that the region responsible for adenylylation 
lies within amino acids 1-396 (the A region) and the region responsible for cyclic 
phosphodiesterase lies in the carboxy-terminus within amino acids 595-827 (the C region). 
Further, we showed that regions K and C were both necessary for measurable kinase 
activity. One interesting deletion construct, DAC, missing amino acids 397-594 in the 
proposed K region of the polypeptide, was still able to complete the splicing reaction at an 
efficiency of 60-100% compared to DAKC, the full-length ligase fusion. This result 
appeared to contradict the finding that both the K and C regions are required for kinase 
activity, essential in phosphorylating the 3' -half tRNA during splicing. 
In this paper, we report the further characterization of DAC and its tRNA splicing 
product. As previously reported, DAC can be adenylylated, and is able to join tRNA 
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halves in the presence of ATP, bind precursor tRNA, and open a 2 ' ,3'-cyclic phosphate to 
a 2' -phosphate. However, ATP-dependent kinase activity was not detected by assaying 
incorporation of radiolabeled phosphate to an oligonucleotide substrate (Apostol et al., 
I 991 ). Phosphorylation is an intrinsic step in the activation of the 3' -half tRNA in the 
normal splicing reaction . The result is that the phosphate in the newly-formed splice 
junction is derived from they-position of a nucleotide triphosphate cofactor (Greer et al., 
1983). Two possibilities exist to explain the ability of DAC to join tRNA halves. Either 
DAC uses a novel mechanism for ligation without kinase activity, or DAC uses the same 
mechanism for ligation as DAKC, but with different cofactor or substrate requirements. 
We favored the second hypothesis, because tRNA joined by DAC appeared to be 
equivalent to that spliced by DAKC. Radiolabeled tRNA spliced by either enzyme migrates 
in the same position on polyacrylamide gels (Apostol et al. , 1991 ). When those spliced 
tRNAs are analyzed by RNase Tl digestion followed by gel electrophoresis, a Tl-resistant 
oligonucleotide of unique size is produced for both enzymes indicating the presence of a 2'-
phosphate at the splice junction (data not shown). Since the RNase Tl patterns are the 
same for both enzymes, it is conceivable that DAC produces a mature tRNA with a 
structure analogous to that produced by the wild type enzyme, and therefore most likely 
uses the same mechanism in splicing. 
In order to test this hypothesis, we further examined the nature of the splice 
junction created by DAC and the cofactor requirements of DAC and DAKC in joining and 
phosphorylation reactions. We describe below experiments which demonstrate that DAC 
joins tRNA halves to produce a splice junction identical to that produced by DAKC, and, 
unexpectedly, can use GTP as the only cofactor in the splicing reaction. This is in contrast 
to DAKC, which has no measurable ligase activity with GTP alone. We further 
demonstrate that both DAC and DAKC have GTP kinase activity with both non-tRNA and 
authentic tRNA substrates. These results have raised the possibility that the mechanism of 
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tRNA splicing by native yeast tRNA ligase in vivo may include the use of two different 
nucleotide cofactors. 
EXPERIMENTAL PROCEDURES 
Materials----Yeast tRNA splicing endonuclease, fraction 71 of a Sepharose CL-6B gel 
filtration step, was kindly provided by R. Rauhut (Rauhut et al., 1990). DEAE-Sephadex 
(A-25), polyoxyethylene 20 cetyl ether (Brij 58), and DNase I were obtained from Sigma. 
Phage T7 RNA polymerase and Ultrapure ATP, CTP, GTP, and UTP were obtained from 
Pharmacia LKB Biotechnology, Inc. Phage T4 polynucleotide kinase (T4 PNKI) was 
obtained from United States Biochemical Corp. Ribonuclease Tl, Pl, and T2 were from 
Calbiochem. Snake venom phosphodiesterase (SVPI), restriction enzyme EcoRI, and calf 
intestine alkaline phosphatase were obtained from Boehringer Mannheim Biochemicals. 
Cellulose polyethyleneirnine impregnated thin-layer chromatography (TLCI) plates were 
obtained from Brinkmann Instruments, Inc. Restriction enzyme BstNI was obtained from 
New England Biolabs. [a-32P]-labeled nucleotide triphosphates (NTPsl) (3000 Ci/mmol) 
and [y-32P]GTP (5000 Ci/mmol) were obtained from Amersham Corp. Methotrexate-
agarose and immunopure sulfosuccinimidy 1-2-(biotinarnido )ethy 1-1,3' -dithioproprionate 
(NHS-SS-Biotinl) were obtained from Pierce. Biotin-Sephacryl S 1000 and succinylavidin 
were from EY Laboratories. N6-(6-Aminohexyl)ATP was obtained from Bethesda 
Research Laboratories. 
Strains and Plasmids----E. coli strain RJ1438 [thil leuB6 thrl [acYl tonA21 sup£44 hsdR 
galK ~lonlOO (F' lacJSQ .fzz::Tn5)] , used for expression of DHFR-ligase fusion proteins or 
derivatives, was kindly provided by R. Johnson. The construction of plasrnids pDAKC 
and pDAC has been previously described (Apostol et al., 1991). Plasmid ptaclO, which 
expresses DHFR alone, was kindly provided by J. Normanly (Normanly et al., 1986). 
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Plasmid pUC13Phe was kindly provided by V. Reyes (Reyes and Abelson, 1987). 
Plasmid pBS+ was obtained from Stratagene. 
Cell Growth and Protein Purification----E. coli strain RJ1438, transformed with pDAKC, 
pDAC, or ptac10, was grown at 37°C in Luria-Bertani media containing 50 J.lg/ml each 
kanamycin and ampicillin. Cells were harvested at an A600 of 1.2-1 .6, resulting in 1. 75-
2.4 g of wet cell weight per liter. Cells were stored at -70°C. The purification method for 
DHFR fusion proteins was basically as described by Baccanari et al. (1975), modified by 
Apostol et al. (1991). Crude extracts were obtained by a single lysozyme-nonionic 
detergent lysis. Cells were resuspended in 40 mM Tris-HCI (pH 8.0) at 2.14 mllg of cells. 
Cells were brought to 1 mM phenylmethanesu1fonyl flouride, 5.73 mM EDTA, 0.65 mg/rnl 
lysozyme, and cell lysate was stirred for 30 min. Brij 58 was added to 1.85 mg/ml and 
lysate was stirred 30 min. Lysate was brought to 13.5 mM MgCl2, 48 J.lg/rnl DNase I, and 
stirred until viscosity was lost (approximately 30 min). Lysate was centrifuged 30 min at 
24,000 X g, and the supernatant was adjusted to 40% saturation with ammonium sulfate 
and centrifuged. The supernatant was further adjusted to 75% saturation with ammonium 
sulfate and centrifuged. The second ammonium sulfate pellet was resuspended at 25-50 
mg/ml protein in 50 mM potassium phosphate (pH 6.0), 200 mM KCI, 0.5 mM EDT A, 1 
mM ~-mercaptoethanol and dialyzed with 7-15 mls of settled methotrexate-agarose resin. 
Resin and bound protein were washed with 200 mM potassium phosphate (pH 6.0) , 1 M 
KCl, 1 mM ~-mercaptoethanol until the A2so of the eluate was less than 0.5 . Protein was 
eluted in 100 mM potassium borate (pH 9.0), 1 M KCI, 1 mM EDTA, 1 mM ~­
mercaptoethanol, 2 mM folic acid, then dialyzed in 100 mM potassium phosphate (pH 
8.0), 250 mM KCl, 1 mM EDTA, 1 mM ~-mercaptoethanol to remove folate , and 
concentrated by precipitation with ammonium sulfate at 75% saturation. Protein was 
dialyzed in 50 mM potassium phosphate (pH 8.0), 10% glycerol, 1 mM ~­
mercaptoethanol, 180 mM KCl, and passed over a 15-30 ml DEAE-Sephadex column to 
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remove nucleic acid. Protein was equilibrated in Buffer F (50 mM potassium phosphate 
(pH 8.0), 100 mM KCI, 35% glycerol, 5 mM ~-mercaptoethanol), and stored at -20°C. 
This procedure typically yielded approximately 0.2 mg protein per liter of cell culture. 
Splicing assays after the methotrexate elution step indicated that proteins were as active as 
those that were also passed through the DEAE-Sephadex column, therefore removal of 
nucleic acids was unnecessary for our purposes and was omitted in some of the protein 
preparations. Protein determinations were by the method of Bradford (Bradford, 1976). 
Sodium dodecyl sulfate (SDSI)-polyacrylamide gel electrophoresis was by the method of 
Laemmli (Laemmli, 1970). 
Preparation of Substrates----The substrate used for splicing assays was a radio labeled 
precursor tRNAPhe (pre-tRNAPhe) prepared in vitro by runoff transcription with T7 RNA 
polymerase of plasmid pUC13Phe linearized with restriction enzyme BstNI (Reyes and 
Abelson, 1987). Transcription reactions (100 Ill) consisted of: 4 11g BstNI-cut 
pUC13Phe; 500 11M each ATP, CTP, and GTP; 10 11M UTP; 100 1-LCi [a-32P]UTP; 10 
mM dithiothreitol (DTTI); 50 mM Tris-HCI (pH 8.0); 10 mM MgCh; 10 mM NaCl; and 
250 units T7 RNA polymerase. Transcriptions were incubated at 37°C for 1 h, stopped by 
heating at 50°C for 20 min with addition of 10 111 2 mg/ml proteinase K, 2% SDS, and 100 
mM EDT A, and products were precipitated with addition of 100% ethanol. Pellets were 
resuspended in 3.5 M urea, 10% sucrose, and 0.05% each bromphenol blue and xylene 
cyanol, heated at 65°C for 5 min, and resolved on 12% acrylamide, 0.4% bis-acrylamide, 
8M urea, 90 mM Tris-borate (pH 8.3), 2.5 mM EDT A gels. The predominant transcription 
product was excised from the gel, eluted at 37°C in 300 mM NaCl, 10 mM Tris-HCl (pH 
7.4), I mM EDTA, 1% phenol, filtered, precipitated with ethanol, and resuspended at 
33,000 dprni~-Ll, equivalent to an approximate specific activity of 5,000 dprnlfmol. 
The substrate for the analysis of splice junction structure was pre-tRNAPhe 
transcribed with each of four [a-32P]-labeled nucleotide triphosphates. Transcription 
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reactions were performed as above except for the substitution of one of the following 
nucleotide mixes: 1) For ATP, CTP, or UTP-labeled transcripts, the following proportions 
appropriate to the labeled species; 100 f.lCi of [a-32P]ATP, 20 f...LM ATP, 200 f...LM each 
CTP, GTP, and UTP; or 2) For GTP-labeled transcripts; 100 f.lCi of [a-32P]GTP, 500 f...LM 
GTP, 200 f...LM ATP, CTP, and UTP (concentrations of GTP greater than 20 f...LM are 
required to effect complete transcription, since the sequence of tRNAPhe begins with 5'-
GGCG.) Transcriptions yielded pre-tRNAPhe with a specific activity of 2-3,000 
dpm/fmol, except for [a-32P]GTP-labeled pre-tRNAPhe, which could be produced only as 
a low specific activity transcript (115 dpm/fmol), due to the constraints imposed by GTP-
dependent transcription initiation. 
The substrate for kinase assays was a 9-nucleotide radio labeled RNA, 5'-
GGGCGAAUU-3', prepared in vitro by runoff transcription with T7 RNA polymerase of 
plasmid pBS+ linearized with EcoRI. Transcription reactions (25 f...Ll) with either 25 f.lCi 
[a-32P]CTP or 25 f.lCi [a-32P]UTP were incubated and precipitated as above. Precipitate 
was resuspended and incubated at 50°C for 1 h with 2 units alkaline phosphatase to remove 
5' -phosphates. Phosphatased RNA was treated with 20 mM [ethylenebis(oxyethylene-
nitrilo)]tetraacetic acid (EGTA) at 65°C for 10 min to deactivate phosphatase. RNAs were 
resolved on 18% acrylamide, 0.9% bis-acrylamide, 8M urea gels as described above. The 
specific activity of this oligonucleotide was 110-220 dpm/fmol. 
Splicing Reactions----Small scale splicing reactions were done essentially as described by 
Greer et al. (1983) . Briefly, 6.8 fmol pre-tRNAPhe were preincubated with 0.1 f.lg/ml 
yeast tRNA splicing endonuclease in 20 mM Hepesl (pH 7.8), 2.5 mM spermidine-HCl 
(pH 7.0), 5 mM MgC12, 0.1 mM DTT, 0.4% Triton X-100, 25 mM NaCl at 30°C for 18 
min. Following the addition of 50 f.lg/ml DHFR-ligase fusion protein (DAKC or DAC) 
and varying concentrations of NTP, reactions were incubated an additional 15 min. 
Spliced products were resolved on 12% polyacrylamide gels as described above. Gels 
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were autoradiographed and products were quantitated by measuring Cerenkov radiation in 
gel slices. 
Kinase Assay----Kinase reactions (5 ~I) contained 10-40,000 cpm substrate (150-1200 
fmol 9-nucleotide oligomer described above), 30 ~g/ml DAKC or DAC or 30 units T4 
PNK, 20 mM Hepes (pH 7.8), 2.5 mM spermidine-HCI (pH 7.0), 5 mM MgCh, 0.1 mM 
DTT, 0.4% Triton X-100, 25 mM NaCl, 0.05 mM EDTA, 2% glycerol, and varying 
concentrations of NTP. Reactions were incubated for 30 min at 30°C, except for reactions 
containing T4 PNK, which were incubated at 37°C. Reactions were resolved on 18% 
polyacrylamide gels as described above. Gels were autoradiographed and reaction 
products were quantitated by measuring Cerenkov radiation in gel slices. 
Origin of the 2 '-Phosphate at the Splice Junction----Preparative splicing assays (I 00 ~I) of 
pre-tRNAPhe labeled with each of four ribonucleotides were carried out essentially as 
described for small scale splicing assays. Briefly, 106 cpm substrate (equal to 1 pmol, or 
30 pmol [a-32P]GTP-Iabeled tRNA) were incubated with 0.02 ~g endonuclease for 30 min 
at 30°C. ATP was added to 4 mM, followed by 1.5 ~g DAKC or DAC, and reactions were 
incubated an additional 30 min. Reactions were stopped as above and precipitated with 
ethanol. Spliced products were separated by gel electrophoresis, eluted, and precipitated as 
described above. 
Ribonuclease Digestion and Thin-Layer Chromatography----For RNase Tl analyses, 
spliced tRNAs were incubated in 6 ~~reaction volumes for 30 min at 37°C in 10 mM Tris-
HCI (pH 7.4), 1 mM EDTA with 10 units RNase T1 and 20 ~g RNA carrier. RNase T1-
digested products were resolved on 23% acrylamide, 0.8% bis-acrylamide, 7.4 M urea gels 
and visualized by autoradiography. 
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For RNase T2 analyses, spliced tRNAs were incubated in 4 )ll for 2 hat 37°C in 20 
mM sodium acetate (pH 5.0) with 5 units RNase T2 and 37 )lg RNA carrier. Reaction 
mixtures were spotted on polyethyleneimine-cellulose TLC plates and developed in 1 M 
LiCI. Plates were dried and autoradiographed. Unlabeled marker nucleotides were 
visualized with shortwave ultraviolet light. 
For Pl nuclease analyses, spliced tRNAs or tRNA halves were incubated in 5 )ll 
for 2 h at 37°C in 20 mM ammonium acetate (pH 5.0) with 5 units Pl nuclease and 37 )lg 
RNA carrier, and chromatographed as above. 
PI-nuclease resistant dinucleotides were further analyzed by SVP digestion. After 
washing plates with 70% ethanol to remove LiCI, radioactive spots were eluted with ice-
cold 30% triethylamine carbonate (pH 9) (Volckaert et al., 1976), dried, and resuspended 
in H20. SVP digests (10 )ll) containing the eluted RNA, 2 )lg SVP, 37 )lg RNA carrier, 
25 mM Tris-HCl (pH 9.5), and 5 mM MgCh were incubated 2 hours at 37°C. Some 
reactions also contained 5-10 )lg unlabeled nucleotide marker. Reaction products were 
analyzed by TLC as described above. 
Incorporation of y-phosphate of GTP into Splice Junction----Biotinylated [a-32P]UTP-
Jabeled pre-tRNAPhe was prepared as follows: 1) For tRNA of high specific activity, T7 
RNA polymerase transcriptions were carried out as described above except that ATP was 
reduced to 250 )lM and N6-(6-Aminohexyl)ATP was added to 250 )lM. Biotinylated [a-
32P]UTP-labeled pre-tRNAPhe of low-specific activity was prepared as above except [a-
32P]UTP was reduced to 10 )lCi/100 )ll reaction and UTP was added to 500 )lM. Purified 
transcripts were biotiny1ated by reaction with NHS-SS-Biotin (Ruby et al., 1990). 
For the preparation and use of the biotin Sephacryl:succinylavidin resin, all steps 
were done at 4°C. Biotin Sephacryl resin was prebound to succinylavidin at a 
concentration of 1 mg succinylavidin per 200 )ll packed resin for 1-12 hours (Ruby et al., 
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1990). Resin was washed with 10 mM Tris-HCl (pH 7.5), 200 mM NaCI (Buffer A) to 
remove unbound avidin, and resuspended in an equal volume of Buffer A. 
Splicing assays were performed as described above, except that reactions contained 
600 fmol of low-specific activity biotinylated [a-32P]UTP-labeled pre-tRNAPhe and 100 
!J.Ci of desiccated ['y-32P]GTP as the only cofactor. Control reactions also contained 6 fmol 
of high-specific activity biotinylated [a-32P]UTP-labeled pre-tRNAPhe as well as 2 mM 
unlabeled ATP instead of [y-32P]GTP. Splicing reactions were stopped as above, 
precipitated with ethanol, resuspended in 5 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 
bound to 60 !J.l avidin resin slurry. After incubation with the splicing reaction for 15-60 
min, 200 !J.l Buffer A was added, resin was vortexed gently, microfuged for 10 seconds, 
and supernatant was removed. This wash step was repeated three times with 5-15 min 
incubations. Material bound to the resin was eluted three times in 150 !J.l of 150 mM DTT, 
40 mM Tris-acetate (pH 8.5), 150 mM NaCl, and 3 mM MgCl2 (Ruby et al., 1990), and 
precipitated with ethanol. Reaction products were resolved by gel electrophoresis as 
described above. 
RESULTS 
DHFR-ligase fusion proteins were expressed in E. coli and purified as described in 
Experimental Procedures. Protein gels confirmed the presence and purity of each protein 
(data not shown). DAKC migrated at its expected molecular mass of 110 kDa and DAC at 
its expected molecular mass of 88 kDa, and estimates of specific activity for ATP-
dependent joining by DAKC and DAC were comparable to that reported elsewhere 
(Apostol et al., 1991). 
We previously reported that the presence of DHFR in the full-length DHFR-ligase 
fusion protein did not interfere with or enhance any activity attributed to the ligase portion 
of the protein (Apostol et al., 1991). Bacterial DHFR alone, purified by the same 
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procedure as that used for the fusion proteins, had no activity in splicing assays under any 
of the conditions tested (see Belford et al., accompanying manuscript). Therefore for the 
purposes of this study, all experiments were done with DAC or DAKC, both with intact 
DHFR domains. 
Determination of the Structure of Spliced Product----Analyses of RNase Tl digestion 
products revealed that the sequences of spliced tRNA produced by DAC and DAKC were 
identical (data not shown). However, it was necessary to show that the specific structure 
of the splice junction and the origins of the splice junction phosphates in tRNAs joined by 
the enzymes were also identical. 
For native yeast tRNA ligase, the 2' -phosphate at the splice junction of mature 
tRNA originates from the pre-tRNA (Greer et al., 1983). We previously determined that 
the 2' -phosphate at the splice junction of tRNA joined by DAC originated from the pre-
tRNA substrate, not from an external cofactor (Apostol et al., 1991). It was necessary to 
show further that this 2' -phosphate originated specifically from the 5' -splice site phosphate 
of the pre-tRNA. Pre-tRNAPhe substrates labeled with each of the four ribonucleotides (in 
the T7 RNA polymerase transcription reaction) were used in preparative splicing reactions 
with endonuclease and DAKC or DAC. Fig. 1 shows the results of the analysis of these 
spliced tRNAs with respect to the origin of the 2' -phosphate. Fig. 1A is a diagram 
depicting the expected products of the splicing reaction (showing only the nucleotides 
surrounding the splice junction) and subsequent nuclease digestions of spliced tRNA. 
Spliced tRNAPhe produced by both DAKC and DAC in the presence of ATP migrates 
identically on polyacrylamide gels (Fig. IB). When these spliced tRNAs are digested with 
Pl nuclease, the predicted products are 5' -monophosphates and a P1 nuclease-resistant 
splice junction dinucleotide of sequence 5'-pG2'ppA-3' (see Fig. lA). Radio1abeled 5'-
monophosphates will result from the ribonucleotide that was used to radiolabel the pre-
tRNA (i.e., either 5'-AMP, 5'-GMP, 5'-UMP, or 5'-CMP). The last base of the 5'-half 
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tRNA is a guanine residue, therefore, in reactions using pre-tRNAPhe transcribed with [a-
32P]GTP, the 5' -phosphate of the PI nuclease-resistant dinucleotide should be 
radiolabeled. The first base of the intron is an adenine residue, therefore, in reactions using 
pre-tRNAPhe transcribed with [a-32P]ATP, the 2' -phosphate of the Pl nuclease-resistant 
dinucleotide should be radio labeled. The products of P 1 nuclease digestion of spliced 
tRNA were as expected for the conventional joining reaction and were identical for both 
DAC and DAKC (Fig. 1 C). When the PI nuclease-resistant dinucleotides were eluted and 
digested with SVP, the predicted products were 5'-AMP and 2',5'-GDP (see Fig. lA). 
The 5' -AMP should be unlabeled because this phosphate should originate from the y-
position of the unlabeled ATP in the splicing reaction. Again, only when [a-32P]GTP-
labeled pre-tRNAPhe or [a-32P]ATP-labeled pre-tRNAPhe is used in the splicing reaction 
will 2' ,5' -GDP be radiolabeled. Fig. lD shows that the products of SVP digestion were 
indeed as predicted and were identical for both enzymes (lanes 5-8). The first four lanes in 
Fig. lD are controls without SVP added. A radiolabeled species was detected which 
migrated with authentic 2' ,5' -GDP in the lanes for [a-32P]GTP-labeled tRNA (lanes 1 and 
2), but not for [a-32P]ATP-labeled tRNA (lanes 3 and 4) . We believe this species is [a-
32P]GTP, originating from the 5' -pppG which is the first nucleotide of T7-transcribed pre-
tRNAPhe. GTP migrates closely above the Pl nuclease-resistant dinucleotide position and 
nearly identically with 2' ,5' -GDP in 1 M LiCl (data not shown). The spot was present in 
amounts approximately equimolar to the PI nuclease-resistant dinucleotide, consistent with 
a single occurrence per molecule. It is probable that both species were coeluted due to 
overexposure of the TLC in Fig. lC. Regardless, the radiolabel in the dinucleotide that 
was present reappeared in 2' ,5' -GDP when digested with SVP, indicating that the Pl 
nuclease-resistant dinucleotide in this case was indeed 5' [32p]pG2'ppA-3'. 
Four similarly labeled pre-tRNAPhe transcripts were used in a splicing reaction with 
each enzyme, and the products were digested with RNase T2 instead bf Pl nuclease. The 
identity and radiolabeling pattern of these products were as predicted, and again identical 
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for both DAC and DAKC (data not shown). These results are consistent with the 
supposition that the 2' -phosphate at the splice junction of tRNA joined by either DAKC or 
DAC originates from the phosphate present at the 5' -splice site of the intron of the pre-
tRNA. Additionally, we have determined that a 5'-half tRNA pretreated with T4 PNK 
(which exhibits both cyclic phosphodiesterase and phosphatase activities capable of 
removing the 2' ,3 '-cyclic phosphate of the 5' -half) and reannealed to a normal 3' -half 
tRNA could not be joined by either DAC or DAKC (data not shown). This is in agreement 
with previous results using yeast tRNA splicing extracts (Knapp et al. , 1979). Together, 
these results indicate that DAC possesses 2',3'-cyclic phosphodiesterase activity which 
opens the cyclic phosphate to a 2' -phosphate (Apostol et al., 1991), and that this phosphate 
constitutes the 2' -phosphate at the splice junction and must be present on the 5' -half tRNA 
for splicing to occur. 
Determination of Cofactor Requirements During Splicing----We began a systematic study 
of splicing in the presence of a variety of nucleotide cofactors to determine whether DAC 
has cofactor or substrate requirements differing from DAKC. Splicing reactions were 
carried out in a separate titration for each of the four NTPs. The results of splicing 
reactions containing either DAKC or DAC, and increasing amounts of NTP are shown in 
Fig. 2. Fig. 2A shows a representative autoradiograph of splicing reactions with a constant 
concentration of DAKC and increasing concentrations of ATP, from 5 JlM to 20 mM, as . 
described in Experimental Procedures. The amount of spliced tRNA product clearly 
increased, up to an ATP concentration of 5 mM. There was a corresponding decrease in 
the amount of tRNA halves, indicating that this tRNA product resulted from the joining of 
tRNA halves. 
There was an abrupt decrease in production of spliced tRNA at ATP concentrations 
above 5 mM. This decrease was similar for both DAKC and DAC, and was observed with 
each of the four NTPs (data not shown). This decrease was apparently not due to NTP 
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concentration-dependent ribonuclease activity since the recovery of pre-tRNA and tRNA 
halves was unaffected. It is possible that this reduction in splicing activity resulted either 
from inhibition by the increasing ionic strength at high concentrations of NTP in these 
reactions, or from the NTP-mediated chelation of Mg2+ (ligase requires a divalent cation in 
the splicing reaction (Greer et al., 1983)). 
Fig. 2B, C, and D are graphs of representative data sets obtained from 
polyacrylamide gels of splicing reactions carried out with increasing concentrations of one 
of the four NTPs, and either DAKC or DAC. Enzyme concentrations were kept constant, 
equal, and limiting for both DAKC and DAC, so as to emphasize the effect of NTP 
concentration on joining. KappNTP values were determined as the NTP concentration 
resulting in 50% maximal activity, and are average values generated from 2-4 separate 
experiments. 
In the presence of ATP, DAC exhibited splicing activity which was comparable to 
DAKC (Fig. 2B), with average KappATP values of 0.7 mM and 0.9 mM, respectively. 
Neither enzyme joined in the presence of CTP alone. Splicing reactions performed in the 
presence of GTP alone (Fig. 2C) or UTP alone (Fig. 2D) allowed us to conclude that 
DAKC cannot join tRNA halves with CTP, GTP, or UTP alone, even at concentrations up 
to 10 mM (data not shown). However, DAC can join tRNA halves with GTP or UTP 
alone, with an average KappGTP of 0.4 J.LM and an average KappUTP of 100 J.LM (Fig. 2C 
and D); values which are 10- to 1000-fold lower than the KappATP for splicing with DAC. 
At first glance, this would appear to be a gain of function mutation for the deletion protein, 
DAC. 
Determination of Cofactor Requirements in the Kinase Reaction----The discovery that DAC 
can splice tRNA using only GTP or UTP led us to evaluate cofactor requirements for the 
kinase reaction. Based on the greater efficiency of GTP- and UTP-dependent splicing (see 
above) and the previous lack of measurable ATP-dependent kinase activity (Apostol et al., 
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1991), we hypothesized that DAC might require a cofactor other than ATP in the kinase 
reaction. It was also possible that DAC might require a higher concentration of ATP to 
detect kinase activity only in assays with synthetic substrates, and that reactions with 
authentic substrates might have different requirements. 
To test these possibilities, a revised kinase assay was developed. The previous 
kinase measurements were obtained using an unlabeled size-fractionated poly(UnG) 
substrate and a labeled cofactor, [y-32P]ATP, allowing only limited concentrations of 
cofactor to be added (Apostol et al., 1991). A second kinase assay was developed using a 
radiolabeled 9-nucleotide RNA transcript with a 5' -hydroxyl, increasing the flexibility of 
the assay and allowing addition of greater concentrations of cofactor (see Experimental 
Procedures). Upon phosphorylation, the nonamer has greater mobility in an 18% 
polyacrylamide gel, presumably because of the added negative charges associated with the 
newly added phosphate group (Fig. 3A). This conclusion is supported by the comigration 
of the nonamer in the reaction with T4 PNK and ATP, as well as the comigration of the 
transcription product without phosphatase pretreatment (possessing the 5' -triphosphate 
from transcription initiation) (Fig. 3A, lanes 9 and 10). Fig. 3B, C, and D are graphs of 
representative data sets obtained from polyacrylamide gels of kinase reactions carried out 
with either DAKC or DAC. Kinase activity (expressed as the percent of oligomer 
phosphorylated) is plotted as a function of increasing concentration of NTP. DAC did not 
exhibit significant kinase activity with CTP or ATP using this artificial substrate (Fig. 3B). 
However, DAKC demonstrated both ATP- and CTP-dependent kinase activity, with 
KappNTP values which differed by approximately 3-fold. 
Both DAKC and DAC were active with GTP alone (Fig. 3C), as well as with UTP 
alone (Fig. 3D). DAKC had an average KappGTP of 0.25 J..LM (see inset, Fig. 3C) and an 
average KappUTP of 25 J..LM for kinase activity, demonstrating a marked preference for GTP 
over UTP. DAC was also 30-fold more efficient at phosphorylation with GTP than with 
UTP, with average Kapp values of0.1 mM and >3 mM, respectively. This preference for 
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GTP during phosphorylation paralleled the efficiency of GTP over UTP in the data from 
DAC splicing reactions shown in Fig. 2. However, the Jack of measurable ATP kinase 
activity for DAC was in direct contrast with those splicing results. If, as we propose, DAC 
must use they-phosphate of ATP to kinase the 3' -half of the tRNA during ATP-dependent 
splicing, then we can infer that DAC not only exhibits different cofactor utilization during 
joining and phosphorylation, but seems to display different reaction characteristics based 
on the nature of the substrate. 
Incorporation of the y-phosphate ofGTP as the 3'-5 ' Splice Junction Phosphate----Fig. 1D 
shows that the 5' -AMP resulting from SVP cleavage of the splice junction dinucleotide 
from tRNA joined by DAC was not labeled for substrates labeled during transcription with 
any of the four NTPs. Thus this phosphate must be derived from a cofactor, as has been 
shown for native tRNA ligase (Greer et al. , 1983). We have shown above that both 
DAKC and DAC can use GTP in the kinase reaction. We have also demonstrated that DAC 
can splice tRNA using GTP alone. Therefore, if DAC employs the same mechanism as 
DAKC, it must then use they-phosphate of GTP to kinase the 3' -half tRNA. In order to 
unequivocally identify the source of this 3' ,5' -splice junction phosphate, [y-32P]GTP was 
used to label a low specific activity substrate in the splicing reaction. 
Both DAKC and DAC were able to kinase a 9-nucleotide RNA which is not a 
natural substrate for tRNA splicing. It is more difficult to demonstrate phosphorylation of 
the native substrate by radiolabel incorporation, because DAKC, DAC, and tRNA 
endonuclease protein fractions all contain an appreciable quantity of cellular RNA. The 
nonspecific kinase activity alluded to above causes high levels of background labeling of 
RNA, completely masking the appearance of authentic tRNA splicing reaction products. 
Therefore we used biotin-avidin affinity chromatography (Ruby et al. , 1990) to separate 
pre-tRNA substrate and spliced products from other incidentally radiolabeled RNA 
contaminants. Briefly, the procedure was as follows: Pre-tRNA transcribed with N6-(6-
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Aminohexyl)ATP was biotinylated through a disulfide bond by reaction with NHS-SS-
Biotin (see Experimental Procedures). This pre-tRNA was used in the splicing reaction 
and then bound to biotin Sephacryl:succinylavidin resin. Nonbiotinylated material was 
washed away and biotinylated tRNA splicing products were released by treatment with 
DTT (Ruby et al., 1990). 
An autoradiograph of a gel from such a splicing assay using biotinylated [a-
32P]UTP-labeled pre-tRNA is shown in Fig. 4A. In this figure, lanes labeled 32?-tRNA 
contained both low-specific activity and high-specific activity biotinylated [a-32P]UTP-
labeled pre-tRNA. Pre-tRNA treated only with tRNA endonuclease produced tRNA halves 
(Fig. 4A , lane 1). The control lanes show the comigration of tRNA spliced by DAKC or 
DAC in the presence of nonradioactive ATP (Fig. 4A, lanes 2 and 3) . Low-specific 
activity pre-tRNA spliced by DAKC was not visible at this exposure (Fig. 4A, lane labeled 
C). Splicing reactions carried out with low-specific activity pre-tRNA, DAKC or DAC, 
and [y-32P]GTP as the only cofactor showed incorporation of radiolabel at a level far above 
the low-specific activity tRNA alone (Fig. 4A, compare lanes labeled y-32?-GTP to lane 
labeled C). Radiolabeled material comigrating with spliced tRNA was produced by DAC 
(Fig. 4A , lane 5). By contrast, DAKC produced a more diffuse band which did not 
precisely comigrate with authentic spliced tRNA (Fig. 4A, lane 6). Other biotinylated 
RNAs containing 5' -hydroxyls were kinased as well, including the 3' -half and the intron, 
which both possess a 5' -hydroxyl through cleavage by endonuclease (Knapp et al., 1979). 
Fig. 4B depicts the normal tRNA splice junction structure and subsequent nuclease 
digestion products. The predicted fate of a labeled junction phosphate is indicated. If the 
3' -half tRNA is phosphorylated with the y-phosphate of [y-32P]GTP, the radiolabeled 
phosphate should be incorporated into the 3' -5' phosphodiester at the splice junction. We 
detected the presence of the predicted splice junction dinucleotide following P1 nuclease 
digestion of tRNA spliced by DAC, but not by DAKC (Fig. 4C, lanes labeled tRNA). 
Instead, for DAKC we detected radiolabeled 5'-CMP, 5'-AMP, and 5'-GMP, indicating 
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that labeled species in the spliced tRNA area of the gel were probably due to 5'-
phosphorylation of pre-tRNA breakdown products. When the Pl nuclease-resistant 
dinucleotide from Fig. 4C, (lane labeled tRNA/DAC), was further digested with SVP, 5'-
[32P]AMP was released as predicted for the structure shown in Fig. 4B. This result proves 
that DAC uses they-phosphate of GTP to kinase the 3' -half tRNA during GTP-dependent 
joining. 
When the bands from the tRNA halves region of the gel were eluted and digested 
with Pl nuclease, the primary product was radiolabeled 5' -AMP, as predicted for a simple 
phosphorylation product (Fig. 4C, lanes labeled halves) . The less intense radiolabeled 5'-
UMP might result either from Pl nuclease digestion of low-specific activity [a-32P]UTP-
labeled tRNA halves, or through cleavage adjacent to the 3' -splice site of pre-tRNA by 
tRNA endonuclease. The 3'-splice site sequence of pre-tRNAPhe is 5'-Up{down 
arrow}ApU-3', with the arrow indicating the normal cleavage site. If cleavage occurs 
either one base upstream or one base downstream of the normal site, the 5' -hydroxyl of a 
U residue will be available for phosphorylation, releasing radiolabeled 5' -UMP upon Pl 
nuclease digestion. Yeast tRNA endonuclease does not normally exhibit significant splice 
site cleavage infidelity with nonbiotinylated pre-tRNAPhe (personal observation, and R. 
Rauhut, personal communication). We hypothesize that a miscleavage at the 3'-splice site 
might occur because the first base of the 3' -half is an adenine residue, and in part of this 
particular pre-tRNA population, this adenine will have been substituted with N6-(6-
Aminohexyl)AMP and should be biotinylated, which may stereochemically interfere with 
tRNA endonuclease cleavage. This hypothesis might also explain the reproducibly diffuse 
nature of the band corresponding to the 3' -half tRNA (see Fig. 4A); the group of bands 
· may represent 3' -halves differing in size by one or two residues due to miscleavage at the 
3' -splice site. In summary, the results of joining with [y-32P]GTP confirm the previous 
observations that both DAKC and DAC can use the y-phosphate of [y-32P]GTP to 
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phosphorylate the 3 '-half of the tRNA, and that while DAC can complete the joining 
reaction, DAKC cannot produce authentic spliced tRNA with GTP as its only cofactor. 
DISCUSSION 
We have shown that spliced tRNAPhe products joined by DAC and DAKC are structurally 
identical, therefore DAC most likely uses the same mechanism for joining as does DAKC 
or native tRNA ligase. Most other enzyme reaction mechanisms that could explain joining 
by DAC have been ruled out by our data. However, it is possible to propose mechanisms 
that are not incompatible with our data. For example, DAC could mediate the 3 '-
phosphorolysis of the 2' ,3' -cyclic phosphate on the 5' -half tRNA using the 5' -phosphate 
on the 3'-half, resulting in a spliced tRNA with a 2'-phosphate, 3',5'-splice junction 
phosphate. In this reaction, the origins of all splice junction phosphates would be as 
predicted for the original mechanism, and the product would be structurally 
indistinguishable from that produced by the original mechanism. However, no adenylylate 
or guanylylate synthetase activity is required in this alternate mechanism to activate the 5'-
phosphate of the 3' -half tRNA. This could explain why DAC was able to join tRNA 
halves in the presence of GTP alone. However, this mechanism requires an intact 2' ,3'-
cyclic phosphate at the 3' -end of the 5' -half tRNA. We have previously shown that DAC 
exhibits 2' ,3' -cyclic phosphodiesterase activity comparable to DAKC using a non-tRNA 
substrate (Apostol et al., 1991). Therefore we believe that it is far more likely that DAC 
uses the same mechanism as DAKC, but uses GTP instead of ATP to activate the 5 '-
phosphate of the 3 '-half during GTP-dependent splicing. If so, then DAC, which is 
missing the central portion of intact ligase, has probably undergone a rearrangement of 
active or substrate/cofactor sites such that GTP can now be used exclusively for both 
cofactor-requiring activities involved in splicing. 
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It is instructive to compare the relative activities of DAC and DAKC with respect to 
the constants for Kapp• or 50% maximal activity for joining or kinase. ATP-dependent 
joining is approximately equal for both enzymes, with a KappATP for DAKC of 0.9 mM and 
for DAC of 0.7 mM. However, DAC has much lower Kapp values for GTP- and UTP-
dependentjoining, of 0.4 J..LM and 100 J..LM, respectively. Greer et al. (1983) reported that 
tRNA ligase purified from yeast was able to effect splicing using 1 mM UTP, and, to a 
lesser extent, CTP or GTP. However, they raised the possibility of either interconversion 
of nucleotides or up to 5% contamination of their cofactors, at which level splicing would 
still be able to occur. A partially purified fraction of tRNA ligase purified from yeast does 
not splice in the presence of any NTP other than ATP when assayed with Ultrapure NTPs 
(Belford et al., accompanying manuscript), and as we have shown above, DAKC cannot 
join using GTP, UTP, or CTP alone. 
A comparison of the constants for the kinase reaction reveals that they are very 
different. The KappATP for kinasing by DAKC is 0.2 mM, which is 5-fold better than the 
KappATP for joining by DAKC. DAKC may have a higher substrate affinity for the non-
tRNA substrate used in the kinase assay than for the pre-tRNAPhe used in the joining 
assay. DAChas a KappATP for kinase of greater than 4 mM, which is more than 5-fold 
greater than the KappATP for joining by this same enzyme, and this may reflect distinct 
features of the reactions measured with synthetic oligonucleotide and authentic pre-tRNA 
substrates. DAKC exhibits Kapp values for GTP-, UTP-, and CTP-dependent kinase 
activity of 0.25 J..LM, 25 J..LM, and 61 J..LM, respectively. By contrast, DAChas Kapp values 
of 100 J..LM and 3 mM for GTP- and UTP-dependent kinase activity, respectively, with no 
activity detected for CTP. These values are up to 400-fold greater than the same values 
using DAKC, and again, may reflect unique requirements for use of a synthetic kinase 
substrate by DAC. It is perhaps not surprising that DAKC can utilize any of the four NTPs 
for phosphorylation, even though it can only complete the splicing reaction with ATP. T4 
PNK has also been shown to use UTP, GTP, or CTP equally as well as ATP in the kinase 
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reaction (reviewed by Richardson, 1981), and we have found sequence similarities in two 
regions of the enzymes (Xu et al., 1990; Apostol et al., 1991 ). The most surprising result 
is that GTP is 1 00-fold more efficient than ATP when used in the kinase reaction with 
either DAC or DAKC. 
We previously showed that DAC had half the binding affinity for pre-tRNA 
substrates as did DAKC (Apostol et al., 1991). Since we do have GTP-dependent kinase 
activity with DAC, the region missing from the center of DAC (the K domain) is probably 
not responsible for GTP-dependent kinase activity, but instead may serve to hold the intact 
protein together when presented with its authentic substrate. We also demonstrated that 
any two of the three domains were sufficient for pre-tRNA binding, implicating a 
composite of multiple areas of the tRNA ligase linear sequence in forming the high affinity 
substrate binding site. Removal of the central "K" region could have a greater effect on 
substrate binding than on kinase or joining activities, such that the measurements of relative 
efficiencies of the individual activities during splicing vary greatly from substrate to 
substrate. Indeed, many protein preparations of DAC were found to be inactive for 
splicing (3 of 11 independent protein preparations were active for splicing, data not shown) 
and this could reflect a general instability of the protein. 
It is provocative that the Kapp for GTP-dependentjoining (0.4 )lM) by DAC closely 
approximates the Kapp for GTP-dependent kinase activity (0.25 )lM) for full-length 
DAKC. This results suggests that the step involving phosphorylation of the 3' -half tRNA 
is probably not the rate limiting step in the normal tRNA splicing reaction, and in addition 
may intimate that the characteristics of GTP-binding are probably similar both in the 
deletion and the full-length polypeptide. 
In summary, the results presented here permit us to propose an amended 
mechanism for yeast tRNA splicing, including GTP as one of the cofactors. Fig. 5 is a 
diagram of this revised mechanism for splicing by endonuclease, yeast tRNA ligase, and 
NAD-dependent 2' -phosphotransferase. This model merges our in vitro observation that 
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GTP is used more efficiently than ATP by ligase in the kinase step with the data which 
indicate that ligase still requires ATP to complete the joining of tRNA halves, thus 
reserving ATP for the adenylylate synthetase function. This requirement for ATP in the 
adenylylate synthetase step is similar to the results seen with T4 RNA ligase, which, of the 
available nucleoside triphosphates, can utilize only ATP or dATP in either the 
circularization of RNA or in the ATP-PPi exchange reaction which indirectly measures 
enzyme adenylylation (reviewed by Uhlenbeck and Gumport, 1982). This model is very 
testable and experiments which address this are described in the accompanying manuscript. 
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FOOTNOTES 
I The abbreviations used are: Pre-tRNA, precursor tRNA; DHFR, dihydrofolate reductase; 
T4 PNK, T4 polynucleotide kinase; SVP, snake venom phosphodiesterase; TLC, thin-
layer chromatography; NTP, nucleotide triphosphate; NHS-SS-Biotin, sulfosuccinirnidyl-
2-(biotinamido )ethy 1-1,3' -dithioproprionate; SDS, sodium dodecyl sulfate; DTT, 
dithiothreitol; Hepes, 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid. 
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FIGURE LEGENDS 
FIG. 1. Origin of the 2'-phosphate of tRNA Ligated by DAKC and DAC. 
Precursor tRNAPhe (pre-tRNAPhe) radiolabeled with each of four ribonucleotides was 
treated with yeast tRNA splicing endonuclease, joined by DAKC or DAC in the presence of 
unlabeled ATP, the ligated product resolved on a polyacrylamide gel, eluted, digested with 
Pl nuclease, and analyzed by thin layer chromatography (TLC). The radiolabeled PI 
nuclease-resistant dinucleotide, if any, was digested with snake venom phosphodiesterase 
(SVP) and analyzed by TLC as described in Experimental Procedures. A is a diagram of 
expected splicing and nuclease digestion products. Spliced product showing only the 
nucleotides surrounding the ligation junction is shown at the top. The products of PI 
nuclease digestion of spliced product, which are radiolabeled mononucleotides and a PI-
nuclease-resistant junction dinucleotide resulting from the presence of the 2' -phosphate, are 
shown in the middle. The products of SVP digestion of eluted PI-nuclease-resistant 
dinucleotide are 5' -adenosine monophosphate and 2' ,5' -guanosine diphosphate, and are 
shown at the bottom. * indicates those phosphates which would be radioactive in an [a-
32P]GTP-labeled substrate. ~indicates those phosphates which would be radioactive in an 
[a-32P]ATP-labeled substrate. t indicates those phosphates which would be radioactive in 
any [a-32P]NTP-labeled substrate. B shows a representative autoradiograph of tRNA 
splicing by DAKC and DAC. Pre-tRNA is pre-tRNAPhe radiolabeled with [a-32P]ATP, 
tRNA is spliced product containing a 2' -phosphate at the splice junction, and halves 
indicate unspliced tRNA halves. C is an autoradiograph of a TLC plate showing the Pl 
nuclease digestion products of tRNA spliced by DAKC or DAC. Location of unlabeled 
nucleotide markers, Pl nuclease-resistant junction dinucleotide, and origin (0) are shown 
at right. Labeled nt indicates which [a-32P]NTP was used to radiolabel the pre-tRNA. 
Those lanes containing no protein or labeled nucleotide are controls containing only carrier 
RNA and PI nuclease. Dotted circles indicate the migration of the products of Pl nuclease 
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digestion of carrier RNA. D is an autoradiograph of a TLC plate showing SVP digestion 
products of eluted dinucleotide spots from C. Appropriate markers are at left. SVP, ( + or 
-), indicates presence or absence of SVP. Solid circled spots indicate migration of 
authentic 2' ,5' -guanosine diphosphate marker visualized under ultraviolet light. 
FIG. 2. Cofactor Requirements in Splicing Reactions with DAKC and DAC. 
Splicing activity was assayed as described in Experimental Procedures. Splicing reactions 
were resolved by electrophoresis in 12% polyacrylamide, 8M urea gels and quantitated by 
measuring Cerenkov radiation in gel slices. Percent joined was calculated a ((cpm of 
spliced product)/(cpm of spliced product+ cpm of halves)) X 100. A, a representative 
autoradiograph of a splicing gel shows an ATP titration with 50 J..lg/ml (0.4 J..lM) DAKC. 
The millimolar concentration of ATP in each lane is shown at the top. The location of 
tRNA species in the reaction is shown at left: pre-tRNA, uncut precursor tRNA; tRNA, 
spliced product; halves, unjoined tRNA halves. B, the yield of spliced product in splicing 
reactions (expressed as %Joined) is plotted as a function of increasing ATP or CTP, up to 
5 mM. Symbols are: DAKC with ATP (filled circles), DAKC with CTP (open circles), 
DAC with ATP (filled squares), DAC with CTP (open squares). C,% Joined is plotted as 
a function of increasing GTP, up to 25 J..lM. Symbols are: DAKC (filled circles), DAC 
(filled squares). D, % Joined is plotted as a function of increasing UTP, up to 1 mM. 
Symbols are the same as in C. 
FIG. 3 . . Polynucleotide Kinase Activity of DAKC and DAC. Polynucleotide 
kinase activity was assayed as described in Experimental Procedures. Reaction products 
were resolved by electrophoresis in 18% polyacrylamide, 8M urea gels and quantitated by 
measuring Cerenkov radiation in gel slices. Percent phosphorylated was calculated as 
((cpm of gel-shifted kinased band)/(total cpm per lane)) X 100. A, an autoradiograph of 
the kinase gel is shown, depicting the gel-shift of RNA in an ATP titration with DAKC. 
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The micromolar concentration of A TP in each lane is shown at the top. U indicates 
unphosphorylated oligonucleotide and P indicates phosphorylated oligonucleotide. CIP, (+ 
or -), indicates whether oligonucleotide substrates were pretreated with alkaline 
phosphatase to remove 5' -phosphates before the kinase assay. DAKC indicates the 
presence of the DHFR-full-length ligase fusion protein. T4 PNK is a control lane 
containing T4 polynucleotide kinase and ATP. B, the yield in phosphorylation reactions 
(expressed as% Phosphorylated) is plotted as a function of increasing ATP or CTP, up to 
5-10 mM. Symbols are as follows: DAKC with ATP (filled circles), DAKC with CTP 
(open circles), DAC with ATP (filled squares), DAC with CTP (open squares). C,% 
Phosphorylated is plotted as a function of increasing GTP, up to 5 mM. Symbols are: 
DAKC (filled circles), DAC (filled squares). D, % Phosphorylated is plotted as a function 
of increasing UTP, up to 5 mM. Symbols are the same as in C. 
FIG. 4 . Incorporation of the y-phosphate of GTP as the Splice Junction 
Phosphate. The analyses of splicing products from reactions containing either low-
specific activity or high-specific activity [a-32P]UTP-labeled biotinylated tRNA substrate, 
either nonradioactive ATP or [y-32P]GTP, and either DAKC or DAC, are described in 
Experimental Procedures. A is an autoradiograph of the splicing reaction. Lanes labeled 
with 32P-tRNA at top contain both low-specific activity and high-specific activity pre-
tRNAPhe, nonradioactive ATP, and enzymes. Lane labeled C contains only low-specific 
activity pre-tRNAPhe, nonradioactive ATP, and enzymes. Lanes labeled y-32P-GTP 
contain only low-specific activity pre-tRNAPhe incubated in the presence of [y-32P]GTP 
and enzymes. B is a diagram depicting the expected splicing and nuclease digestion 
products. The top line represents spliced product showing only the nucleotides 
surrounding the splice junction. In the middle are the products of Pl nuclease digestion. 
At the bottom are the products of snake venom phosphodiesterase (SVP) digestion. *p 
indicates radiolabeled phosphate incorporated from they-phosphate of [y-32P]GTP. Cis 
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an autoradiograph of a thin-layer chromatography (TLC) plate showing Pl nuclease 
digestion products of eluted tRNA bands from panel A. 0 indicates the origin. Positions 
of carrier RNA digestion products and Pl nuclease-resistant junction dinucleotide are 
shown at left. Positions of radiolabeled nucleotides are shown at right. D is an 
autoradiograph of the TLC plate showing the SVP digestion product of the eluted junction 
dinucleotide from panel C. 
FIG. 5. Mechanism for tRNA Splicing in Yeast. A diagram is presented describing 
the mechanism for tRNA splicing in yeast, based on the model described in the text for the 
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SUMMARY 
We have examined multiple cofactor usage by yeast tRNA ligase in splicing in vitro. The 
ligase mechanism of action requires expenditure of two molar equivalents of nucleotide 
cofactor per mole of tRNA product. Recent evidence [Westaway, S. K., Belford, H. G., 
Apostol, B. A., Abelson, J. and Greer, C. L. (1992) J. Biol. Chern., accompanying 
manuscript] demonstrated that the ligase-associated kinase activity is more efficient with 
GTP as cofactor than with ATP. Employing a ligase fusion construct with dihydrofolate 
reductase [Apostol, B. L., Westaway, S. K., Abelson, J. and Greer, C. L. (1991) J. Biol. 
Chern. 266, 7445-7455] for purposes of enzyme purification, we performed joining 
assays demonstrating that ATP and GTP are the most effective combination of cofactors. 
ATP was essential to the joining reaction, while UTP, CTP, or ATP replaced GTP 
inefficiently. Specific and functionally independent binding sites were confirmed for ATP 
and GTP by direct binding measurement. A third site was implicated in UTP- and CTP-
ligase interactions. Comparison of binding constants with Kapp values determined for 
nucleotide-dependent joining suggested both that NTP binding may be limiting in tRNA 
joining and that tRNA ligation occurs most efficiently using GTP for the kinase reaction 
and ATP as the adenylylate synthetase cofactor. 
INTRODUCTION 
A significant number of nuclear tRNA genes from a wide range of eukaryotes contain a 
single intervening sequence (IVS) located uniformly one nucleotide downstream of the 
anticodon triplet position (Perlman et al., 1990). In the yeast, Saccharomyces cerevisiae, 
an intervening sequence is present in about 20% of the tRNA genes comprising 10 
isoaccepting families (Abelson, 1991). Penetrance is complete in that either all or none of 
the genes in a family contain an IVS. A required step in processing precursor tRNA 
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transcripts (pre-tRNAs) to functional maturity is splicing; the precise removal of the 
intervening sequence and subsequent ligation of the tRNA halves. Mutations which 
specifically prevent splicing of pre-tRNA to mature tRNA sequence are lethal (Phizicky et 
al., 1992). Thus tRNA splicing is essential and the mechanism of this reaction has been 
the subject of our research .. The focus of the present study is the ligation of tRNA half 
molecules subsequent to the removal of the IVS. 
IVS excision in yeast is accomplished by tRNA endonuclease which is a 
multisubunit, site-specific enzyme associated with the nuclear membrane (Peebles et al., 
1983; Rauhut et al., 1990). The endonuclease generates a cyclic 2',3'-phosphodiester 
bond at the 3' end of the 5' half tRNA and a 5' -OH at the 5' terminus of the 3' half tRNA 
(Peebles et al., 1983). These ends are joined by tRNA ligase which must perform three 
steps prior to the final ligation of halves (Greer et al., 1983). The cyclic phosphate bond is 
opened to a 2' -phosphomonoester. The 3' half is phosphorylated at the 5' -OH position . 
and the phosphorylated 3' half is activated by the transfer of AMP to the 5' -phosphate in a 
phosphoanhydride linkage. Subsequently the tRNA halves are joined and AMP released. 
The result is a splice junction structure with a 2' -phosphomonoester derived from the 5' 
splice site and a 3',5'-phosphodiester bond the phosphate of which derives from the 
cofactor, not from the tRNA. Inherent in this ligase reaction mechanism is a requirement 
for at least two molar equivalents of cofactor per mole of pre-tRNA spliced. The final step 
in the splicing reaction is the removal of the 2' -phosphate by an NAD+-dependent 
phosphotransferase activity recently characterized by McCraith and Phizicky (1991). 
The yeast tRNA ligase is a single polypeptide of 827 amino acids with an apparent 
molecular mass of 95 kDa containing all the enzymatic activities necessary for ligation 
(Greer et al., 1983; Phizicky et al., 1986; Westaway et al., 1988) as well as binding sites 
for tRNA substrates (Apostol and Greer, 1991). Lysine-114 has been characterized as the 
enzyme adenylylation site (Xu et al., 1990). The ligase gene is single copy and has been 
isolated (Phizicky et al., 1986) and sequenced (Westaway et al., 1988). Each ligase 
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molecule contains a single high affinity tRNA substrate binding site (Apostol and Greer, 
1991) which is complex in nature requiring the minimum combination of two or more 
elements dispersed throughout the polypeptide linear sequence (Apostol et al., 1991). 
Previous work (Apostol et al., 1991) has shown that the enzymatic domains are 
distributed within the protein sequence in a somewhat linear fashion and in accord with 
predictions made on the basis of sequence comparisons primarily with phage T4 RNA 
ligase and T4 polynucleotide kinase. Xu et al. (1990) generated proteolytic fragments of 
tRNA ligase which were shown to retain a subset of the normal enzymatic activities. 
Extending this work, Apostol et al. (1991) designed ligase gene deletions which were 
expressed in E. coli as fusions with bacterial dihydrofolate reductase (DHFR). The DHFR 
segment (D domain) was used to purify the ligase constructs by affinity chromatography 
with methotrexate agarose resin and did not affect the ligase activities measured. By 
comparing enzymatic activities of the full length ligase polypeptide (DAKC) to those of the 
deletion constructs, it was demonstrated that adenylylate synthetase activity is located 
within the amino-terminal half of the polypeptide (domain A), while cyclic 
phosphodiesterase activity is located within the carboxy-terminal quarter of the protein 
(domain C). A minimal kinase position was not so clearly delimited. The removal of any 
one of the terminal or middle regions of the ligase polypeptide significantly diminished or 
abolished kinase activity when assayed with ATP (Apostol et al., 1991). Subsequent data 
(Westaway et al., accompanying manuscript) suggested that ligase prefers to use GTP as 
cofactor in the kinase reaction over ATP by a margin of approximately 1000-fold and that 
the deletion of amino acids 396-595 (K domain; Apostol et al., 1991) does not significantly 
reduce GTP-dependent kinase activity. Indeed, a primary function of the K domain may be 
determination of protein structure and substrate specificity. A further important observation 
from this latter work was that DAKC demonstrates CTP- and UTP-dependent kinase 
activity with Kapp values intermediate between those for GTP and ATP. The novel 
inference is that ligase might bind and use multiple nucleotide triphosphate cofactors. 
143 
In this paper we have explored the potential and practicality of multiple cofactor 
usage. We employed the DAKC fusion gene construct (Apostol et al., 1991) expressed in 
E. coli as a source of full length ligase polypeptide because of the advantages of reliable 
and efficient purification of quantities of active enzyme. Joining assays were used to 
demonstrate that while ATP is essential and sufficient for joining, ATP and GTP in 
micromolar concentrations are the most effective combination of cofactors. CTP or UTP 
may also replace GTP inefficiently. Functionally independent binding sites were confirmed 
for ATP and GTP and the evidence suggests that nucleoside triphosphate (NTP) binding 
may be a rate limiting step in tRNAjoining. UTP and CTP binding characteristics suggest 
a third NTP binding site for ligase. We postulate that tRNA ligation occurs most efficiently 
using GTP for the kinase reaction and ATP as the adenylylate synthetase cofactor. 
EXPERIMENTAL PROCEDURES 
Materials----Restriction enzyme BstN1 was obtained from New England Biolabs. 
Immunopure sulfosuccinimidyl-2-(biotinamido )ethyl-1 ,3 ' -dithiopropionate (NHS-SS-
Biotin) were from Pierce. Bovine serum albumin (BSA) was obtained from BRL or ICN 
(Fraction V, BSA). T7 RNA polymerase and Ultrapure nucleotide triphosphates: ATP, 
CTP, GTP and UTP, were obtained from Pharmacia. Labeled nucleotides: [a-32P]ATP 
(3000 Ci/mmol), [a-32P]CTP (3000 Ci/mmol), [a-32P]GTP (3000 Ci/mmol), [a-
32P]UTP (3000 Ci/mmol) and [y-32P]GTP (5000 Ci/mmol), were obtained from 
Amersham. N6-(6-Aminohexyl)ATP was from BRL. Polygram CEL 300 PEl plates for 
thin layer chromatography were obtained from Brinkmann Instruments, Inc. Highly 
purified yeast tRNA endonuclease (4.8 J..lg protein/ml) was the kind gift of R. Rauhut and 
was the equivalent of the Sepharose CL-6B purified fraction (Rauhut et al., 1990). E·Y 
succinyl avidin and E·Y biotin Sephacryl S 1000™ resin were from E·Y Labs, Inc. (San 
Mateo, CA). Ultrafree-MC 30,000 NMWL and 10,000 NMWL polysulfone Type PTTK 
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filter units were obtained from Millipore. Nuclease PI was from Calbiochem and snake 
venom phosphodiesterase (SVP) was from Boehringer Mannheim. 
Strains and plasmids----Plasmid pDAKC contains the full length yeast tRNA ligase gene 
fused to the carboxyl terminus of the E. coli dihydrofolate reductase (DHFR) gene all under 
control of the E. coli tac promoter as described by Apostol et al. (1991). Plasmid ptaclO 
has the DHFR gene alone under control of the tac promoter (Normanly et al., 1986). E. 
coli strain RJ1438 [thi1leuB6 thr1 lacY! tonA21 supE44 hsdR galK illon100 (F' lacJSQ 
fzz::Tn5)], used for expression of DHFR and the DHFR-ligase fusion protein, was kindly 
provided by R. Johnson. Plasmid pUC13Phe containing the T7 promoter/pre-tRNA 
construct is described in Reyes and Abelson (1987). 
Cell growth and protein purification----RJ1438 cells transformed with pDAKC or ptaclO 
were grown, harvested, extracted, and the ligase or DHFR polypeptides purified as 
described by Westaway et al. (accompanying manuscript) . Yields were typically 0.2 mg 
per liter culture. Specific activities of the DAKC ligase varied from 700-9000 U/mg protein 
(1 Unit= 1 pmol tRNAjoined per minute; Greer et al., 1983). 
Authentic yeast ligase used in this study was a partially purified soluble fraction 
from S. cerevisiae containing 0.18 mg/ml total protein with joining activity of 1100 U/mg 
protein. 
Pre-tRNA substrate preparation----In vitro transcription with T7 RNA polymerase and 
pUC13Phe linearized with BstNI was used to generate radiolabeled pre-tRNAPhe 
transcripts of authentic sequence and mature ends (Reyes and Abelson, 1987). To yield 
precursor of high specific activity ( 4.8 X 1Q3 dpm/fmol), reactions containing 50 mM Tris-
HCl (pH 8), 10 mM MgCI2 .• 10 mM NaCl, 10 mM DTT, 0.5 mM each CTP, ATP and 
GTP, 0.01 mM UTP, 100 1-LCi [a.-32P]UTP, 4 !lg restricted plasmid template and 250 U 
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T7 RNA polymerase in 100 ).11 were incubated 60 min at 37°C. Reactions were stopped 
with the addition of0.2 mg/ml proteinase K, 0.2% SDS, 10 mM EDTA (stop mix) for 15 
min at 50°C, adjusted to 0.4 M ammonium acetate, pH 7, and precipitated with ethanol. 
RNA products were purified by acrylamide gel electrophoresis (Apostol et al., 1991). 
Preparation of biotinylated transcripts was done in two steps to yield substituted 
RNAs from which the biotin moieties could be specifically cleaved. In step 1, T7 RNA 
polymerase reactions were carried out as above except that ATP concentration was reduced 
to 250 ).lM and 250 ).lM N6-(6-Aminohexyl)ATP was added. In step 2, gel-purified, N6-
(6-Aminohexyl)ATP substituted pre-tRNA transcripts were biotinylated by reaction with 
NHS-SS-biotin (Ruby et al., 1990). Note that at this level of substitution and 
biotinylation, splicing reactions are unaffected and 55-65% of transcripts can be bound to 
avidin-agarose resin (data not shown). To produce biotiny1ated precursor of low specific 
activity (9.6 dprn/fmo1), radiolabe1ed and unlabeled UTP concentrations in the transcription 
reaction were adjusted to 10 ).lCi/100 ).11 and 0.5 mM, respectively. Biotinylated transcripts 
were purified by three repetitions of ethanol precipitation in the presence of 0.4 M 
ammonium acetate, pH 7. 
Splicing reactions----Analytical splicing reactions contained 6.2 fmol pre-tRNAPhe. 
Endonuclease fractions were dialyzed to remove (NH4hS04. In order to minimize sample 
to sample variation, as much as 124 fmol pre-tRNA were first incubated with endonuclease 
(equivalent to approximately 3 X 10-5 U/fmol pre-tRNA (Rauhut et al., 1990) or 0.15 
ng/fmol pre-tRNA in 24 mM Hepes (pH 7.5), 6 mM MgC12 , 3 mM spermidine, 0.12 mM 
DTT, 0.48% triton X-100, 30 mM NaCl, for 18-20 min at 30°C. Endonuclease-treated 
pre-tRNA (6.2 fmol in 8 ).11) was added to 1 ).11 nucleoside triphosphate (NTP: ATP, CTP, 
GTP or UTP) and 1 ).11 ligase protein extract. Ligase concentrations were chosen 
operationally as the amount of ligase necessary to join 50% of available substrate 
(approximately 3 fmol) in a 15 min, 30°C incubation with 1 mM ATP. After 15 min 
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incubation at 30°C, reactions were stopped by the additi~n of stop mix and incubation at 
50°C as described above. An equal volume of sample buffer (20% sucrose, 7 M urea, 
0.1% each xylene cyanol and bromphenol blue) was added. Products were separated on 8 
M urea, 12% polyacrylamide (ac~ylamide/bisacrylamide 30: 1) gels, visualized by 
autoradiography and quantitated by Cerenkov cpm in gel slices. 
Biotinylated pre-tRNA was used as substrate in experiments to label the splice 
junction phosphodiester bond. This use was necessary so that the specific splicing 
products of the reaction might by isolated from a background of RNAs in the DHFR-ligase 
enzyme fraction which were also labeled in the presence of [y-32P]GTP. As above, 
endonuclease was dialyzed to remove (NH4hS04 and pre-tRNAs were precut (3 ).lg 
endonuclease per rnl) in the absence of nucleoside triphosphates or ligase. Control splicing 
reactions contained 620 fmol biotinylated pre-tRNA of low specific activity and 6.2 fmol 
high specific activity biotinylated pre-tRNA. In reactions assaying incorporation of labeled 
phosphate into the splice junction, pre-tRNA of high specific activity was omitted and [y-
32P]GTP was added at 100 ).lCi/10 ).ll total reaction volume by drying the labeled GTP in 
the tube to which the joining reaction was added. Assays were joined and stopped as 
described above, adjusted to 0.4 M ammonium acetate (pH 7) and precipitated with 
ethanol. Biotinylated products were then isolated by the bridge-binding method of Ruby et 
al. (1990) using E·Y biotin-Sephacryl combined with E·Y succinyl avidin. A brief 
description follows. All operations were carried out at 4°C. Biotin Sephacryl was reacted 
with succinyl avidin 1 h. Unbound avidin was removed by washing extensively with 
binding buffer (0.2 M NaCI, 10 mM Tris-HCl, pH 7.5). Splicing reaction precipitates 
were resuspended in binding buffer, added to the avidin-biotin-Sephacryl resin (1 ).ll 
resin/10 fmol pre-tRNA), and incubated 1 h with occasional vortexing. The resin was then 
washed extensively with binding buffer to remove unbound material. RNA was eluted 
from the washed resin with 3 X 5 volumes of 150 mM DTT, 150 mM NaCl, 40 mM Tris-
acetate (pH 8.5), 3 mM MgC12. Eluted RNAs were concentrated by ethanol precipitation in 
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the presence of glycogen carrier (20 )..lg/ml). RNA precipitates were dissolved in sample 
buffer, and subjected to gel electrophoresis and quantification as described above. 
Nuclease digestion----Nuclease Pl and snake venom phosphodiesterase (SVP) reactions 
were performed essentially as described by Apostol et al. (1991). In addition to labeled 
splicing reaction products, Pl digests contained 20 mM ammonium acetate (pH 5.0), 30 )..lg 
carrier RNA and 1 U Pl nuclease in 5 )..ll. Samples were incubated 1 h at 37°C, then 
spotted on polyethyleneimine (PEl) cellulose thin layer plates and developed with 1 M 
LiCI. Digestion products were visualized by UV-shadowing and autoradiography prior to 
recovery from the PEl-cellulose by elution with triethylamine, pH 8.0 (Volckaert and Piers, 
1976). SVP reactions (10 )..ll) containing radiolabeled Pl products, 37 )..lg carrier RNA and 
2 )..lg snake venom phosphodiesterase in 25 mM Tris-HCl (pH 9), 10 mM MgC12, were 
incubated overnight at 37°C. Samples were chromatographed on PEl-cellulose in 1M LiCl 
and visualized as above. 
Nucleotide triphosphate binding experiments----All procedures were carried out on ice at 
4°C. BSA was used as a control for nonspecific binding of NTP to protein. A sample 
lacking protein was included to measure nonspecific nucleotide retention by filter units. I 
buffer (50 mM potassium phosphate (pH 8.0), 10 mM KCl, 10 mM MgC12, 0.5 mM ~­
mercaptoethanol, 3.5% glycerol) was used to dilute radiolabeled and unlabeled NTPs. F 
Buffer was used to dilute DHFR and DAKC protein fractions. [a-32P]GTP binding 
assays contained 0.58 )..lM protein and 5 )..lCi [a-32P]GTP (33 nM GTP). [a-32P]ATP, 
-CTP, and -UTP binding assays contained 2.94-8.36 )..lM protein and 10 )..lCi [a-32P]NTP 
(66 nM NTP) . Protein and radioactive nucleotide concentrations were chosen to yield 
reproducible binding measurements at least ten-fold over background BSNNTP binding. 
Unlabeled NTP was added in increasing concentration up to 10 mM. Binding assays were 
executed as follows. Sequentially, 10 )..ll DAKC, DHFR, or BSA were mixed with 30 )..ll I 
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Buffer. [a-32P]NTP alone or with unlabeled NTP was mixed with I buffer in a volume of 
lO 1.1.1. The protein-! buffer dilution was added to the NTP tube, and rapidly mixed by 
pipetting up and down. Immediately, the mixture was transferred to prechilled Ultrafree-
MC filter units and centrifuged in an Eppendorf microfuge at 15,600 x g. 30,000 NMWL 
filters were centrifuged 15 min for NTP-ligase binding experiments; 10,000 NMWL filters 
used for NTP-DHFR binding assays required 40 min centrifugation. Filter units and 
filtrates were assayed for Cerenkov cpm. Binding is expressed as the dpm bound minus 
background with background defined as dpm retained by the filter in the presence of BSA. 
RESULTS 
The ligation of tRNA halves generated by tRNA endoimclease cleavage includes two steps 
requiring the expenditure of high energy equivalents. The 3' half must be sequentially 
phosphorylated and then activated by the addition of AMP through an adenylylated enzyme 
intermediate. Previous work demonstrated that the yeast tRNA ligase fusion polypeptide, 
DAKC, is able to kinase 3' tRNA halves using GTP as cofactor (Westaway et al., 
accompanying manuscript). GTP was, in fact, the preferred phosphate donor over ATP, 
CTP, and UTP by a ratio of 100-fold or greater in experiments measuring DAKC kinase 
activity on a synthetic oligonucleotide substrate. However, the DAKC polypeptide was 
unable to complete the tRNA joining reaction in the presence of GTP alone. This finding 
suggests that GTP cannot be used for activation of the phosphorylated 3' -half as this is the 
only other ligase activity requisite to joining requiring a high energy cofactor. 
Adenylylation of tRNA ligase has been demonstrated (Greer et al., 1983; Xu et al., 
1990) and AMP transfer to the kinased 3 '-half tRNA molecule has been postulated to 
activate the 3' -half prior to joining in reactions dependent solely on ATP (Greer et al., 1983; 
Phizicky et al., 1986). To determine whether A TP could be used to complete the joining of 
halves kinased by GTP, splicing reactions were carried out in the presence of [y-32P]GTP 
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in concert with unlabeled ATP. Radiolabeled reaction products were then analyzed to 
determine the position of 32P-incorporation. The results are shown in Fig. 1 and suggest 
that ATP is, indeed, necessary and sufficient to complete the joining of halves 
phosphorylated with they-phosphate of GTP. Fig. lA shows an autoradiogram of splicing 
products prepared and separated by polyacrylamide gel electrophoresis as described in 
Experimental Procedures. The first three lanes, labeled 32P-tRNA, show control reactions 
in which precursor of high specific activity was included and splicing carried out in the 
presence or absence ofDAKC and nonradioactive GTP and ATP as indicated. Note that as 
previously observed (Westaway et al., accompanying manuscript), no spliced tRNA is 
formed with DAKC and GTP alone. Lanes 5 and 6 contain only precursor of low specific 
activity spliced in the presence of [y-32P]GTP with or without unlabeled ATP. In the 
absence of ATP, only RNA species in the halves area of the gel become radiolabeled while, 
in the presence of ATP, 32P-labeled species are also observed in the position of joined 
product. That the source of labeled phosphate is the [y-32P]GTP is demonstrated by 
comparison of lanes 5 and 6 with lane 4 containing pre-tRNA of low specific activity 
spliced with unlabeled GTP and ATP, without labeled NTP. 
If ATP were used to complete joining of 3' -halves phosphorylated by DAKC using 
32P-GTP, the splice junction of that tRNA would contain a 32P-labeled 3' ,5' splice 
junction phosphate and an unlabeled 2' -phosphate (originating from the 5' splice site). As 
described in Fig. IB, this splice junction structure is resistant to PI nuclease and can be 
isolated as a dinucleotide. The dinucleotide can then be analyzed for labeled phosphate 
position by SVP digestion. The [y-32P]GTP-labeled halves and tRNA bands shown in 
Fig. lA were thus eluted and characterized by sequential digestion with Pl nuclease and 
SVP as described in Experimental Procedures. The results are given in Fig. IC and D. Pl 
nuclease digestion of tRNA halves. resulted in labeled 5' -AMP as expected if the y-32p of 
GTP were used to phosphorylate the 5' -OH of the 3' -half tRNA. Pl nuclease digestion of 
RNA eluted from the spliced tRNA area of the polyacrylamide gel (IA) yielded a labeled 
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species migrating close to the origin on TLC plates as expected of a PI-resistant 
dinucleotide. SVP digestion of this dinucleotide yielded labeled 5' -AMP thereby 
confirming that not only was they-phosphate of GTP used by DAKC to kinase the 5' -OH 
position of the 3' -half tRNA; but that in the presence of ATP, the ligase could complete 
joining of such kinased halves in the normal fashion. These results suggest that ATP was 
used to adenylylate the ligase whlch then activated the kinased 3' -half and resulted in joined 
product with a splice junction 2'-phosphomonoester, 3' -5'-(32P)-phosphodiester bond. 
The important implication here is that multiple cofactor usage is permitted by the ligase. 
The pursuant question is whether multiple cofactor use is preferred. 
To examine the efficacy of multiple cofactor usage, joining reactions were carried 
out with pair-wise combinations of nucleotides. In the presence of a limiting concentration 
of either ATP or GTP, an increasing concentration of ATP, CTP, GTP or UTP was added 
to the joining assays. CTP and UTP were included in this titration series for two reasons. 
First, UTP and CTP were each previously shown to support kinase activity with the 
DAKC ligase. Secondly, UTP, like GTP, was demonstrated to allow the complete joining 
reaction with the deletion polypeptide DAC (although UTP use was not as efficient as GTP 
by approximately 250-fold; Westaway et al., accompanying manuscript). Therefore it was 
of interest to investigate the potential for stimulation of single nucleotide joining by CTP or 
UTP as well as by A TP and GTP. 
The results of joining assays performed with two nucleotides are given in Figure 2. 2A 
shows an autoradiograph of pre-tRNA halves joined by DAKC in the presence of limiting 
amounts of ATP (1 0 J.!M) and an increasing concentration of GTP as indicated. As 
previously determined (Westaway et al., accompanying manuscript), DAKC ligase joined 
halves with ATP as the sole cofactor; half maximal joining activity occurred at 0.9 mM 
ATP (KappATP). Thus with limiting ATP (10 J.!M), a limited amount of joining (21 %; Fig. 
2A) was observed. The joining yield at this limiting ATP concentration was augmented 
with the addition of GTP over the range of 0.01 J.!M to 500 J.!M. At higher concentrations 
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of GTP, the joining yield fell away (data not shown). This decline, which was observed 
with high concentrations of each of the four NTPs, may simply reflect an inhibition of the 
joining reaction due to increasing ionic strength or chelation of Mg2+ by nucleoside 
triphosphates and will not be discussed further. Experiments similar to that shown in Fig. 
2A were performed for each nucleotide pair. Figure 2B is a graph of data for joining in the 
presence of limiting ATP concentrations with increasing concentrations of GTP added. 
Fig. 2C shows data for joining in the presence of limiting GTP concentration in 
conjunction with increasing ATP concentrations, while Fig. 2D summarizes joining data 
obtained in the presence of a limiting level of either ATP or GTP together with increasing 
concentrations of CTP or UTP. No joining was supported by GTP, UTP, or CTP alone 
(data not shown; also Westaway et al., accompanying manuscript), or GTP in concert with 
UTP or CTP (Fig. 2C). GTP-dependent joining was enhanced only by the addition of 
ATP (Fig. 2C). Conversely, increasing concentrations of GTP, UTP and CTP stimulated 
ATP-dependentjoining (Fig. 2B and D). 
In Fig. 2B and C, joining curves are shown for two concentrations of DAKC 
ligase, 0.02 nM and 0.08 nM. The effect of the quadrupled enzyme concentration was to 
raise the maximum percent of substrate joined while the NTP concentration at which half 
maximal stimulation of joining occurs (Kapp) remained unchanged. This is the result 
expected if reaction rates, rather than extents, are being measured as expected in this assay. 
Kapp values were determined as the average Kapp derived from 2-4 experiments and are 
summarized in Table 1. The measured KappGTP (derived from GTP stimulation of ATP 
joining) was 0.8 ).1M GTP. KappATP (derived from A TP stimulation of GTP joining) was 2 
).1M ATP. CTP and UTP stimulation of ATP joining required significantly higher 
concentrations of second nucleotide to enhance the reaction. Kapp measured for CTP was 
0.2 mM , while Kapp for UTP was 0.1 mM. 
Joining data with authentic yeast ligase is included for comparison with DAKC 
ligase activity in Fig. 2B and C. Reaction extents vary, probably reflecting variations in the 
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concentration of active enzyme as observed with DAKC. However, the Kapp values for 
ATP and GTP with authentic yeast ligase, 4 J.tM ATP and 0.4 J.tM GTP, closely match the 
values obtained with the DAKC ligase (2 J.tM and 0.8 J.tM, respectively). Since joining is 
the composite of its individual enzymatic activities, these similar Kapp values suggest that 
activity measurements with DAKC provide a valid picture of the authentic yeast ligase 
mechanism and further support the previous observation (Apostol et al., 1991) that the 
DHFR segment does not substantially interfere with the measured ligase properties of the 
fusion polypeptide. 
The interaction of multiple cofactors with ligase might reflect a differential ability 
either to bind each cofactor or, once bound, to use a given cofactor in the kinase reaction or 
in the activation of the 3' -half tRNA, or a combination thereof. Furthermore, nucleotide 
binding might involve interaction at more than one binding site, each with unique NTP-
specific affinity. Therefore, nucleotide binding to DAKC ligase was examined in order to 
determine the multiplicity and specificity of binding sites on the enzyme. Increasing 
amounts of unlabeled NTP were mixed with constant amounts of DAKC ligase and [a-
32P]NTP such that the molar concentration of labeled NTP was significantly below the 
concentration of DAKC (33-67 nM NTP versus 0.53.-2.65 J.tM DAKC ligase). NTP 
binding was measured as the retention of radioactivity by 30,000 molecular weight cutoff 
filters in the presence of DAKC ligase as described in Experimental Procedures. BSA was 
used as a control for nonspecific NTP/protein binding and showed no significant increase 
in filter retention of 32P-NTP over the no protein control. In order to assure that nucleotide 
binding measurements were dependent on the ligase moiety of the fusion protein, DHFR 
was also examined for nucleotide binding and showed no increase over the no protein or 
BSA controls. At the DAKC protein concentrations practically available for the binding 
assays, no significant binding of CTP or UTP was detected. Binding of labeled ATP and 
GTP was readily observed and could be reduced by the addition of unlabeled nucleotide to 
the reaction. 
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Binding reduction curves are shown Fig. 3; 3A presents the results with (a-
32P]ATP, 3B with (a;-32P]GTP. The unlabeled NTP concentration at which labeled NTP 
binding is reduced 50% is a measure of the affinity of the unlabeled NTP for the binding 
pocket of the labeled NTP or, conversely, a measure of the dissociation of the labeled 
NTP. Kv is the dissociation constant used to describe the self reaction, e.g., 32P-ATP 
binding reduced by the addition of unlabeled ATP. KvC is the constant used for the 
heterologous reaction, e.g., 32P-ATP with unlabeled GTP. In the circumstance of these 
experiments wherein the concentration of labeled nucleotide is very much less than its Kv 
for DAKC ligase, Kvc is equivalent to an IC50 value (inhibitor concentration reducing the 
amount of bound label by 50%). Thus the 50% reduction in labeled GTP binding by 
unlabeled GTP at a concentration of 0.1 J.LM indicates a Kv of 0.1 J.LM, while the 50% 
reduction by unlabeled ATP at a concentration of 1 mM suggests a Kvc (IC50) of 1 mM 
ATP for the GTP binding site. Conversely, the 50% reduction in labeled ATP binding 
requires 4 J.LM A TP or 5 mM GTP; a Kv of 4 J.LM and a Kvc of 5 mM, respectively, for the 
ATP site. Binding Kv and Kvc values were determined as the average from 2-6 
experiments and are summarized in Table 1. 
It might be argued that NTP binding by ligase would differ in the presence of tRNA 
substrate. The conformation of the ligase polypeptide would necessarily be restricted by 
binding to tRNA since it has been suggested that, although a ligase molecule contains only 
one high affinity tRNA binding site (Apostol and Greer, 1991), widely separated areas of 
the ligase linear sequence participate in that substrate binding (Apostol et al., 1991). Thus 
when ligase is structurally confined in its substrate bound form, access to nucleotide 
binding sites might be specifically enhanced or restricted. Binding experiments were 
therefore carried out in the presence of tRNA. Binding assays were performed as 
described in Experimental Procedures with the addition of yeast tRNAPhe (Sigma) to the 
DAKC-binding buffer mix in molar concentration equal to DAKC. (At this concentration 
the tRNA is approximately 500- to 2500-fold above its measured affinity for yeast ligase; 
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Apostol and Greer, 1991 ). No significant changes in KD or KDC values were observed for 
GTP or ATP binding in the presence of tRNAPhe (data not shown) suggesting that NTP 
binding sites are either insensitive to conformational change induced by substrate binding 
or that no conformational change is induced. This finding is consistent with expectations 
based on the similarity of KD values, determined in the absence of tRNA, with Kapp values 
measured for ATP and GTP in the 2-nucleotide joining assays. 
DISCUSSION 
The data presented here suggest that yeast tRNA ligase joins tRNA halves most efficiently 
in the presence of multiple nucleotide cofactors. The results are summarized in Table 1 
together with Kapp values derived from single nucleotide joining assays and kinase assays 
presented previously (Westaway et al., accompanying manuscript). The results of the two 
nucleotide joining assays suggest that while A TP is the only cofactor absolutely necessary 
for joining with tRNA ligase, multiple cofactor usage results in more efficient joining with 
respect to cofactor concentrations required. The best combination is ATP plus GTP. 
Joining with ATP as the sole cofactor requires ATP concentrations approximately 500-fold 
higher than when joining occurs in the presence of micromolar concentrations of GTP. 
That is, the Kapp for A TP as the only joining cofactor is 0.9 mM, while the Kapp values for 
ATP and GTP in mixed cofactor reactions are 2 flM and 0.8 f.tM, respectively. CTP and 
UTP also stimulate ATP-dependentjoining though less dramatically, with Kapp values 100-
to 200-fold greater than for GTP. Earlier work suggesting that ligase could join at least 
inefficiently using GTP, CTP or UTP alone, recognized interpretation of that data was 
limited by use of a partially purified ligase extract as well as by use of nucleotides of 
qualified purity (Greer et al., 1983). Given the micromolar amounts of GTP and ATP 
contaminants which would be required to stimulate joining, the results of this previous 
work are not inconsistent with our present observations. 
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In order to participate in the varied ligase activities, the cofactor must bind to the 
enzyme or substrate. Comparison of KD with KDC values indicates that GTP binds 
strongly and specifically to a GTP binding site. Likewise ATP binds tightly and 
specifically to an ATP binding site. Moreover UTP and CTP are equally poor at reducing 
specific nucleotide binding, requiring millimolar concentrations. This would suggest that 
ATP and GTP binding sites are not only preferential with respect to nucleotide use, but are 
operationally exclusive given the thousand-fold (or greater) difference in KD and KDC 
values. It is difficult to interpret what effect these NTP specificities may have in vivo. 
Only limited information on NTP concentration in either the whole cell or the nucleus is 
available. Compartmentation within the nucleus could also affect nucleotide pools available 
to the ligase. It is, however, interesting to note that relative estimates of nucleotide levels 
place the cellular GTP concentration approximately four to eight-fold below the ATP 
concentration (Burridge et al., 1977). This order of magnitude difference parallels the 
order of magnitude difference observed in KD values for ATP and GTP binding to ligase. 
KD values for A TP and GTP binding match the Kapp values determined for ATP 
and GTP stimulation of joining in the presence of both nucleotides. Also as previously 
noted, the KD for GTP binding matches well with the Kapp for GTP in the kinase assay 
(Table 1). These similar values suggest that nucleotide binding to DAKC might be a 
limiting step for joining under these reaction conditions. The comparison of KD and KDC 
values for ATP or for GTP also suggests indirectly that GTP and ATP binding are 
independent events. That is, the presence of the second nucleotide does not influence the 
binding characteristics of the first as measured by the Kapp for that nucleotide in joining 
stimulation assay. If binding of one nucleotide facilitated (or inhibited) binding of the 
second nucleotide, Kapp values derived from 2-nucleotide joining assays should be lower 
(higher) than the corresponding KD value. Since the KD and Kapp values are approximately 
equal within the error of the assays, independent binding events are implied. 
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The similarity of the ATP Kapp determined for single nucleotide joining, 0.9 mM, 
and the KDC of ATP for the GTP binding site, 1 mM, suggests that when ATP is used for 
the kinase activity, it may be bound at the GTP site rather than at the ATP binding site. 
This is in contrast to the mechanism of action suggested for GTP use by the DAKC 
deletion derivative DAC (Westaway et al., accompanying manuscript). DAC can complete 
joining using only GTP as cofactor with an observed Kapp for GTP of 0.4 JlM. The 
similarity of this Kapp with both the DAKC KD for GTP binding (0.15 JlM) and Kapp for 
GTP-dependent kinase activity (0.25 JlM) is consistent with the idea that GTP binds to the 
GTP-specific site of DAC and then is used by both the kinase and adenylylate synthetase 
activities to complete the joining of tRNA halves. The comparison of DAKC and DAC 
results also suggests that the K domain (amino acids 396-595) not only influences tRNA 
substrate recognition (Westaway et al., accompanying manuscript), but also may mediate 
the transfer of bound cofactor to the active sites for the adeny1ylate synthetase and/or kinase 
activities. 
The fact that the Kapp values for GTP, CTP, and UTP stimulation of ATP-dependent 
joining closely parallel the Kapp measurements for kinase activity, suggests that the joining 
stimulation reflects the ligase enzyme ability to use each of the four nucleotides in the 
kinase step; GTP>>UTP>CTP>ATP. GTP, CTP, and UTP do not allow joining in the 
absence of A TP despite the demonstrated ability of these nucleotides to bind the ATP site at 
high concentrations. These results are consistent with the hypothesis that only ATP can 
successfully complete the adenylylate synthetase reaction (Westaway et al., accompanying 
manuscript) and further suggest that cofactor discrimination by the adenylylate synthetase 
activity occurs at a step subsequent to NTP binding at the ATP site. 
Comparison of the UTP and CTP binding and displacement data with UTP and 
CTP kinase and two-nucleotide joining data suggests that DAKC ligase may have a third 
nucleotide binding site which can interact with the kinase active site. The Kapp values for 
the stimulation of ATP-dependent joining reasonably match the kinase Kapp values which 
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might suggest that the UTP and CTP cofactors enhance ATP-joining by serving as kinase 
activity cofactors. However, the results of binding displacement assays suggest that UTP 
and CTP do not bind to the GTP (or ATP) binding site except with extremely low affinity. 
Thus, in order to reconcile binding displacement data with joining stimulation and kinase 
data, it is reasonable to invoke a minimum of three distinct NTP binding sites for the 
DAKC ligase molecule. More than three sites are possible, but further experiments must be 
done to assay UTP and CTP binding to DAKC directly. Based on existing data for 
nucleotide usage it is predicted that 20-60 ).lM protein would be required to measure UTP 
or CTP binding to DAKC ligase reliably, while the highest molarity obtained for use in the 
current work was 8.3 ).lM. 
In summary, Figure 4 presents a model for the interaction of cofactors with the 
nucleotide binding and enzyme active sites in yeast tRNA ligase. ATP binds and is used in 
the adenylylate synthetase reaction. GTP or ATP may bind at the GTP binding site, or 
UTP or CTP binds at a third NTP site, and subsequently are channeled to the kinase active 
site. GTP use is preferred in the kinase reaction The use of multiple cofactors by ligase 
may have important implications for integration of events in tRNA biosynthesis. In vivo, 
this requirement may effectively couple pre-tRNA splicing to the nucleotide requirements 
for transcription and/or translation increasing sensitivity and response to changes in 
intracellular environment. To assess the degree of interdependence among processes will 
require the identification of the ligase site of action within the nucleus as well as the ability 
to measure local levels of nucleotide concentrations. 
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FIGURE LEGENDS 
FIG. 1. Labeling the splice junction phosphodiester bond with [y- 32P]GTP. 
A. Biotinylated pre-tRNAPhe (620 fmol, 9.6 dpm/fmol) was cut with tRNA endonuclease, 
subsequently incubated with a combination of the DAKC ligase, GTP and ATP. Products 
were resolved by polyacrylamide gel electrophoresis and visualized by autoradiography as 
described in Experimental Procedures. From the left, lanes 1-3 also contained 6.2 fmol 
pre-tRNA of high specific activity (4.8 x 103 dprn/fmol). The mobilities of pre-tRNA 
substrate, halves produced by endonuclease cleavage and spliced tRNA product are 
indicated at left edge. Lane 4 contained only low specific activity substrate incubated with 
DAKC, GTP and ATP. The final lanes contained low specific activity substrate and a 
combination ofDAKC, ATP and [y-32P]GTP (5000 Ci/mmol; 100 11Ci/assay, equivalent to 
211M GTP in the assay) as specified. With the exception of reactions containing pre-tRNA 
of high specific activity, splicing products were purified prior to electrophoresis by binding 
to avidin affinity resin as described in Experimental Procedures. B. Schematic of the 
tRN APhe splice junction structure and nuclease digestion products. Shown are the 2'-
phosphate and 3' ,5' -phosphodiester bond and the digestion products expected with Pl 
nuclease and SVP. The asterisk indicates 32P-label position. C. Pl nuclease analysis of 
32P-labeled tRNA (A, lane 6) and halves (A, lanes 5 and 6). D. SVP analysis of the tRNA 
P1 digestion product (C, tRNA). RNAs were eluted, digested, chromatographed, and 
visualized by autoradiography and UV -shadowing as described in Experimental 
Procedures. Dotted lines show the position of unlabeled nucleotide monophosphate and 
diphosphate digestion products. The position of the labeled junction is also indicated. 
FIG. 2. Effects of combined cofactor use in tRNA joining. A. Autoradiograph of 
a joining titration. Each joining assay contained 6.2 fmol pre-tRNA, 10 11M ATP, 0.4 11M 
DAKC ligase, and 0-500 11M GTP as described in Experimental Procedures and indicated 
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in the figure. The position of pre-tRNA, tRNA halves and mature tRNA product are 
indicated on the left. B. GTP stimulation of ATP-dependent joining. Joining assays like 
that shown in A were quantitated by Cerenkov cpm in gel slices. % Joined was determined 
as [CPM tRNA/(CPM tRNA + CPM halves)] x 100; joining due to the presence of ATP 
alone has not been subtracted. Reactions contained GTP as specified, and 10 J.lM A TP and 
0.02 nM DAKC (squares), 2 J.lM ATP and 0.08 nM DAKC (circles), or 10 J.lM ATP and 
1.9 nM yeast ligase (triangles). C. ATP stimulation ofGTP-dependentjoining. Reactions 
contained ATP as specified, 1 J.lM GTP and 0.02 nM DAKC (squares), 0.08 nM DAKC 
(circles), or 1.9 nM yeast ligase (triangles). D. CTP and UTP stimulation of ATP- or 
GTP-dependent joining. Titrations contained the following; filled circles, varied CTP 
concentration, 10 J.lM ATP, and 0.04 nM DAKC;filled squares, varied UTP, 10 J.lM ATP, 
0.14 nM DAKC; open circles, varied CTP, 1 mM GTP, 0.02 nM DAKC; open squares, 
varied UTP, 1 mM GTP, 0.14 nM DAKC. Background cpm in gel slices have not been 
subtracted and account for initial apparent low levels of joining in the absence of ATP. 
Solid lines in panels B, C, and D were generated by nonlinear regression analysis of the 
data using SigmaPlot™ (Jandel Corp.). 
FIG. 3. Nucleotide triphosphate binding by DAKC ligase. Binding experiments 
were performed as described in Experimental Procedures. Bound NTP was calculated as 
dpm retained by filters in the presence of DAKC minus the background dpm retained in the 
presence of BSA. Bound dpm is plotted versus increasing concentration of nonradioactive 
NTP competitor added. Panel A shows the reduction of bound [a-32P]ATP by unlabeled 
ATP (filled circles), GTP (hollow circles), UTP (filled squares), or CTP (hollow squares) . 
The inset graph expands the scale for the [a-32P]ATP versus ATP curve in the J.lM range. 
Panel B shows the reduction of bound [a-32P]GTP by increasing addition of unlabeled 
GTP (filled circles), ATP (hollow circles), UTP (filled squares) and CTP (hollow 
squares) . Inset graph expands the [a-32P]GTP versus GTP curve in the J.lM range. Solid 
162 
lines in panels A and B represent curves generated by nonlinear regression analysis of the 
data using SigmaPlot™ (Jande! Corp.) . 
FIG. 4. Model for interactions among nucleotide binding and enzyme active 
sites in tRNA ligase. Bold arrows indicate preferred interactions; dotted arrows, 
interactions prevented by the presence of amino acids 397-595. Symbols are C, the cyclic 
phosphodiesterase active site; Ad, the adenylylate synthetase active site; K, the kinase 
active site. Nucleotide binding sites are indicated as boxes. 
lbj 
TABLE I 
Summary of activity and binding constants 
Activity Assaya ATP GTP UTP CTP 
Joiningb 900 J.tM 0 0 0 
Joining with constant 2J.tM N/Ad 0 0 
GTPb 
Joining with constant N/Ad 0.8 J.tM 0.1 0.2 
ATPb mM rnM 
Kinaseb 200 J.tM 0.25 J.tM 25 J.tM 60 J.tM 
NTP Bindingc, 4J.tM 5 mM 7mM 3 mM 
*ATP 
NTP Bindingc, lmM 0.15 J.tM 2 mM 6mM 
*GTP 
aLigase enzymatic activity assays were performed as described in Experimental 
Procedures with the exceptions of single nucleotide-dependent joining and kinase assays 
which were reported elsewhere (Westaway et al., accompanying paper) and 
summarized here. Data were analyzed by nonlinear regression using SigmaPlot™ 
(Jandel Corp.). 
bResults shown for joining and kinase reactions are Kapp values. 
cvalues shown for NTP binding assays are binding constants (Kv, KvC) determined as 
the reduction of bound radiolabelled A TP or GTP (indicated by *) by added unlabelled 
NTP as specified. 


































































































































































































































































(J) a...~ <! <! Q.) 
.-::i.. z z > -<..9...__ 0::: 0::: 0 
+- +- ..c I . Q.) 




0 0 0 0 0 0 0 0 














0 0 0 0 0 0 0 0 0 









• • lO . 0 
~ 
~ 












0 0 0 0 0 
l't') N ....... 
• 
0 pau1or % 
Figure 2D 
CD ""'t C'ol 0 
punos 
• 
169 
0 
I") 
......... 
0~ 
C'ol ::J 
.......... 
oa... 
I-..... < 
0 
punos 
Figure 3A 
N 
._.. 
lO 
0 
0 
.......-.. 
~ 
E 
'-' 
0.... 
r-
z 
170 
("'I -~ 
:::J -..-a.. 
1-
(!) 
0 
0 
punos 
• 
m punos 
Figure 3B 
N 
..--
(!) 
0 
0 
............... 
~ 
E 
"-"' 
a... 
1-
z 
171 
A 
c 
c 
Figure 4 
